data_6o6w_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6o6w _Structure_validation_residue.Date_analyzed 2019-11-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 120.892 0.288 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.1 m170 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.393 0.14 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 CA-C-O 120.654 0.189 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.5 1.876 0 N-CA-C 111.432 -0.257 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.9 t0 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.502 2.014 0 N-CA-C 111.502 -0.23 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.5 1.887 0 CA-C-O 120.754 0.231 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.502 2.012 0 CA-C-O 120.843 0.268 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 CA-C-O 120.885 0.286 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.5 1.893 0 CA-C-O 120.834 0.264 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.9 m170 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.503 2.037 0 CA-C-O 120.569 0.154 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.577 0.227 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.505 2.197 0 CA-C-O 120.939 0.308 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.502 2.018 0 CA-C-O 120.754 0.231 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 m170 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 N--CA 1.504 2.089 0 CA-C-O 120.657 0.19 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.427 0.156 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.502 1.991 0 N-CA-C 111.43 -0.258 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 N--CA 1.507 2.318 0 N-CA-C 111.512 -0.226 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.5 1.864 0 CA-C-O 120.79 0.246 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 111.404 -0.268 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.504 2.124 0 CA-C-O 120.552 0.147 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.1 t0 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.498 1.773 0 CA-C-O 120.773 0.239 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.501 1.959 0 N-CA-C 111.592 -0.195 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.505 2.174 0 N-CA-C 111.222 -0.338 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -133.87 124.03 25.76 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.69 0.281 . . . . 0.0 110.866 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -133.49 148.67 51.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.42 165.45 54.8 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 82.2 p -128.38 158.81 37.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.682 0.277 . . . . 0.0 110.855 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.47 127.89 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.17 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -127.16 148.74 50.17 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.665 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -128.44 88.93 51.09 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.435 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.83 151.15 62.72 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.148 1.899 . . . . 0.0 112.247 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.1 m170 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.04 147.05 28.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.85 138.21 48.71 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.169 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -107.95 112.07 24.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.888 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 49.0 -85.24 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.812 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -115.38 23.34 12.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -123.0 144.55 49.18 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.109 0.481 . . . . 0.0 111.644 -176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 t -72.1 145.88 47.89 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.273 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -77.01 162.15 27.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -56.94 129.25 40.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.3 p -161.9 169.09 21.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.772 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 58.93 75.24 0.41 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.985 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 71.6 p -112.58 14.35 20.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.052 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -145.98 142.96 29.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.306 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.673 179.695 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -128.58 158.12 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 111.01 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.79 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.446 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 -167.55 43.02 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -125.21 155.46 40.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.598 0.237 . . . . 0.0 110.69 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.17 160.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.171 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 t -148.61 149.51 31.66 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.38 82.2 66.4 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.659 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.11 148.39 89.59 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.338 2.025 . . . . 0.0 111.782 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.14 40.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -63.44 104.55 0.64 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -113.69 107.36 15.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 45.92 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -91.44 0.78 57.47 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -115.03 139.06 50.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.454 0.169 . . . . 0.0 110.707 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -83.83 162.73 20.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -90.56 115.38 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.177 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.09 142.45 57.56 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 99.3 p -141.88 161.67 37.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -87.22 123.57 32.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.875 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 91.5 m -126.85 119.72 27.49 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -157.53 147.29 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.782 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.765 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -63.22 -23.02 67.24 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -142.92 153.67 43.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.663 0.268 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.21 -148.38 9.08 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -149.63 176.07 10.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.215 . . . . 0.0 110.522 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.91 -43.11 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.145 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.7 m 57.74 47.33 15.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.709 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.8 76.7 28.91 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.22 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.42 155.98 67.49 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.0 1.8 . . . . 0.0 111.432 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.83 141.97 31.88 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.82 134.24 56.7 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.585 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.72 126.71 30.25 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 63.21 -80.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.417 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -144.63 3.34 1.12 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -139.64 161.71 36.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.668 0.27 . . . . 0.0 111.707 -177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 p 84.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.67 0.788 . . . . 0.0 112.717 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -88.24 115.0 25.41 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.49 136.78 58.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.0 p -137.56 -39.04 0.58 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -61.12 -45.4 94.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.015 0.197 . . . . 0.0 111.492 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.2 t 178.72 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.203 0.525 . . . . 0.0 110.15 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -63.0 -40.48 97.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.963 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.922 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -61.15 -43.86 98.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.669 0.271 . . . . 0.0 110.639 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -151.47 153.87 35.46 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.089 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.49 177.66 40.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.3 m -121.26 120.51 35.35 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.53 155.67 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.08 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -132.35 148.34 52.42 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.391 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -133.61 65.13 70.64 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.852 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.38 145.3 98.36 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.258 1.972 . . . . 0.0 111.502 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.4 148.35 28.28 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.96 131.69 31.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.84 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -87.05 127.84 35.1 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.865 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 66.39 -77.06 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 mtp-105 -135.8 -16.27 1.75 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -148.06 174.57 11.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p 95.63 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.535 1.134 . . . . 0.0 112.856 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -84.37 114.95 22.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.999 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.01 139.96 58.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.71 14.51 1.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -137.42 125.84 23.43 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-O 120.545 0.212 . . . . 0.0 110.813 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.0 m -137.87 106.24 5.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.94 154.16 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.879 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 t 69.41 -67.38 0.22 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.589 0.356 . . . . 0.0 111.654 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -59.59 -45.05 93.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.224 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.11 149.29 21.26 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 p -134.66 158.92 42.83 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.515 0.197 . . . . 0.0 110.71 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.85 149.21 31.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.501 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -162.37 164.03 27.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.87 68.83 81.26 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 147.1 57.36 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.099 1.866 . . . . 0.0 112.067 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.31 140.63 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.85 132.52 54.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 111.688 -178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -113.36 171.03 7.81 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.709 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.58 -39.17 70.34 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -106.75 6.32 29.52 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -131.73 146.84 52.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.73 0.3 . . . . 0.0 111.403 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.7 p -89.39 166.23 13.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.542 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -90.2 115.35 27.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.593 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.82 139.49 58.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -62.21 -39.99 94.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -123.83 136.59 54.48 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -99.47 15.47 26.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -58.29 131.26 50.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.968 -178.23 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -151.77 161.58 42.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.75 146.06 25.83 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.894 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 159.31 53.89 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -148.64 153.43 38.29 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.696 0.284 . . . . 0.0 111.433 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.78 159.82 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -117.16 125.86 51.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -108.98 119.22 49.49 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 156.25 61.98 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.991 1.794 . . . . 0.0 111.989 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 136.58 34.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.77 135.1 57.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.234 0.54 . . . . 0.0 111.265 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -111.06 170.03 8.38 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.805 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.17 -39.11 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.52 3.57 27.24 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -130.43 146.3 51.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.744 0.307 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -85.92 165.15 17.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.422 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -85.92 115.81 23.77 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.344 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.91 137.31 47.31 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.6 t -153.07 145.01 23.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 111.524 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 -23.99 5.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.339 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 p -124.38 37.12 4.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.085 0.469 . . . . 0.0 111.034 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.4 -42.0 90.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.98 179.765 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -70.8 -14.32 62.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -141.04 158.22 44.24 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 120.61 0.243 . . . . 0.0 111.088 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.06 48.04 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.6 p -116.91 21.27 13.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t 68.93 65.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.415 0.626 . . . . 0.0 110.087 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -62.02 -40.45 95.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 69.58 81.23 0.2 Allowed Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.536 2.157 . . . . 0.0 112.693 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.36 146.09 29.56 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -55.58 135.73 50.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.415 0.447 . . . . 0.0 110.433 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -82.81 124.54 30.39 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.027 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 71.48 -55.9 0.65 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 123.963 0.789 . . . . 0.0 112.049 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 4.5 ptp85 -164.42 -7.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 174.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -142.4 176.8 8.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.869 -176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t 71.88 49.87 0.25 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.603 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -90.44 115.92 27.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.626 176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.88 138.55 57.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.5 p -154.54 162.13 41.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -95.57 124.59 39.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 78.8 m -124.96 120.92 32.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -154.78 141.14 18.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.983 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.1 p -152.42 159.55 43.38 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.578 0.228 . . . . 0.0 110.804 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -118.5 -47.23 2.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.07 170.7 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -135.57 163.74 29.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.282 0.233 . . . . 0.0 110.47 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.45 149.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.128 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.2 m -136.32 155.35 50.19 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -127.7 66.95 71.93 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.8 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.4 151.99 71.15 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.248 1.965 . . . . 0.0 112.059 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.9 m170 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.72 34.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -67.01 130.18 42.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.231 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.9 169.01 9.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.883 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -38.04 70.1 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -99.68 5.58 45.74 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.052 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -131.13 175.51 9.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.6 p -124.46 156.15 37.7 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.187 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -85.55 118.09 24.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.552 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -57.1 132.96 54.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.3 m -108.13 -63.6 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.809 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.43 155.34 30.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.624 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.2 p -131.98 33.96 3.88 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.167 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.71 -51.85 67.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.659 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 pp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.631 179.04 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 53.76 -178.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.539 0.209 . . . . 0.0 110.71 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.34 126.3 54.28 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.084 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.11 15.71 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.9 p -130.45 158.94 38.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.603 0.24 . . . . 0.0 110.759 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.04 156.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.772 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -130.4 147.26 52.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -129.97 70.37 82.07 Favored Pre-proline 0 CA--C 1.56 1.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.54 150.57 63.7 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.76 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.06 135.86 37.28 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.67 133.0 55.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.225 0.536 . . . . 0.0 111.641 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -113.79 170.59 8.15 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.063 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -56.72 -39.37 73.81 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -107.83 6.97 27.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -134.65 153.54 51.94 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 120.725 0.298 . . . . 0.0 111.203 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 98.7 p -104.34 154.65 19.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.516 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -82.37 157.25 23.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.533 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.76 134.71 57.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.9 t -156.56 145.07 19.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -137.54 129.39 28.77 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.307 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.7 p -136.0 -62.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 66.83 -71.16 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.488 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.176 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.6 m -127.51 155.93 42.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 73.17 -70.16 0.17 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.92 -146.89 50.43 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.4 p -133.12 161.18 35.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.15 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.725 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.1 p -151.05 164.78 35.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.458 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -127.32 156.62 74.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.106 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 145.43 82.1 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.941 1.76 . . . . 0.0 112.123 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.41 133.73 34.91 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.5 132.91 54.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -113.77 108.51 17.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.246 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 44.38 -86.8 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.0 mtm-85 -93.37 3.58 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -115.93 133.29 56.18 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.768 0.318 . . . . 0.0 111.309 -177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 82.8 p -74.65 160.44 30.81 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.092 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -86.57 161.16 18.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -63.04 136.49 57.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 92.1 p -65.28 -38.13 89.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.052 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -150.71 135.66 17.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.976 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -134.39 51.77 2.1 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.482 0.658 . . . . 0.0 110.687 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.82 -41.3 99.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.082 179.899 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -64.2 -23.75 67.42 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? 55.06 -179.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.92 89.64 1.91 Allowed Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -45.7 89.98 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.8 m -134.81 152.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.9 m -106.11 -8.02 17.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.3 mp0 46.19 56.1 15.98 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 120.481 0.181 . . . . 0.0 110.637 -178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.35 152.53 60.99 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.404 2.069 . . . . 0.0 112.505 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 m170 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.8 110.92 22.55 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 47.64 98.15 0.01 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.009 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.13 129.56 41.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 64.11 -80.09 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -137.1 -12.56 1.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -150.22 162.35 40.64 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.238 0.542 . . . . 0.0 112.363 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 p 66.81 98.82 0.05 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.958 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -80.37 161.44 25.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.431 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.42 113.0 8.0 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 t -155.89 138.65 15.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -162.79 137.81 6.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 9.4 t -160.27 65.96 0.34 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.385 0.612 . . . . 0.0 110.495 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -61.99 -40.36 95.36 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.956 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -104.05 107.8 18.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.589 0.233 . . . . 0.0 110.645 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 tptt 39.89 30.2 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.208 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.16 158.23 27.66 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m 63.61 104.57 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.14 158.79 32.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.359 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -115.45 132.61 56.57 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.858 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.12 116.23 52.34 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.62 148.17 92.26 Favored 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 122.176 1.918 . . . . 0.0 111.843 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.3 141.78 31.57 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.94 129.12 39.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 111.754 -178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.47 170.31 8.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.433 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -56.15 -39.17 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.9 mtm180 -104.5 6.63 34.92 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -133.01 157.84 44.2 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.575 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.4 t -108.09 140.14 41.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.792 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -64.07 128.81 37.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.609 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.41 138.11 58.04 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.8 p -62.7 -35.53 80.01 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.763 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -155.24 161.33 41.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.5 m -123.04 117.75 26.17 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -167.18 155.06 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.536 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.861 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -57.35 -16.83 9.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -59.27 -40.05 84.82 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.018 0.199 . . . . 0.0 110.788 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.24 -31.19 5.68 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 p 61.93 155.06 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.073 0.549 . . . . 0.0 109.75 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.88 156.15 38.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -120.64 -42.27 2.54 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -131.46 79.64 69.06 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.548 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.49 154.55 68.65 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.053 1.836 . . . . 0.0 111.43 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.76 137.89 33.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.31 127.28 31.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.031 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -113.34 170.28 8.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.908 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -56.15 -38.6 71.09 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -106.55 3.18 26.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.43 150.13 51.79 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.381 . . . . 0.0 111.654 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.5 p -91.65 165.96 13.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -89.52 115.37 26.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.573 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.76 120.35 10.5 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 84.1 p -76.97 160.17 29.36 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.306 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 72.46 -45.63 0.63 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 m 77.67 48.86 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.594 0.711 . . . . 0.0 110.38 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.95 -40.96 97.35 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.772 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -71.53 -61.31 1.82 Allowed 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -137.23 -50.47 0.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.231 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.99 158.16 34.27 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -127.18 129.82 48.58 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.98 126.64 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -137.85 -78.85 0.37 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 177.47 138.05 0.23 Allowed Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.91 149.52 69.57 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 122.075 1.85 . . . . 0.0 111.512 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 66.1 mm-40 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.09 141.12 32.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 107.24 1.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.035 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -113.75 108.43 17.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.498 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 46.73 -87.05 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -90.49 1.6 56.53 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.81 139.21 49.92 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.706 0.289 . . . . 0.0 111.235 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.8 p -84.14 164.92 18.87 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.283 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.38 114.91 25.48 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.401 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.46 112.06 5.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 t -164.38 151.36 11.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 57.59 35.82 26.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.379 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.1 p -134.86 157.3 47.18 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.875 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -168.37 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.354 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 111.828 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 62.25 128.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.697 0.284 . . . . 0.0 111.13 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.72 139.61 52.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 176.58 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 t -153.89 150.13 28.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.508 0.194 . . . . 0.0 111.242 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.91 151.71 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.7 m -102.36 -6.16 23.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 61.3 148.87 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 122.235 0.214 . . . . 0.0 110.857 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.78 150.81 62.62 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.003 1.802 . . . . 0.0 112.108 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.71 143.37 30.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.54 139.72 55.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -178.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -88.69 130.93 35.21 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.513 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 61.27 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 O-C-N 123.59 0.556 . . . . 0.0 110.719 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -136.15 -6.59 2.07 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -151.5 167.83 26.81 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.4 t 101.15 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.653 1.581 . . . . 0.0 112.146 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -85.08 114.71 22.42 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.666 177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.21 129.62 42.96 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.0 t -60.9 -47.55 85.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -170.49 130.28 0.88 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.767 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -158.2 148.7 20.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -165.85 32.03 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.763 -179.601 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -130.66 152.87 49.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 111.063 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.48 -39.83 92.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.33 174.01 37.82 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.3 p -126.27 153.66 44.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.684 0.278 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.55 155.78 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.203 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -133.42 149.61 51.79 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.2 65.59 73.44 Favored Pre-proline 0 CA--C 1.561 1.399 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.88 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.1 152.07 39.84 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.279 1.986 . . . . 0.0 111.404 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 138.44 33.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 134.66 15.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.962 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -95.33 130.4 42.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.784 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 69.6 -77.33 0.05 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -134.2 -11.37 2.53 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.51 176.09 5.92 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.095 0.474 . . . . 0.0 112.201 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p 93.57 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.797 1.239 . . . . 0.0 113.04 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -90.53 145.64 24.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.448 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.75 141.96 56.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.8 p -62.86 -37.4 86.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -154.91 156.33 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 67.9 p -126.2 -15.6 5.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 59.3 39.89 21.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.208 0.528 . . . . 0.0 110.402 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.79 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p 58.64 27.81 16.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.616 0.246 . . . . 0.0 111.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -94.99 97.62 10.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.17 -7.62 67.58 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 72.8 m -124.25 124.84 43.31 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.129 0.464 . . . . 0.0 110.288 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.66 -49.77 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.0 m 56.47 45.7 22.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.383 0.611 . . . . 0.0 110.366 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.14 157.51 89.69 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.562 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.16 151.25 66.72 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.197 1.931 . . . . 0.0 111.736 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.77 31.11 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.82 134.83 56.62 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -67.66 122.67 18.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 63.75 -79.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 O-C-N 123.491 0.494 . . . . 0.0 110.603 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -137.52 -12.3 1.57 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -128.57 161.88 28.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p 85.87 42.34 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.028 0.931 . . . . 0.0 112.498 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -90.05 115.44 27.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.25 113.05 2.17 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -64.14 -39.85 94.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.99 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm-85 -117.44 160.99 20.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.954 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 85.8 m -112.8 119.24 37.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -148.72 141.54 24.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.4 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.872 -179.397 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -148.74 142.18 25.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.6 0.238 . . . . 0.0 110.917 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -150.09 135.78 18.38 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.586 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.38 134.3 12.13 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -88.53 -47.22 8.47 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -129.14 125.39 62.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -165.96 62.26 0.11 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -62.68 135.21 95.64 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.436 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.92 158.12 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.48 2.12 . . . . 0.0 112.461 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.82 151.22 27.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -54.21 134.61 44.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.49 126.11 28.61 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 63.68 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.519 0.512 . . . . 0.0 110.52 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -136.64 -14.55 1.66 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.406 0.282 . . . . 0.0 111.724 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -141.37 167.17 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -176.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 p 91.63 37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.295 1.038 . . . . 0.0 112.458 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.13 121.98 22.01 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.915 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.8 137.45 58.05 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.6 t -106.46 -64.63 1.15 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.991 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? 44.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.5 m 76.6 -5.83 2.11 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.856 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 55.1 31.58 16.56 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 120.793 0.33 . . . . 0.0 111.107 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.742 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t 61.24 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.481 0.312 . . . . 0.0 111.31 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -152.89 109.76 3.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.44 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.74 24.56 76.25 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.012 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.2 p -130.35 163.55 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.714 0.257 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.58 159.85 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.778 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.0 m -123.81 145.19 49.24 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.667 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -79.84 152.37 74.59 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.225 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.15 158.93 51.11 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.359 2.04 . . . . 0.0 111.592 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.97 37.75 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 42.88 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.713 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.92 128.33 36.69 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 65.03 -75.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -133.72 -15.94 2.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.331 0.252 . . . . 0.0 111.632 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -161.99 178.67 8.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.921 -175.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 t 70.16 82.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.341 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.21 130.63 43.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.611 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.1 112.24 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.2 t -64.23 -45.84 86.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -159.18 159.56 34.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.062 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.9 p -116.85 12.04 14.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.208 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -61.25 -49.01 78.83 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.146 0.498 . . . . 0.0 110.071 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.091 176.171 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -111.35 119.28 38.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.613 0.244 . . . . 0.0 110.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt 49.34 -175.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.936 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 154.74 25.8 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.8 m -129.43 132.11 46.91 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.614 0.245 . . . . 0.0 110.438 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.31 40.94 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.791 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -117.26 146.32 43.37 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -145.43 159.48 48.22 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.952 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.26 158.8 55.97 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.036 1.824 . . . . 0.0 111.222 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.19 33.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.95 131.25 18.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.391 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.71 129.38 38.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.095 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 63.25 -82.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.642 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -135.86 -7.83 2.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -138.96 174.53 10.41 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t 76.28 44.12 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.05 0.94 . . . . 0.0 112.754 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -90.72 114.92 27.37 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.9 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.77 138.39 57.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.8 t -126.08 130.83 51.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.498 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -154.43 160.0 41.39 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.633 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -119.71 -21.88 7.09 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 58.69 160.2 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.2 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 pp . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.031 -179.534 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 120.892 0.288 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 31' ' ' PRO . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 29' ' ' VAL . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 64' ' ' PHE . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' NH2' HD12 ' A' ' 133' ' ' LEU . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.482 ' H ' HD13 ' A' ' 133' ' ' LEU . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 136' ' ' LEU . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.393 0.14 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.483 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 CA-C-O 120.654 0.189 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG23 ' H ' ' A' ' 32' ' ' GLY . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.622 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 68' ' ' ILE . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.635 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.635 ' CD2' HG22 ' A' ' 57' ' ' THR . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.568 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 39' ' ' PHE . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.568 ' CE3' HG22 ' A' ' 67' ' ' THR . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 122' ' ' VAL . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.822 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.571 ' OG ' HD21 ' A' ' 110' ' ' LEU . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 129' ' ' PHE . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG21 ' CD ' ' A' ' 85' ' ' GLU . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 110' ' ' LEU . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 137' ' ' VAL . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.56 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.5 1.876 0 N-CA-C 111.432 -0.257 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 27' ' ' HIS . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 41' ' ' TYR . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 12' ' ' VAL . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.682 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' CE1' HD13 ' A' ' 136' ' ' LEU . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.6 m80 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.614 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' C ' ' HG ' ' A' ' 134' ' ' SER . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.9 t0 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 96' ' ' ALA . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 110' ' ' LEU . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 39' ' ' PHE . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.502 2.014 0 N-CA-C 111.502 -0.23 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 54' ' ' SER . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 27' ' ' HIS . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 12' ' ' VAL . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.514 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.9 m80 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 57' ' ' THR . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.523 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 136' ' ' LEU . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 117' ' ' VAL . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' OE2' HG21 ' A' ' 122' ' ' VAL . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 86' ' ' VAL . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' C ' ' HG ' ' A' ' 134' ' ' SER . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 134' ' ' SER . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' ALA . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 85' ' ' GLU . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.461 ' CB ' HD11 ' A' ' 110' ' ' LEU . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.512 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.735 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.5 1.887 0 CA-C-O 120.754 0.231 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 12' ' ' VAL . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 68' ' ' ILE . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 27' ' ' HIS . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.591 HG22 ' CE3' ' A' ' 69' ' ' TRP . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.591 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 133' ' ' LEU . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.482 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.558 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.502 2.012 0 CA-C-O 120.843 0.268 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 27' ' ' HIS . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 16' ' ' VAL . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 12' ' ' VAL . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' ' 86' ' ' VAL . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.414 ' O ' HD21 ' A' ' 77' ' ' LEU . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 55' ' ' LEU . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' PHE . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.626 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 47' ' ' THR . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' HE1' HD21 ' A' ' 133' ' ' LEU . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 136' ' ' LEU . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' SG ' ' A' ' 37' ' ' CYS . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.418 ' OG ' HD21 ' A' ' 110' ' ' LEU . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.419 HD21 ' HE1' ' A' ' 79' ' ' PHE . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.439 ' CB ' HD11 ' A' ' 110' ' ' LEU . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 84' ' ' ALA . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.487 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 CA-C-O 120.885 0.286 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 53' ' ' MET . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 53' ' ' MET . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.458 ' O ' HD21 ' A' ' 77' ' ' LEU . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 11' ' ' THR . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 69' ' ' TRP . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.409 ' O ' HD22 ' A' ' 133' ' ' LEU . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 47' ' ' THR . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HE1' HD21 ' A' ' 133' ' ' LEU . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.405 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.541 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HB2' ' HE2' ' A' ' 35' ' ' TYR . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 94' ' ' ALA . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 134' ' ' SER . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 119' ' ' LYS . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 133' ' ' LEU . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 84' ' ' ALA . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.5 1.893 0 CA-C-O 120.834 0.264 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 16' ' ' VAL . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 31' ' ' PRO . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 29' ' ' VAL . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 89' ' ' ALA . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 68' ' ' ILE . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.624 HG22 ' CD2' ' A' ' 64' ' ' PHE . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' CE3' ' A' ' 69' ' ' TRP . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.505 HD12 ' CD2' ' A' ' 39' ' ' PHE . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 67' ' ' THR . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 86' ' ' VAL . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 134' ' ' SER . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 119' ' ' LYS . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 118' ' ' THR . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.569 ' HB3' HD11 ' A' ' 110' ' ' LEU . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.509 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.75 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.503 2.037 0 CA-C-O 120.569 0.154 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.676 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.431 ' HG2' HG23 ' A' ' 68' ' ' ILE . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.577 0.227 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 79' ' ' PHE . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.626 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.505 2.197 0 CA-C-O 120.939 0.308 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.455 ' ND1' HD21 ' A' ' 55' ' ' LEU . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 31' ' ' PRO . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 29' ' ' VAL . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.697 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 68' ' ' ILE . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.653 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 139' ' ' VAL . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.446 HG22 ' CE3' ' A' ' 69' ' ' TRP . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 39' ' ' PHE . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CE3' HG22 ' A' ' 67' ' ' THR . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.426 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' OG ' ' A' ' 98' ' ' SER . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 119' ' ' LYS . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 118' ' ' THR . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 97' ' ' TYR . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 96' ' ' ALA . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.502 2.018 0 CA-C-O 120.754 0.231 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.625 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CE3' HG22 ' A' ' 67' ' ' THR . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 91' ' ' ILE . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 86' ' ' VAL . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.927 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 96' ' ' ALA . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 N--CA 1.504 2.089 0 CA-C-O 120.657 0.19 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 53' ' ' MET . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 27' ' ' HIS . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.529 ' ND1' HD11 ' A' ' 55' ' ' LEU . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 68' ' ' ILE . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.442 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 11' ' ' THR . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' ND1' ' A' ' 27' ' ' HIS . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.59 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.476 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' HD1' ' A' ' 39' ' ' PHE . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 67' ' ' THR . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 133' ' ' LEU . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.427 0.156 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.572 ' N ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 96' ' ' ALA . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.502 1.991 0 N-CA-C 111.43 -0.258 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 27' ' ' HIS . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 12' ' ' VAL . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 32' ' ' GLY . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.734 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.405 HG22 ' NZ ' ' A' ' 83' ' ' LYS . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.413 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 57' ' ' THR . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 139' ' ' VAL . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CE3' HG22 ' A' ' 67' ' ' THR . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.405 ' NZ ' HG22 ' A' ' 40' ' ' THR . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG22 HD11 ' A' ' 91' ' ' ILE . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.573 HD11 HG22 ' A' ' 86' ' ' VAL . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.862 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 110' ' ' LEU . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 98' ' ' SER . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 96' ' ' ALA . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 65' ' ' THR . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.734 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 N--CA 1.507 2.318 0 N-CA-C 111.512 -0.226 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' MET . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 27' ' ' HIS . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.517 ' CE1' HG23 ' A' ' 12' ' ' VAL . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 13' ' ' ALA . 20.1 mm100 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.651 ' O ' HG23 ' A' ' 11' ' ' THR . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 ' HB ' ' A' ' 29' ' ' VAL . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.527 ' CD2' ' OE2' ' A' ' 92' ' ' GLU . 10.9 m80 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 122' ' ' VAL . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.403 ' CG1' HG22 ' A' ' 86' ' ' VAL . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 63' ' ' HIS . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 83' ' ' LYS . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HZ2' ' HB2' ' A' ' 97' ' ' TYR . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 96' ' ' ALA . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.5 1.864 0 CA-C-O 120.79 0.246 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 12' ' ' VAL . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.641 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 68' ' ' ILE . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.522 HG22 ' CE3' ' A' ' 69' ' ' TRP . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.522 ' CE3' HG22 ' A' ' 67' ' ' THR . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ2' ' HA ' ' A' ' 124' ' ' HIS . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.404 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' HIS . . . . . 0.418 ' HA ' ' HZ2' ' A' ' 83' ' ' LYS . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 133' ' ' LEU . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.577 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 111.404 -0.268 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.603 HG21 ' CE1' ' A' ' 27' ' ' HIS . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CE1' HG21 ' A' ' 10' ' ' THR . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.738 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 89' ' ' ALA . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.641 ' CE2' HD11 ' A' ' 68' ' ' ILE . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.402 ' O ' HD21 ' A' ' 77' ' ' LEU . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.757 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 139' ' ' VAL . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' CE3' ' A' ' 69' ' ' TRP . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.641 HD11 ' CE2' ' A' ' 39' ' ' PHE . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.619 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 47' ' ' THR . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.756 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 134' ' ' SER . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 119' ' ' LYS . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 118' ' ' THR . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 133' ' ' LEU . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.444 ' CB ' HD11 ' A' ' 110' ' ' LEU . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 96' ' ' ALA . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.757 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.504 2.124 0 CA-C-O 120.552 0.147 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 41' ' ' TYR . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.607 ' CD2' HD11 ' A' ' 55' ' ' LEU . 1.6 t60 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 16' ' ' VAL . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 27' ' ' HIS . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 64' ' ' PHE . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.731 ' HD2' HG22 ' A' ' 57' ' ' THR . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' CE3' ' A' ' 69' ' ' TRP . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.975 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 110' ' ' LEU . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.1 t0 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 98' ' ' SER . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.975 HD23 ' HB2' ' A' ' 96' ' ' ALA . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.597 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.498 1.773 0 CA-C-O 120.773 0.239 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' CE1' ' A' ' 27' ' ' HIS . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 10' ' ' THR . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.664 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.651 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.612 ' O ' HD21 ' A' ' 77' ' ' LEU . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 68' ' ' ILE . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' CD2' ' A' ' 64' ' ' PHE . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.5 m80 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.472 HG22 ' CE3' ' A' ' 69' ' ' TRP . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.651 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 47' ' ' THR . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' C ' HD13 ' A' ' 110' ' ' LEU . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.423 ' C ' ' HG ' ' A' ' 134' ' ' SER . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 129' ' ' PHE . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.475 ' CE1' HD23 ' A' ' 110' ' ' LEU . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 68' ' ' ILE . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.501 1.959 0 N-CA-C 111.592 -0.195 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' HG ' ' A' ' 55' ' ' LEU . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 42' ' ' ALA . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 55' ' ' LEU . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 68' ' ' ILE . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 16' ' ' VAL . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.541 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 27' ' ' HIS . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD2' HG22 ' A' ' 57' ' ' THR . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 139' ' ' VAL . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.705 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD11 ' CE2' ' A' ' 39' ' ' PHE . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.705 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HB3' HD22 ' A' ' 133' ' ' LEU . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.441 ' O ' HD23 ' A' ' 133' ' ' LEU . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.787 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 91' ' ' ILE . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.788 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 118' ' ' THR . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.787 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 96' ' ' ALA . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 65' ' ' THR . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.505 2.174 0 N-CA-C 111.222 -0.338 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' CE1' ' A' ' 27' ' ' HIS . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' HIS . . . . . 0.639 ' ND1' HD21 ' A' ' 55' ' ' LEU . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 68' ' ' ILE . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD21 ' ND1' ' A' ' 27' ' ' HIS . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.617 HG22 ' CD2' ' A' ' 64' ' ' PHE . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD12 ' CD2' ' A' ' 39' ' ' PHE . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.697 HD21 ' OE2' ' A' ' 132' ' ' GLU . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.484 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.697 ' OE2' HD21 ' A' ' 110' ' ' LEU . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 133' ' ' LEU . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -133.87 124.03 25.76 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.69 0.281 . . . . 0.0 110.866 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -133.49 148.67 51.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.42 165.45 54.8 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' OE2' ' A' ' 59' ' ' GLU . 82.2 p -128.38 158.81 37.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.682 0.277 . . . . 0.0 110.855 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.47 127.89 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.17 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -127.16 148.74 50.17 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.665 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -128.44 88.93 51.09 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.435 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.83 151.15 62.72 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.148 1.899 . . . . 0.0 112.247 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 31' ' ' PRO . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 29' ' ' VAL . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 64' ' ' PHE . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' OE2' HG22 ' A' ' 5' ' ' THR . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' NH2' HD12 ' A' ' 133' ' ' LEU . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.482 ' H ' HD13 ' A' ' 133' ' ' LEU . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 136' ' ' LEU . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.04 147.05 28.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -55.85 138.21 48.71 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.169 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -107.95 112.07 24.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.888 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 49.0 -85.24 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.812 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -115.38 23.34 12.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.612 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 60.5 mt-10 -123.0 144.55 49.18 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.109 0.481 . . . . 0.0 111.644 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 t -72.1 145.88 47.89 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.273 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -77.01 162.15 27.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -56.94 129.25 40.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.3 p -161.9 169.09 21.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.772 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 58.93 75.24 0.41 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.985 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 71.6 p -112.58 14.35 20.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.052 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -145.98 142.96 29.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.306 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.673 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -128.58 158.12 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 111.01 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.79 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.446 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 -167.55 43.02 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -125.21 155.46 40.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.598 0.237 . . . . 0.0 110.69 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.17 160.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.171 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 t -148.61 149.51 31.66 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.38 82.2 66.4 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.659 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.11 148.39 89.59 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.338 2.025 . . . . 0.0 111.782 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG23 ' H ' ' A' ' 32' ' ' GLY . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 68' ' ' ILE . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.635 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.635 ' CD2' HG22 ' A' ' 57' ' ' THR . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.568 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 39' ' ' PHE . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.568 ' CE3' HG22 ' A' ' 67' ' ' THR . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 122' ' ' VAL . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.822 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.571 ' OG ' HD21 ' A' ' 110' ' ' LEU . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.14 40.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -63.44 104.55 0.64 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -113.69 107.36 15.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 45.92 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -91.44 0.78 57.47 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -115.03 139.06 50.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.454 0.169 . . . . 0.0 110.707 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -83.83 162.73 20.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 18.3 t70 -90.56 115.38 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.177 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 129' ' ' PHE . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG21 ' CD ' ' A' ' 85' ' ' GLU . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 110' ' ' LEU . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 137' ' ' VAL . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.56 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -62.09 142.45 57.56 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 99.3 p -141.88 161.67 37.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -87.22 123.57 32.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.875 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 91.5 m -126.85 119.72 27.49 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -157.53 147.29 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.782 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.765 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -63.22 -23.02 67.24 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -142.92 153.67 43.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.663 0.268 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.21 -148.38 9.08 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -149.63 176.07 10.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.215 . . . . 0.0 110.522 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.91 -43.11 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.145 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.7 m 57.74 47.33 15.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.709 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.8 76.7 28.91 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.22 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.42 155.98 67.49 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.0 1.8 . . . . 0.0 111.432 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 27' ' ' HIS . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 41' ' ' TYR . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 12' ' ' VAL . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.682 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' CE1' HD13 ' A' ' 136' ' ' LEU . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.6 m80 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.614 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' C ' ' HG ' ' A' ' 134' ' ' SER . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.83 141.97 31.88 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.701 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.82 134.24 56.7 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.585 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.72 126.71 30.25 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 63.21 -80.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.417 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -144.63 3.34 1.12 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.689 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 62.0 mt-10 -139.64 161.71 36.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.668 0.27 . . . . 0.0 111.707 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 p 84.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.67 0.788 . . . . 0.0 112.717 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.701 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 64.9 t0 -88.24 115.0 25.41 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 96' ' ' ALA . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 110' ' ' LEU . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 39' ' ' PHE . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.527 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -59.49 136.78 58.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.0 p -137.56 -39.04 0.58 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -61.12 -45.4 94.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.015 0.197 . . . . 0.0 111.492 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 145' ' ' THR . 4.2 t 178.72 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.203 0.525 . . . . 0.0 110.15 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -63.0 -40.48 97.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.963 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.922 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -61.15 -43.86 98.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.669 0.271 . . . . 0.0 110.639 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -151.47 153.87 35.46 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.089 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.49 177.66 40.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.3 m -121.26 120.51 35.35 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.53 155.67 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.08 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -132.35 148.34 52.42 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.391 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -133.61 65.13 70.64 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.852 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.38 145.3 98.36 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.258 1.972 . . . . 0.0 111.502 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 54' ' ' SER . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 27' ' ' HIS . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 16' ' ' VAL . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 12' ' ' VAL . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.514 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 65.9 m80 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.9 m80 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 57' ' ' THR . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.523 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 136' ' ' LEU . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 117' ' ' VAL . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' OE2' HG21 ' A' ' 122' ' ' VAL . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 86' ' ' VAL . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' C ' ' HG ' ' A' ' 134' ' ' SER . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.4 148.35 28.28 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.96 131.69 31.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.84 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -87.05 127.84 35.1 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.865 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 66.39 -77.06 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 mtp-105 -135.8 -16.27 1.75 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -148.06 174.57 11.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p 95.63 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.535 1.134 . . . . 0.0 112.856 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -84.37 114.95 22.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.999 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 134' ' ' SER . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' ALA . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 85' ' ' GLU . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.461 ' CB ' HD11 ' A' ' 110' ' ' LEU . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.512 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.735 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.01 139.96 58.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.71 14.51 1.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -137.42 125.84 23.43 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-O 120.545 0.212 . . . . 0.0 110.813 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.0 m -137.87 106.24 5.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.94 154.16 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.879 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 t 69.41 -67.38 0.22 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.589 0.356 . . . . 0.0 111.654 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -59.59 -45.05 93.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.224 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.11 149.29 21.26 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 p -134.66 158.92 42.83 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.515 0.197 . . . . 0.0 110.71 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.85 149.21 31.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.501 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -162.37 164.03 27.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.87 68.83 81.26 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 147.1 57.36 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.099 1.866 . . . . 0.0 112.067 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 12' ' ' VAL . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 68' ' ' ILE . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 27' ' ' HIS . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.591 HG22 ' CE3' ' A' ' 69' ' ' TRP . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.591 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.31 140.63 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -60.85 132.52 54.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 111.688 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -113.36 171.03 7.81 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.709 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.58 -39.17 70.34 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -106.75 6.32 29.52 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -131.73 146.84 52.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.73 0.3 . . . . 0.0 111.403 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.7 p -89.39 166.23 13.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.542 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 41.3 t0 -90.2 115.35 27.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.593 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.457 HD12 ' C ' ' A' ' 133' ' ' LEU . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.482 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.558 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -63.82 139.49 58.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -62.21 -39.99 94.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -123.83 136.59 54.48 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -99.47 15.47 26.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -58.29 131.26 50.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.968 -178.23 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -151.77 161.58 42.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.75 146.06 25.83 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.894 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 159.31 53.89 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -148.64 153.43 38.29 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.696 0.284 . . . . 0.0 111.433 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.78 159.82 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -117.16 125.86 51.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -108.98 119.22 49.49 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 156.25 61.98 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.991 1.794 . . . . 0.0 111.989 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 27' ' ' HIS . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 16' ' ' VAL . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 12' ' ' VAL . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' ' 86' ' ' VAL . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.414 ' O ' HD21 ' A' ' 77' ' ' LEU . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 55' ' ' LEU . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' PHE . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.626 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 47' ' ' THR . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' HE1' HD21 ' A' ' 133' ' ' LEU . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 136' ' ' LEU . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' SG ' ' A' ' 37' ' ' CYS . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.418 ' OG ' HD21 ' A' ' 110' ' ' LEU . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 136.58 34.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.77 135.1 57.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.234 0.54 . . . . 0.0 111.265 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -111.06 170.03 8.38 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.805 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.17 -39.11 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.52 3.57 27.24 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -130.43 146.3 51.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.744 0.307 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -85.92 165.15 17.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.422 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 36.8 t70 -85.92 115.81 23.77 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.344 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.419 HD21 ' HE1' ' A' ' 79' ' ' PHE . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.439 ' CB ' HD11 ' A' ' 110' ' ' LEU . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 84' ' ' ALA . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.487 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . . . -71.91 137.31 47.31 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.6 t -153.07 145.01 23.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 111.524 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 -23.99 5.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.339 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 p -124.38 37.12 4.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.085 0.469 . . . . 0.0 111.034 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.4 -42.0 90.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -70.8 -14.32 62.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -141.04 158.22 44.24 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 120.61 0.243 . . . . 0.0 111.088 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.06 48.04 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.6 p -116.91 21.27 13.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t 68.93 65.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.415 0.626 . . . . 0.0 110.087 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -62.02 -40.45 95.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 69.58 81.23 0.2 Allowed Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.536 2.157 . . . . 0.0 112.693 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 53' ' ' MET . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 53' ' ' MET . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.458 ' O ' HD21 ' A' ' 77' ' ' LEU . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 11' ' ' THR . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 69' ' ' TRP . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.409 ' O ' HD22 ' A' ' 133' ' ' LEU . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 47' ' ' THR . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HE1' HD21 ' A' ' 133' ' ' LEU . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.541 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HB2' ' HE2' ' A' ' 35' ' ' TYR . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 94' ' ' ALA . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 134' ' ' SER . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.36 146.09 29.56 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -55.58 135.73 50.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.415 0.447 . . . . 0.0 110.433 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -82.81 124.54 30.39 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.027 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 104' ' ' ARG . 0.6 OUTLIER 71.48 -55.9 0.65 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 123.963 0.789 . . . . 0.0 112.049 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.418 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 4.5 ptp85 -164.42 -7.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.629 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 21.7 mt-10 -142.4 176.8 8.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.869 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t 71.88 49.87 0.25 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.603 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 67.9 t0 -90.44 115.92 27.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.626 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 119' ' ' LYS . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 133' ' ' LEU . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 84' ' ' ALA . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -59.88 138.55 57.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.5 p -154.54 162.13 41.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -95.57 124.59 39.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 78.8 m -124.96 120.92 32.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -154.78 141.14 18.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.983 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.1 p -152.42 159.55 43.38 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.578 0.228 . . . . 0.0 110.804 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -118.5 -47.23 2.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.07 170.7 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -135.57 163.74 29.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.282 0.233 . . . . 0.0 110.47 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.45 149.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.128 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.2 m -136.32 155.35 50.19 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -127.7 66.95 71.93 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.8 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.4 151.99 71.15 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.248 1.965 . . . . 0.0 112.059 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 16' ' ' VAL . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 31' ' ' PRO . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 29' ' ' VAL . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 89' ' ' ALA . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 68' ' ' ILE . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.624 HG22 ' CD2' ' A' ' 64' ' ' PHE . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' CE3' ' A' ' 69' ' ' TRP . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.505 HD12 ' CD2' ' A' ' 39' ' ' PHE . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 67' ' ' THR . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 86' ' ' VAL . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.72 34.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -67.01 130.18 42.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.231 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.9 169.01 9.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.883 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -38.04 70.1 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -99.68 5.58 45.74 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.052 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -131.13 175.51 9.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.6 p -124.46 156.15 37.7 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.187 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.713 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 35.5 t70 -85.55 118.09 24.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.552 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 134' ' ' SER . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 119' ' ' LYS . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 118' ' ' THR . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.569 ' HB3' HD11 ' A' ' 110' ' ' LEU . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.509 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.75 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -57.1 132.96 54.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.3 m -108.13 -63.6 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.809 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.43 155.34 30.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.624 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.2 p -131.98 33.96 3.88 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.167 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.71 -51.85 67.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.659 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.449 ' C ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.631 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 53.76 -178.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.539 0.209 . . . . 0.0 110.71 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.34 126.3 54.28 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.084 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.11 15.71 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.524 HG21 ' OE1' ' A' ' 59' ' ' GLU . 80.9 p -130.45 158.94 38.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.603 0.24 . . . . 0.0 110.759 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.04 156.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.772 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -130.4 147.26 52.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -129.97 70.37 82.07 Favored Pre-proline 0 CA--C 1.56 1.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.54 150.57 63.7 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.76 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.676 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.431 ' HG2' HG23 ' A' ' 68' ' ' ILE . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 5' ' ' THR . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.2 m80 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.06 135.86 37.28 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . . . -60.67 133.0 55.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.225 0.536 . . . . 0.0 111.641 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -113.79 170.59 8.15 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.063 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -56.72 -39.37 73.81 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -107.83 6.97 27.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -134.65 153.54 51.94 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 120.725 0.298 . . . . 0.0 111.203 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 98.7 p -104.34 154.65 19.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.516 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 3.6 p-10 -82.37 157.25 23.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.533 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 79' ' ' PHE . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.626 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -60.76 134.71 57.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.9 t -156.56 145.07 19.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -137.54 129.39 28.77 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.307 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.7 p -136.0 -62.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 66.83 -71.16 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.488 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.176 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.6 m -127.51 155.93 42.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 73.17 -70.16 0.17 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.92 -146.89 50.43 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.4 p -133.12 161.18 35.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.15 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.725 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.1 p -151.05 164.78 35.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.458 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -127.32 156.62 74.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.106 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 145.43 82.1 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.941 1.76 . . . . 0.0 112.123 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.455 ' ND1' HD21 ' A' ' 55' ' ' LEU . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 31' ' ' PRO . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 29' ' ' VAL . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.697 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 68' ' ' ILE . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.653 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 43.0 m80 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.5 m80 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 139' ' ' VAL . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.446 HG22 ' CE3' ' A' ' 69' ' ' TRP . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 39' ' ' PHE . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CE3' HG22 ' A' ' 67' ' ' THR . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.426 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.41 133.73 34.91 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -61.5 132.91 54.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -113.77 108.51 17.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.246 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 44.38 -86.8 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.0 mtm-85 -93.37 3.58 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.508 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 58.2 mt-10 -115.93 133.29 56.18 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.768 0.318 . . . . 0.0 111.309 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 82.8 p -74.65 160.44 30.81 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.092 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -86.57 161.16 18.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' OG ' ' A' ' 98' ' ' SER . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 119' ' ' LYS . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 118' ' ' THR . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 97' ' ' TYR . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 96' ' ' ALA . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -63.04 136.49 57.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 92.1 p -65.28 -38.13 89.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.052 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -150.71 135.66 17.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.976 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -134.39 51.77 2.1 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.482 0.658 . . . . 0.0 110.687 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.82 -41.3 99.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -64.2 -23.75 67.42 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? 55.06 -179.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.92 89.64 1.91 Allowed Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -45.7 89.98 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.505 HG23 ' OE2' ' A' ' 8' ' ' GLU . 35.8 m -134.81 152.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.9 m -106.11 -8.02 17.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' OE2' HG23 ' A' ' 6' ' ' VAL . 47.3 mp0 46.19 56.1 15.98 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 120.481 0.181 . . . . 0.0 110.637 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.35 152.53 60.99 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.404 2.069 . . . . 0.0 112.505 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 16' ' ' VAL . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.625 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CE3' HG22 ' A' ' 67' ' ' THR . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 91' ' ' ILE . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 86' ' ' VAL . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.927 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.8 110.92 22.55 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 47.64 98.15 0.01 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.009 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.13 129.56 41.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 64.11 -80.09 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -137.1 -12.56 1.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -150.22 162.35 40.64 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.238 0.542 . . . . 0.0 112.363 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 p 66.81 98.82 0.05 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.958 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -80.37 161.44 25.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.431 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 96' ' ' ALA . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.42 113.0 8.0 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 t -155.89 138.65 15.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -162.79 137.81 6.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 145' ' ' THR . 9.4 t -160.27 65.96 0.34 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.385 0.612 . . . . 0.0 110.495 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -61.99 -40.36 95.36 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.956 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -104.05 107.8 18.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.589 0.233 . . . . 0.0 110.645 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 tptt 39.89 30.2 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.208 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.16 158.23 27.66 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m 63.61 104.57 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.14 158.79 32.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.359 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -115.45 132.61 56.57 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.858 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.12 116.23 52.34 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.62 148.17 92.26 Favored 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 122.176 1.918 . . . . 0.0 111.843 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 53' ' ' MET . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 27' ' ' HIS . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.529 ' ND1' HD11 ' A' ' 55' ' ' LEU . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 68' ' ' ILE . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.442 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 11' ' ' THR . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' ND1' ' A' ' 27' ' ' HIS . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.59 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.476 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' HD1' ' A' ' 39' ' ' PHE . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 67' ' ' THR . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 133' ' ' LEU . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.3 141.78 31.57 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -61.94 129.12 39.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 111.754 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.47 170.31 8.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.433 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -56.15 -39.17 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.9 mtm180 -104.5 6.63 34.92 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -133.01 157.84 44.2 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.575 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.4 t -108.09 140.14 41.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.792 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 18.8 t70 -64.07 128.81 37.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.609 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.572 ' N ' HD22 ' A' ' 133' ' ' LEU . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 96' ' ' ALA . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.41 138.11 58.04 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.8 p -62.7 -35.53 80.01 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.763 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -155.24 161.33 41.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.5 m -123.04 117.75 26.17 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -167.18 155.06 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.536 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.861 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -57.35 -16.83 9.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -59.27 -40.05 84.82 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.018 0.199 . . . . 0.0 110.788 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.24 -31.19 5.68 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 p 61.93 155.06 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.073 0.549 . . . . 0.0 109.75 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.88 156.15 38.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -120.64 -42.27 2.54 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -131.46 79.64 69.06 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.548 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.49 154.55 68.65 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.053 1.836 . . . . 0.0 111.43 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 27' ' ' HIS . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 12' ' ' VAL . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 32' ' ' GLY . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.734 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.405 HG22 ' NZ ' ' A' ' 83' ' ' LYS . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.413 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 57' ' ' THR . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 139' ' ' VAL . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CE3' HG22 ' A' ' 67' ' ' THR . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' NZ ' HG22 ' A' ' 40' ' ' THR . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG22 HD11 ' A' ' 91' ' ' ILE . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.573 HD11 HG22 ' A' ' 86' ' ' VAL . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.862 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 110' ' ' LEU . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.76 137.89 33.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -57.31 127.28 31.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.031 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -113.34 170.28 8.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.908 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -56.15 -38.6 71.09 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -106.55 3.18 26.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.43 150.13 51.79 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.381 . . . . 0.0 111.654 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.5 p -91.65 165.96 13.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 34.9 t70 -89.52 115.37 26.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.573 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 98' ' ' SER . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 96' ' ' ALA . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 65' ' ' THR . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.734 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -61.76 120.35 10.5 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 84.1 p -76.97 160.17 29.36 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.306 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 72.46 -45.63 0.63 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 m 77.67 48.86 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.594 0.711 . . . . 0.0 110.38 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.95 -40.96 97.35 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.772 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -71.53 -61.31 1.82 Allowed 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -137.23 -50.47 0.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.231 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.99 158.16 34.27 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -127.18 129.82 48.58 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.98 126.64 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -137.85 -78.85 0.37 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 177.47 138.05 0.23 Allowed Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.91 149.52 69.57 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 122.075 1.85 . . . . 0.0 111.512 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' MET . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 27' ' ' HIS . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB2' ' OE1' ' A' ' 52' ' ' GLN . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.517 ' CE1' HG23 ' A' ' 12' ' ' VAL . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' OE1' ' HB2' ' A' ' 13' ' ' ALA . 20.1 mm100 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.651 ' O ' HG23 ' A' ' 11' ' ' THR . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 ' HB ' ' A' ' 29' ' ' VAL . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.527 ' CD2' ' OE2' ' A' ' 92' ' ' GLU . 10.9 m80 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 122' ' ' VAL . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.403 ' CG1' HG22 ' A' ' 86' ' ' VAL . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.527 ' OE2' ' CD2' ' A' ' 63' ' ' HIS . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.09 141.12 32.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 107.24 1.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.035 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -113.75 108.43 17.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.498 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 46.73 -87.05 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -90.49 1.6 56.53 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.81 139.21 49.92 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.706 0.289 . . . . 0.0 111.235 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.8 p -84.14 164.92 18.87 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.283 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.38 114.91 25.48 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.401 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 83' ' ' LYS . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HZ2' ' HB2' ' A' ' 97' ' ' TYR . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 96' ' ' ALA . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.46 112.06 5.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 t -164.38 151.36 11.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 57.59 35.82 26.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.379 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.1 p -134.86 157.3 47.18 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.875 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -168.37 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.354 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 111.828 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 62.25 128.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.697 0.284 . . . . 0.0 111.13 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.72 139.61 52.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 176.58 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 t -153.89 150.13 28.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.508 0.194 . . . . 0.0 111.242 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.91 151.71 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.7 m -102.36 -6.16 23.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 61.3 148.87 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 122.235 0.214 . . . . 0.0 110.857 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.78 150.81 62.62 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.003 1.802 . . . . 0.0 112.108 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 12' ' ' VAL . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.641 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 68' ' ' ILE . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 67.5 m80 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.522 HG22 ' CE3' ' A' ' 69' ' ' TRP . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.522 ' CE3' HG22 ' A' ' 67' ' ' THR . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ2' ' HA ' ' A' ' 124' ' ' HIS . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.404 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.71 143.37 30.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.54 139.72 55.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -88.69 130.93 35.21 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.513 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 61.27 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 O-C-N 123.59 0.556 . . . . 0.0 110.719 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -136.15 -6.59 2.07 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -151.5 167.83 26.81 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.4 t 101.15 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.653 1.581 . . . . 0.0 112.146 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 60.6 t0 -85.08 114.71 22.42 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.666 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.418 ' HA ' ' HZ2' ' A' ' 83' ' ' LYS . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 133' ' ' LEU . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.512 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.577 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -59.21 129.62 42.96 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.0 t -60.9 -47.55 85.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -170.49 130.28 0.88 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.767 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -158.2 148.7 20.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -165.85 32.03 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.763 -179.601 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -130.66 152.87 49.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 111.063 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.48 -39.83 92.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.33 174.01 37.82 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.3 p -126.27 153.66 44.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.684 0.278 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.55 155.78 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.203 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -133.42 149.61 51.79 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.2 65.59 73.44 Favored Pre-proline 0 CA--C 1.561 1.399 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.88 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.1 152.07 39.84 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.279 1.986 . . . . 0.0 111.404 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.603 HG21 ' CE1' ' A' ' 27' ' ' HIS . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CE1' HG21 ' A' ' 10' ' ' THR . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.738 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 89' ' ' ALA . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.641 ' CE2' HD11 ' A' ' 68' ' ' ILE . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.402 ' O ' HD21 ' A' ' 77' ' ' LEU . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.757 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 139' ' ' VAL . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' CE3' ' A' ' 69' ' ' TRP . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.641 HD11 ' CE2' ' A' ' 39' ' ' PHE . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.619 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 47' ' ' THR . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.756 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 138.44 33.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 134.66 15.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.962 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -95.33 130.4 42.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.784 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 69.6 -77.33 0.05 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -134.2 -11.37 2.53 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.51 176.09 5.92 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.095 0.474 . . . . 0.0 112.201 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p 93.57 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.797 1.239 . . . . 0.0 113.04 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -90.53 145.64 24.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.448 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 134' ' ' SER . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 119' ' ' LYS . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 118' ' ' THR . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 133' ' ' LEU . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.444 ' CB ' HD11 ' A' ' 110' ' ' LEU . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 96' ' ' ALA . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.504 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.757 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.75 141.96 56.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.8 p -62.86 -37.4 86.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -154.91 156.33 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 67.9 p -126.2 -15.6 5.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 59.3 39.89 21.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.208 0.528 . . . . 0.0 110.402 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.79 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p 58.64 27.81 16.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.616 0.246 . . . . 0.0 111.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -94.99 97.62 10.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.17 -7.62 67.58 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 HG22 ' OG ' ' A' ' 7' ' ' SER . 72.8 m -124.25 124.84 43.31 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.129 0.464 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.66 -49.77 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.433 ' OG ' HG22 ' A' ' 5' ' ' THR . 50.0 m 56.47 45.7 22.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.383 0.611 . . . . 0.0 110.366 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.14 157.51 89.69 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.562 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.16 151.25 66.72 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.197 1.931 . . . . 0.0 111.736 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 41' ' ' TYR . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.607 ' CD2' HD11 ' A' ' 55' ' ' LEU . 1.6 t60 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 16' ' ' VAL . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.607 HD11 ' CD2' ' A' ' 27' ' ' HIS . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 64' ' ' PHE . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.731 ' HD2' HG22 ' A' ' 57' ' ' THR . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' CE3' ' A' ' 69' ' ' TRP . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.975 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 110' ' ' LEU . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.77 31.11 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -57.82 134.83 56.62 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -67.66 122.67 18.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 63.75 -79.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 O-C-N 123.491 0.494 . . . . 0.0 110.603 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -137.52 -12.3 1.57 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.664 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 44.1 mt-10 -128.57 161.88 28.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p 85.87 42.34 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.028 0.931 . . . . 0.0 112.498 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 66.1 t0 -90.05 115.44 27.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 98' ' ' SER . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.975 HD23 ' HB2' ' A' ' 96' ' ' ALA . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.597 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.25 113.05 2.17 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -64.14 -39.85 94.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.99 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm-85 -117.44 160.99 20.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.954 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 85.8 m -112.8 119.24 37.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -148.72 141.54 24.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.4 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.872 -179.397 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -148.74 142.18 25.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.6 0.238 . . . . 0.0 110.917 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -150.09 135.78 18.38 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.586 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.38 134.3 12.13 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.551 HG22 ' OE1' ' A' ' 59' ' ' GLU . 8.8 t -88.53 -47.22 8.47 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.422 ' N ' HG23 ' A' ' 5' ' ' THR . 57.4 t -129.14 125.39 62.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -165.96 62.26 0.11 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -62.68 135.21 95.64 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.436 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.92 158.12 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.48 2.12 . . . . 0.0 112.461 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' CE1' ' A' ' 27' ' ' HIS . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 10' ' ' THR . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.664 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.651 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.612 ' O ' HD21 ' A' ' 77' ' ' LEU . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 68' ' ' ILE . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' CD2' ' A' ' 64' ' ' PHE . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' OE1' HG22 ' A' ' 5' ' ' THR . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 61.5 m80 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.472 HG22 ' CE3' ' A' ' 69' ' ' TRP . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.651 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 47' ' ' THR . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' C ' HD13 ' A' ' 110' ' ' LEU . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' C ' ' HG ' ' A' ' 134' ' ' SER . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.82 151.22 27.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.615 ' HB1' ' C ' ' A' ' 105' ' ' GLU . . . -54.21 134.61 44.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.49 126.11 28.61 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 63.68 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.519 0.512 . . . . 0.0 110.52 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -136.64 -14.55 1.66 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.406 0.282 . . . . 0.0 111.724 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 39.8 mt-10 -141.37 167.17 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -176.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 p 91.63 37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.295 1.038 . . . . 0.0 112.458 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 38.0 t70 -74.13 121.98 22.01 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.915 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 129' ' ' PHE . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.475 ' CE1' HD23 ' A' ' 110' ' ' LEU . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 68' ' ' ILE . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.8 137.45 58.05 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.6 t -106.46 -64.63 1.15 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.991 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? 44.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 145' ' ' THR . 7.5 m 76.6 -5.83 2.11 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.856 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 55.1 31.58 16.56 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 120.793 0.33 . . . . 0.0 111.107 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.742 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t 61.24 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.481 0.312 . . . . 0.0 111.31 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -152.89 109.76 3.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.44 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.74 24.56 76.25 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.012 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.2 p -130.35 163.55 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.714 0.257 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.58 159.85 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.778 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.0 m -123.81 145.19 49.24 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.667 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -79.84 152.37 74.59 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.225 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.15 158.93 51.11 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.359 2.04 . . . . 0.0 111.592 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' HG ' ' A' ' 55' ' ' LEU . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 42' ' ' ALA . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 55' ' ' LEU . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 68' ' ' ILE . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 16' ' ' VAL . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.541 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 27' ' ' HIS . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 44.9 m80 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD2' HG22 ' A' ' 57' ' ' THR . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 139' ' ' VAL . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.705 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD11 ' CE2' ' A' ' 39' ' ' PHE . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.705 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HB3' HD22 ' A' ' 133' ' ' LEU . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.441 ' O ' HD23 ' A' ' 133' ' ' LEU . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.787 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 91' ' ' ILE . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.788 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.97 37.75 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 105' ' ' GLU . . . 42.88 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.713 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.92 128.33 36.69 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 65.03 -75.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -133.72 -15.94 2.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.331 0.252 . . . . 0.0 111.632 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' HB1' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -161.99 178.67 8.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.921 -175.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 t 70.16 82.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.341 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.21 130.63 43.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.611 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 118' ' ' THR . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.787 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 96' ' ' ALA . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.517 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 65' ' ' THR . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.1 112.24 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.2 t -64.23 -45.84 86.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -159.18 159.56 34.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.062 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.9 p -116.85 12.04 14.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.208 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -61.25 -49.01 78.83 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.146 0.498 . . . . 0.0 110.071 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.091 176.171 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -111.35 119.28 38.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.613 0.244 . . . . 0.0 110.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt 49.34 -175.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.936 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 154.74 25.8 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.8 m -129.43 132.11 46.91 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.614 0.245 . . . . 0.0 110.438 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.31 40.94 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.791 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -117.26 146.32 43.37 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -145.43 159.48 48.22 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.952 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.26 158.8 55.97 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.036 1.824 . . . . 0.0 111.222 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' CE1' ' A' ' 27' ' ' HIS . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' HIS . . . . . 0.639 ' ND1' HD21 ' A' ' 55' ' ' LEU . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 68' ' ' ILE . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD21 ' ND1' ' A' ' 27' ' ' HIS . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.617 HG22 ' CD2' ' A' ' 64' ' ' PHE . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD12 ' CD2' ' A' ' 39' ' ' PHE . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.19 33.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -48.95 131.25 18.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.391 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.71 129.38 38.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.095 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 63.25 -82.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.642 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -135.86 -7.83 2.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.613 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 14.1 mp0 -138.96 174.53 10.41 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t 76.28 44.12 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.05 0.94 . . . . 0.0 112.754 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 37.5 t70 -90.72 114.92 27.37 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.9 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.697 HD21 ' OE2' ' A' ' 132' ' ' GLU . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.484 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.697 ' OE2' HD21 ' A' ' 110' ' ' LEU . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -59.77 138.39 57.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.8 t -126.08 130.83 51.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.498 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -154.43 160.0 41.39 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.633 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -119.71 -21.88 7.09 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 58.69 160.2 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.2 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.5 pp . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.031 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.501 1.962 0 CA-C-O 120.892 0.288 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 31' ' ' PRO . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 29' ' ' VAL . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 64' ' ' PHE . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.1 m170 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.439 ' NH2' HD12 ' A' ' 133' ' ' LEU . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.482 ' H ' HD13 ' A' ' 133' ' ' LEU . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 136' ' ' LEU . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 . . . . . 0 N--CA 1.448 -0.563 0 CA-C-O 120.393 0.14 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.483 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.502 2.019 0 CA-C-O 120.654 0.189 . . . . 0.0 111.782 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.622 HG23 ' H ' ' A' ' 32' ' ' GLY . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.622 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 68' ' ' ILE . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.448 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.635 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.635 ' CD2' HG22 ' A' ' 57' ' ' THR . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.568 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 39' ' ' PHE . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.568 ' CE3' HG22 ' A' ' 67' ' ' THR . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 122' ' ' VAL . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.822 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.571 ' OG ' HD21 ' A' ' 110' ' ' LEU . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.3 t70 . . . . . 0 C--O 1.236 0.376 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 129' ' ' PHE . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.417 HG21 ' CD ' ' A' ' 85' ' ' GLU . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 110' ' ' LEU . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.56 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo . . . . . 0 N--CA 1.5 1.876 0 N-CA-C 111.432 -0.257 . . . . 0.0 111.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 27' ' ' HIS . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 41' ' ' TYR . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 12' ' ' VAL . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.682 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.553 ' CE1' HD13 ' A' ' 136' ' ' LEU . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.614 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' C ' ' HG ' ' A' ' 134' ' ' SER . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.9 t0 . . . . . 0 C--O 1.238 0.475 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 96' ' ' ALA . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 110' ' ' LEU . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 39' ' ' PHE . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 N--CA 1.502 2.014 0 N-CA-C 111.502 -0.23 . . . . 0.0 111.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 54' ' ' SER . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 27' ' ' HIS . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.606 ' HB2' HE22 ' A' ' 52' ' ' GLN . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 12' ' ' VAL . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.606 HE22 ' HB2' ' A' ' 13' ' ' ALA . 98.8 mm-40 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.514 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 57' ' ' THR . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.523 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 136' ' ' LEU . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 117' ' ' VAL . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' OE2' HG21 ' A' ' 122' ' ' VAL . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 86' ' ' VAL . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' C ' ' HG ' ' A' ' 134' ' ' SER . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.466 0.343 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 134' ' ' SER . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' ALA . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 85' ' ' GLU . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.461 ' CB ' HD11 ' A' ' 110' ' ' LEU . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.512 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.735 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 N--CA 1.5 1.887 0 CA-C-O 120.754 0.231 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 12' ' ' VAL . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.558 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 68' ' ' ILE . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 27' ' ' HIS . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.591 HG22 ' CE3' ' A' ' 69' ' ' TRP . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.591 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 41.3 t0 . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 110.593 -0.151 . . . . 0.0 110.593 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 133' ' ' LEU . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.482 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.558 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 N--CA 1.502 2.012 0 CA-C-O 120.843 0.268 . . . . 0.0 111.989 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 27' ' ' HIS . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 16' ' ' VAL . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 12' ' ' VAL . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' ' 86' ' ' VAL . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.414 ' O ' HD21 ' A' ' 77' ' ' LEU . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 55' ' ' LEU . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' PHE . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.626 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 47' ' ' THR . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.419 ' HE1' HD21 ' A' ' 133' ' ' LEU . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 136' ' ' LEU . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' SG ' ' A' ' 37' ' ' CYS . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.418 ' OG ' HD21 ' A' ' 110' ' ' LEU . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.419 HD21 ' HE1' ' A' ' 79' ' ' PHE . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.439 ' CB ' HD11 ' A' ' 110' ' ' LEU . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 84' ' ' ALA . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.487 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo . . . . . 0 N--CA 1.505 2.18 0 CA-C-O 120.885 0.286 . . . . 0.0 112.693 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 53' ' ' MET . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 53' ' ' MET . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.458 ' O ' HD21 ' A' ' 77' ' ' LEU . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 11' ' ' THR . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 69' ' ' TRP . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.409 ' O ' HD22 ' A' ' 133' ' ' LEU . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 47' ' ' THR . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HE1' HD21 ' A' ' 133' ' ' LEU . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.405 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.541 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HB2' ' HE2' ' A' ' 35' ' ' TYR . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 94' ' ' ALA . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 134' ' ' SER . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 67.9 t0 . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 119' ' ' LYS . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 133' ' ' LEU . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 84' ' ' ALA . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 N--CA 1.5 1.893 0 CA-C-O 120.834 0.264 . . . . 0.0 112.059 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 16' ' ' VAL . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 31' ' ' PRO . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 29' ' ' VAL . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 89' ' ' ALA . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 68' ' ' ILE . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.624 HG22 ' CD2' ' A' ' 64' ' ' PHE . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.9 m170 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' CE3' ' A' ' 69' ' ' TRP . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.505 HD12 ' CD2' ' A' ' 39' ' ' PHE . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 67' ' ' THR . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.437 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 86' ' ' VAL . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.5 t70 . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 111.552 0.205 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 134' ' ' SER . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 119' ' ' LYS . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 118' ' ' THR . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.569 ' HB3' HD11 ' A' ' 110' ' ' LEU . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.567 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.509 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.75 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo . . . . . 0 N--CA 1.503 2.037 0 CA-C-O 120.569 0.154 . . . . 0.0 111.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.626 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.676 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.431 ' HG2' HG23 ' A' ' 68' ' ' ILE . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 . . . . . 0 N--CA 1.449 -0.522 0 CA-C-O 120.577 0.227 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 79' ' ' PHE . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.626 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo . . . . . 0 N--CA 1.505 2.197 0 CA-C-O 120.939 0.308 . . . . 0.0 112.123 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.455 ' ND1' HD21 ' A' ' 55' ' ' LEU . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 31' ' ' PRO . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 29' ' ' VAL . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.697 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 68' ' ' ILE . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.653 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 139' ' ' VAL . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.446 HG22 ' CE3' ' A' ' 69' ' ' TRP . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 39' ' ' PHE . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CE3' HG22 ' A' ' 67' ' ' THR . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.426 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 . . . . . 0 N--CA 1.445 -0.696 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' OG ' ' A' ' 98' ' ' SER . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 119' ' ' LYS . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 118' ' ' THR . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 97' ' ' TYR . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 96' ' ' ALA . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 N--CA 1.502 2.018 0 CA-C-O 120.754 0.231 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 16' ' ' VAL . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.625 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 m170 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CE3' HG22 ' A' ' 67' ' ' THR . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 91' ' ' ILE . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 86' ' ' VAL . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.927 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 . . . . . 0 N--CA 1.445 -0.71 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 96' ' ' ALA . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo . . . . . 0 N--CA 1.504 2.089 0 CA-C-O 120.657 0.19 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 53' ' ' MET . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 27' ' ' HIS . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.529 ' ND1' HD11 ' A' ' 55' ' ' LEU . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 68' ' ' ILE . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.442 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 11' ' ' THR . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' ND1' ' A' ' 27' ' ' HIS . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.59 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.476 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' HD1' ' A' ' 39' ' ' PHE . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 67' ' ' THR . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 133' ' ' LEU . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 18.8 t70 . . . . . 0 N--CA 1.468 0.427 0 CA-C-O 120.427 0.156 . . . . 0.0 110.609 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 96' ' ' ALA . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 N--CA 1.502 1.991 0 N-CA-C 111.43 -0.258 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 27' ' ' HIS . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 12' ' ' VAL . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 32' ' ' GLY . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.734 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.405 HG22 ' NZ ' ' A' ' 83' ' ' LYS . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.413 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 57' ' ' THR . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 139' ' ' VAL . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CE3' HG22 ' A' ' 67' ' ' THR . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.405 ' NZ ' HG22 ' A' ' 40' ' ' THR . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.573 HG22 HD11 ' A' ' 91' ' ' ILE . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.573 HD11 HG22 ' A' ' 86' ' ' VAL . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.862 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 110' ' ' LEU . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.573 -0.158 . . . . 0.0 110.573 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 98' ' ' SER . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 96' ' ' ALA . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 65' ' ' THR . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.734 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . . . . . . 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo . . . . . 0 N--CA 1.507 2.318 0 N-CA-C 111.512 -0.226 . . . . 0.0 111.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' MET . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 27' ' ' HIS . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.517 ' CE1' HG23 ' A' ' 12' ' ' VAL . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 13' ' ' ALA . 66.1 mm-40 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.651 ' O ' HG23 ' A' ' 11' ' ' THR . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 ' HB ' ' A' ' 29' ' ' VAL . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 122' ' ' VAL . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.403 ' CG1' HG22 ' A' ' 86' ' ' VAL . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 . . . . . 0 C--O 1.237 0.421 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 83' ' ' LYS . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HZ2' ' HB2' ' A' ' 97' ' ' TYR . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 96' ' ' ALA . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo . . . . . 0 N--CA 1.5 1.864 0 CA-C-O 120.79 0.246 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 12' ' ' VAL . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.641 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 68' ' ' ILE . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.484 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.522 HG22 ' CE3' ' A' ' 69' ' ' TRP . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.522 ' CE3' HG22 ' A' ' 67' ' ' THR . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ2' ' HA ' ' A' ' 124' ' ' HIS . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.404 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 C--O 1.238 0.457 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . 0.418 ' HA ' ' HZ2' ' A' ' 83' ' ' LYS . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 133' ' ' LEU . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.577 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.498 1.767 0 N-CA-C 111.404 -0.268 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.603 HG21 ' CE1' ' A' ' 27' ' ' HIS . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CE1' HG21 ' A' ' 10' ' ' THR . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.738 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 89' ' ' ALA . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.641 ' CE2' HD11 ' A' ' 68' ' ' ILE . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.402 ' O ' HD21 ' A' ' 77' ' ' LEU . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.757 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 139' ' ' VAL . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' CE3' ' A' ' 69' ' ' TRP . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.641 HD11 ' CE2' ' A' ' 39' ' ' PHE . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.619 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 47' ' ' THR . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.756 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 N--CA 1.441 -0.876 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 134' ' ' SER . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 119' ' ' LYS . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 118' ' ' THR . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 133' ' ' LEU . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.444 ' CB ' HD11 ' A' ' 110' ' ' LEU . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 96' ' ' ALA . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.757 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo . . . . . 0 N--CA 1.504 2.124 0 CA-C-O 120.552 0.147 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' HE1' ' A' ' 27' ' ' HIS . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 41' ' ' TYR . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HE1' HG22 ' A' ' 10' ' ' THR . 21.7 t-160 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 16' ' ' VAL . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.407 HD11 ' ND1' ' A' ' 27' ' ' HIS . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 64' ' ' PHE . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.731 ' HD2' HG22 ' A' ' 57' ' ' THR . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' CE3' ' A' ' 69' ' ' TRP . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.975 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 110' ' ' LEU . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 66.1 t0 . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 98' ' ' SER . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.975 HD23 ' HB2' ' A' ' 96' ' ' ALA . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.499 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.597 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.498 1.773 0 CA-C-O 120.773 0.239 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' CE1' ' A' ' 27' ' ' HIS . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 10' ' ' THR . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.664 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.651 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.612 ' O ' HD21 ' A' ' 77' ' ' LEU . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 68' ' ' ILE . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' CD2' ' A' ' 64' ' ' PHE . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.472 HG22 ' CE3' ' A' ' 69' ' ' TRP . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.651 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 47' ' ' THR . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' C ' HD13 ' A' ' 110' ' ' LEU . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.423 ' C ' ' HG ' ' A' ' 134' ' ' SER . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 129' ' ' PHE . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.475 ' CE1' HD23 ' A' ' 110' ' ' LEU . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 68' ' ' ILE . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.501 1.959 0 N-CA-C 111.592 -0.195 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' HG ' ' A' ' 55' ' ' LEU . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 42' ' ' ALA . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 55' ' ' LEU . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 68' ' ' ILE . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 16' ' ' VAL . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.541 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 27' ' ' HIS . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD2' HG22 ' A' ' 57' ' ' THR . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 139' ' ' VAL . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.705 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 HD11 ' CE2' ' A' ' 39' ' ' PHE . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.705 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HB3' HD22 ' A' ' 133' ' ' LEU . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.441 ' O ' HD23 ' A' ' 133' ' ' LEU . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.787 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 91' ' ' ILE . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.788 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 118' ' ' THR . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.787 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 96' ' ' ALA . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 65' ' ' THR . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.505 2.174 0 N-CA-C 111.222 -0.338 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' CE1' ' A' ' 27' ' ' HIS . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' HIS . . . . . 0.639 ' ND1' HD21 ' A' ' 55' ' ' LEU . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 68' ' ' ILE . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.639 HD21 ' ND1' ' A' ' 27' ' ' HIS . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.617 HG22 ' CD2' ' A' ' 64' ' ' PHE . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.432 HD12 ' CD2' ' A' ' 39' ' ' PHE . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.697 HD21 ' OE2' ' A' ' 132' ' ' GLU . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.484 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.697 ' OE2' HD21 ' A' ' 110' ' ' LEU . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . . . . . . 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.394 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.8 t -133.87 124.03 25.76 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.69 0.281 . . . . 0.0 110.866 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -133.49 148.67 51.71 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.529 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.42 165.45 54.8 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.531 HG22 ' OE2' ' A' ' 59' ' ' GLU . 82.2 p -128.38 158.81 37.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.682 0.277 . . . . 0.0 110.855 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.2 t -124.47 127.89 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.17 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.1 m -127.16 148.74 50.17 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.665 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -128.44 88.93 51.09 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.435 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.83 151.15 62.72 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.148 1.899 . . . . 0.0 112.247 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.6 m -123.0 133.24 54.37 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.74 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -99.55 141.57 32.18 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.953 0.406 . . . . 0.0 111.809 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.8 t -130.98 130.39 63.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.231 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.3 143.28 37.38 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.611 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -146.03 160.84 41.32 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.324 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -100.44 127.1 46.87 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.408 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 99.0 t -94.83 108.04 20.27 Favored 'Isoleucine or valine' 0 C--N 1.345 0.372 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.3 mtp85 -109.41 112.38 59.15 Favored Pre-proline 0 CA--C 1.552 1.053 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.254 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.74 173.05 15.15 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 C-N-CA 122.29 1.993 . . . . 0.0 112.235 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.18 12.18 0.74 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-N 115.779 -0.646 . . . . 0.0 112.409 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.6 26.71 73.66 Favored Glycine 0 CA--C 1.533 1.209 0 N-CA-C 111.651 -0.58 . . . . 0.0 111.651 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.8 t -110.25 128.11 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.2 t -73.51 120.05 21.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.213 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.11 138.33 51.34 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.718 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.4 m -117.34 127.12 53.74 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.789 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -127.49 144.38 51.07 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.646 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 97.2 p -154.3 162.94 40.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.917 0.389 . . . . 0.0 111.76 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 19.4 t-80 -139.11 131.13 27.9 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.241 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -101.97 164.49 11.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.02 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG12 ' HD2' ' A' ' 31' ' ' PRO . 66.3 t -121.3 129.4 75.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.29 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -50.33 -66.27 2.47 Favored Glycine 0 CA--C 1.547 2.085 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HG12 ' A' ' 29' ' ' VAL . 73.5 Cg_exo -54.57 -40.44 83.9 Favored 'Trans proline' 0 N--CA 1.506 2.208 0 C-N-CA 121.992 1.795 . . . . 0.0 111.593 177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.39 83.29 1.25 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -60.52 -36.27 77.97 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.444 0.164 . . . . 0.0 111.36 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -95.19 -18.37 20.96 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -80.83 119.31 23.22 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.099 0.249 . . . . 0.0 111.164 -177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -158.18 160.61 37.4 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.53 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.1 m -115.68 141.67 47.77 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.929 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -125.87 145.04 50.41 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.757 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -139.49 113.01 8.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.615 -178.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.4 m -116.14 127.01 54.47 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.73 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -154.29 161.78 41.57 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.94 136.1 50.87 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.793 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 m -132.48 154.18 50.16 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.409 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -125.84 129.51 49.54 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.937 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.9 -173.0 41.47 Favored Glycine 0 C--O 1.237 0.331 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -4.16 12.29 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-O 119.742 -0.477 . . . . 0.0 113.208 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 63.6 m -130.13 130.14 44.4 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 117.47 0.635 . . . . 0.0 111.553 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -85.97 178.4 7.28 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.168 177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -157.94 174.02 15.88 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.317 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -113.4 129.45 56.54 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.141 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -115.18 144.55 43.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.666 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -101.08 145.94 28.1 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 123.426 0.454 . . . . 0.0 110.048 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 90.7 mtp -123.95 151.34 43.73 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.318 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.2 t -141.58 123.49 15.34 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 123.574 0.546 . . . . 0.0 110.372 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.38 145.38 51.19 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.518 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.53 155.5 26.12 Favored Glycine 0 C--O 1.238 0.369 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.512 HG22 ' CD2' ' A' ' 64' ' ' PHE . 77.8 p -130.49 156.05 45.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.575 -0.313 . . . . 0.0 110.252 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -66.94 152.44 45.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.87 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.531 ' OE2' HG22 ' A' ' 5' ' ' THR . 25.0 pt-20 -55.74 -27.99 53.53 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 123.117 0.261 . . . . 0.0 111.226 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -105.93 10.52 32.36 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.95 177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.1 m170 60.72 28.56 18.28 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 122.853 0.461 . . . . 0.0 111.952 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -77.78 -29.41 50.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.868 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -130.23 143.98 51.1 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.794 0.33 . . . . 0.0 111.329 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.9 m-85 -127.95 137.01 52.1 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.219 178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.88 142.17 36.54 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.7 m -129.33 132.77 47.17 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.429 177.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.4 m -129.36 133.53 47.45 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.805 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -126.49 129.03 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 26.5 p90 -150.37 161.94 41.51 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.488 174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.439 ' NH2' HD12 ' A' ' 133' ' ' LEU . 31.7 ptt-85 -92.29 153.93 42.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.07 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.88 -36.83 3.26 Favored 'Trans proline' 0 N--CA 1.513 2.631 0 C-N-CA 122.721 2.28 . . . . 0.0 113.7 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -64.18 -39.44 94.0 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.086 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.73 -27.11 21.28 Favored Glycine 0 CA--C 1.538 1.495 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -142.08 121.16 12.93 Favored 'General case' 0 C--N 1.347 0.492 0 C-N-CA 122.398 0.279 . . . . 0.0 110.351 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.482 ' H ' HD13 ' A' ' 133' ' ' LEU . 29.4 t -116.79 135.37 53.8 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -102.84 88.06 3.1 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.227 0.537 . . . . 0.0 111.436 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.0 mt -141.38 150.05 41.89 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.317 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 54.4 t80 -93.73 98.25 10.98 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -84.86 132.17 34.43 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.568 -176.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.3 m -73.24 -43.05 61.81 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.554 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.26 165.73 0.22 Allowed 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.12 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.412 ' CD1' HD21 ' A' ' 136' ' ' LEU . 53.1 p90 -137.46 148.88 46.43 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 121.005 -0.278 . . . . 0.0 111.569 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt -142.97 151.23 40.68 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.158 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.02 145.29 32.11 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.385 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -153.94 163.61 39.78 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.463 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.76 157.5 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 120.635 0.255 . . . . 0.0 111.354 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -132.79 148.51 52.32 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.317 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.19 3.11 90.72 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.295 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.96 168.79 26.13 Favored 'General case' 0 C--N 1.346 0.45 0 CA-C-N 117.052 0.426 . . . . 0.0 110.976 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.6 pt-20 -103.87 147.46 27.29 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.958 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 74.2 mt -88.24 123.69 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.83 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -83.27 -40.58 19.38 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.091 177.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -170.17 132.98 1.09 Allowed 'General case' 0 C--N 1.345 0.378 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.596 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.66 133.15 53.32 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.125 178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -159.74 170.01 22.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.263 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.496 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -140.8 158.73 43.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.886 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -118.39 107.2 13.56 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -68.37 -41.07 81.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.522 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -133.02 131.36 40.6 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.286 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.04 147.05 28.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.354 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.612 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -55.85 138.21 48.71 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.169 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -107.95 112.07 24.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.888 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 49.0 -85.24 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.812 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -115.38 23.34 12.5 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.612 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 60.5 mt-10 -123.0 144.55 49.18 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.109 0.481 . . . . 0.0 111.644 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.7 t -72.1 145.88 47.89 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.273 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -77.01 162.15 27.77 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.536 -1.211 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -111.24 107.4 57.31 Favored Pre-proline 0 CA--C 1.564 1.514 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.472 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -84.13 152.87 12.58 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 C-N-CA 122.382 2.054 . . . . 0.0 112.649 178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.5 mt -74.74 150.17 39.52 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 176.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -66.34 131.63 46.53 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.81 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -61.3 -37.17 82.26 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.066 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.65 -1.65 2.89 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -62.83 -28.7 70.19 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.561 0.219 . . . . 0.0 110.829 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.9 164.11 37.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.874 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.607 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.9 tp10 -115.24 131.12 57.03 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.413 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -129.61 147.04 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.439 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.561 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 67.2 p -136.97 165.3 26.32 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.071 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.45 -21.55 60.21 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.348 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.3 t -148.27 24.03 1.03 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.561 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -160.15 163.71 33.49 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.57 0.224 . . . . 0.0 111.028 179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -137.58 140.8 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.627 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.51 160.0 42.69 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.578 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -112.87 158.96 19.52 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.6 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 39.2 mmt180 -112.66 148.84 40.14 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.242 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -71.3 152.22 61.0 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 C-N-CA 122.016 1.81 . . . . 0.0 111.261 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.03 14.22 80.97 Favored Glycine 0 CA--C 1.54 1.635 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.079 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.96 146.7 4.47 Favored 'General case' 0 C--N 1.349 0.559 0 CA-C-O 120.966 0.412 . . . . 0.0 111.065 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -69.63 145.25 52.59 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.435 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -133.34 152.89 51.95 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.874 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.552 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 55.81 17.6 2.55 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.313 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -101.99 130.9 48.64 Favored 'General case' 0 C--N 1.348 0.501 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.482 HD13 ' H ' ' A' ' 75' ' ' SER . 0.4 OUTLIER -107.33 126.53 52.57 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.49 -178.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.4 t -159.18 173.27 16.63 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.954 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.483 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -115.81 148.57 39.74 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.75 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.412 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.2 mp -111.34 150.5 29.63 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.957 0.408 . . . . 0.0 112.006 -178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -143.05 124.05 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.792 177.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.9 mp -125.07 127.56 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.747 -177.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.59 122.12 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -126.36 147.32 49.77 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.89 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -96.73 140.34 31.46 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.908 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.408 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -56.94 129.25 40.77 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.493 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.3 p -161.9 169.09 21.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.772 -179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 58.93 75.24 0.41 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 110.985 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 71.6 p -112.58 14.35 20.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.052 179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -145.98 142.96 29.17 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.779 0.323 . . . . 0.0 110.306 -179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.444 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.474 0.753 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.673 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.47 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.5 m -128.58 158.12 39.35 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.742 0.306 . . . . 0.0 111.01 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm 65.79 137.18 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.446 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.14 -167.55 43.02 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.4 p -125.21 155.46 40.01 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.598 0.237 . . . . 0.0 110.69 179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -132.17 160.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.171 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.8 t -148.61 149.51 31.66 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.541 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -126.38 82.2 66.4 Favored Pre-proline 0 CA--C 1.558 1.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.659 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -60.11 148.39 89.59 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.338 2.025 . . . . 0.0 111.782 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.0 m -112.03 129.36 56.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.968 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.4 m -113.57 123.53 50.19 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.322 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.3 t -130.17 129.83 65.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.72 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.5 149.67 24.16 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.312 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -145.79 160.38 41.84 Favored 'General case' 0 C--N 1.347 0.468 0 CA-C-O 120.656 0.265 . . . . 0.0 111.318 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -101.59 127.29 48.38 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.461 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.1 t -95.03 109.64 22.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 175.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.5 mtp85 -109.35 112.55 59.19 Favored Pre-proline 0 CA--C 1.55 0.962 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.423 -177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -75.86 171.24 18.55 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 122.264 1.976 . . . . 0.0 112.794 -177.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.23 12.54 0.36 Allowed Glycine 0 CA--C 1.544 1.892 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.468 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.3 26.94 72.5 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.9 t -107.66 127.79 63.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 80.0 t -72.41 120.57 21.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.415 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -116.13 138.2 51.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.618 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.7 m -118.63 130.01 55.63 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.551 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -127.95 145.82 50.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.2 p -155.9 165.03 37.7 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.847 0.356 . . . . 0.0 111.809 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -150.53 141.64 23.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.276 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -116.8 166.55 12.01 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.361 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.622 HG23 ' H ' ' A' ' 32' ' ' GLY . 29.4 m -125.94 151.64 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.481 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -61.47 -50.99 60.79 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-O 119.477 -0.624 . . . . 0.0 111.859 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.52 -42.87 43.92 Favored 'Trans proline' 0 N--CA 1.506 2.252 0 C-N-CA 121.989 1.792 . . . . 0.0 111.438 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.622 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.76 84.99 1.14 Allowed Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.397 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.42 -36.33 82.03 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.638 0.256 . . . . 0.0 110.77 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -99.5 -4.79 30.51 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 42.8 t80 -85.68 112.62 21.19 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.399 0.142 . . . . 0.0 110.949 -178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.1 m -138.82 135.14 34.28 Favored 'General case' 0 C--N 1.347 0.495 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -94.26 135.67 35.4 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 66.7 mtt -124.33 140.51 52.88 Favored 'General case' 0 CA--C 1.506 -0.742 0 CA-C-O 120.918 0.389 . . . . 0.0 111.679 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.401 ' CD2' HD12 ' A' ' 68' ' ' ILE . 89.0 m-85 -134.8 111.63 10.07 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.737 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.7 m -114.02 126.97 55.72 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.98 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -157.5 161.97 38.86 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -127.3 139.84 52.61 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.541 177.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.6 m -135.42 154.65 51.38 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -128.79 130.69 47.34 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.659 176.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 176.75 177.01 45.38 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.76 7.66 31.67 Favored Glycine 0 CA--C 1.539 1.556 0 CA-C-O 119.871 -0.405 . . . . 0.0 112.921 -179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.9 t -149.52 148.38 29.32 Favored 'General case' 0 C--N 1.348 0.525 0 CA-C-N 117.221 0.511 . . . . 0.0 111.975 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -78.38 158.48 28.75 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.725 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -131.32 148.97 52.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.473 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -102.58 126.77 49.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.414 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -125.66 144.92 50.39 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.294 -178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -104.58 138.62 40.66 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.354 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 84.5 mtp -116.73 130.58 56.81 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 66.1 m -130.06 132.54 46.23 Favored 'General case' 0 CA--C 1.505 -0.753 0 O-C-N 123.285 0.366 . . . . 0.0 110.549 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.92 148.56 50.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.912 178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -152.93 173.61 31.83 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.635 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.0 p -129.0 159.1 36.97 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.329 -0.436 . . . . 0.0 110.239 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 p -70.51 164.31 25.03 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.903 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.86 -32.61 65.99 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.072 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.6 3.99 45.57 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.655 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 44.0 m-70 59.92 24.67 13.78 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 120.765 0.317 . . . . 0.0 111.327 -178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -81.37 -28.68 34.31 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.757 177.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -124.66 145.54 49.6 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.191 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.635 ' CD2' HG22 ' A' ' 57' ' ' THR . 78.5 m-85 -129.64 140.95 51.03 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.519 -178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 10.1 t -139.9 147.29 40.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.0 m -126.04 134.72 51.35 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.319 176.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.568 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.5 m -134.16 134.53 42.26 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.6 0.238 . . . . 0.0 111.483 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.401 HD12 ' CD2' ' A' ' 39' ' ' PHE . 73.7 mt -129.08 128.67 67.34 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.083 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.568 ' CE3' HG22 ' A' ' 67' ' ' THR . 30.7 p90 -154.38 161.6 41.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.016 175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.473 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.7 ptp85 -86.11 149.52 50.3 Favored Pre-proline 0 CA--C 1.575 1.91 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -77.28 -38.63 0.72 Allowed 'Trans proline' 0 N--CA 1.511 2.505 0 C-N-CA 122.674 2.249 . . . . 0.0 113.873 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -62.85 -39.06 93.22 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.61 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.99 -22.75 38.2 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.349 -0.842 . . . . 0.0 111.515 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -140.8 120.11 13.03 Favored 'General case' 0 C--N 1.349 0.549 0 CA-C-O 120.738 0.304 . . . . 0.0 111.102 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.6 t -119.11 137.46 53.57 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.412 177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -104.33 86.69 2.58 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.225 0.536 . . . . 0.0 110.041 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.0 mt -141.49 150.58 42.39 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.383 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -100.5 94.22 6.03 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -79.67 133.91 36.4 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.774 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -73.17 -43.36 61.59 Favored 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.8 pt20 174.14 167.79 0.22 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.313 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -144.67 147.65 33.3 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.432 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -142.7 153.65 43.57 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.2 145.62 34.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.669 0.271 . . . . 0.0 111.207 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.417 ' CD ' HG21 ' A' ' 122' ' ' VAL . 15.7 pt-20 -155.42 161.53 40.97 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.513 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.53 162.49 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 O-C-N 123.242 0.339 . . . . 0.0 110.702 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -135.91 153.15 51.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.828 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.52 13.69 82.69 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.112 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.451 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . . . -161.47 169.19 22.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 116.801 0.301 . . . . 0.0 111.204 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -104.63 142.18 35.11 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.478 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.2 mt -88.09 125.14 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.622 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.85 -40.49 20.23 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.902 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -173.67 141.5 0.85 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.045 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.36 141.54 41.77 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.236 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.2 ptp -160.1 167.38 27.92 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.758 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.822 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -131.42 137.74 48.79 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.813 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -106.46 107.9 19.14 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.629 0.252 . . . . 0.0 111.437 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.571 ' OG ' HD21 ' A' ' 110' ' ' LEU . 69.1 m -66.37 -40.26 89.63 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.005 177.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -133.86 132.73 40.7 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.97 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -97.96 135.14 40.1 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.242 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.485 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -63.44 104.55 0.64 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.982 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -113.69 107.36 15.66 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.621 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 45.92 -86.56 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -91.44 0.78 57.47 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -115.03 139.06 50.17 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.454 0.169 . . . . 0.0 110.707 -178.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -83.83 162.73 20.48 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.448 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 18.3 t70 -90.56 115.38 27.65 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.177 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.81 107.12 55.63 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -84.25 158.18 13.02 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.359 2.039 . . . . 0.0 111.919 177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.828 HD22 ' CE1' ' A' ' 129' ' ' PHE . 95.7 mt -96.38 144.27 26.67 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.036 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -75.0 156.78 35.9 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.745 -0.661 . . . . 0.0 112.547 -176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.4 m -65.3 -38.87 91.56 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.9 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -54.9 -18.29 4.74 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.456 -177.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -63.33 -37.58 87.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 120.915 0.388 . . . . 0.0 110.54 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -151.96 159.85 43.66 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.623 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -113.76 130.59 56.42 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 120.842 0.354 . . . . 0.0 111.35 -179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.5 t -127.4 129.13 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.805 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.3 m -132.4 157.43 44.57 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.136 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.65 -20.1 19.7 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.0 t -142.03 7.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -152.04 142.01 22.12 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 121.102 0.477 . . . . 0.0 112.124 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.417 HG21 ' CD ' ' A' ' 85' ' ' GLU . 64.8 t -131.05 131.55 63.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.677 178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -148.93 141.59 24.47 Favored 'General case' 0 C--O 1.231 0.111 0 O-C-N 123.422 0.451 . . . . 0.0 111.317 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -79.14 154.21 29.5 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.8 mmt-85 -114.93 157.04 44.29 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.262 178.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -66.75 148.87 83.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.685 1.59 . . . . 0.0 110.849 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.85 7.17 86.09 Favored Glycine 0 CA--C 1.546 2.005 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.97 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.64 144.87 9.99 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 117.012 0.406 . . . . 0.0 110.64 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.828 ' CE1' HD22 ' A' ' 110' ' ' LEU . 67.9 m-85 -68.53 147.07 52.51 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.374 -178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -132.01 -77.07 0.51 Allowed 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.981 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -64.23 -21.09 66.45 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.796 0.332 . . . . 0.0 110.812 176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.04 135.25 38.63 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.764 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 67.9 mt -115.42 150.39 36.49 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.821 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 43.9 t -161.86 176.87 10.4 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.95 0.405 . . . . 0.0 111.905 -177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.71 152.72 31.52 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.35 177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.822 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.4 mt -112.85 141.77 46.28 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.807 -177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 137' ' ' VAL . 9.8 p -141.71 118.12 6.91 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.409 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.529 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.8 mp -121.82 127.74 75.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 -177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.74 121.34 66.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.56 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -132.31 146.14 51.77 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.253 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -96.68 127.68 42.9 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.499 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -62.09 142.45 57.56 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.824 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 99.3 p -141.88 161.67 37.38 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.863 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -87.22 123.57 32.37 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.875 -178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 91.5 m -126.85 119.72 27.49 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -157.53 147.29 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.782 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.471 0.584 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.765 -179.758 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.1 p -63.22 -23.02 67.24 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 111.544 0.201 . . . . 0.0 111.544 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -142.92 153.67 43.32 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.663 0.268 . . . . 0.0 111.139 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.21 -148.38 9.08 Favored Glycine 0 C--N 1.338 0.645 0 N-CA-C 111.091 -0.803 . . . . 0.0 111.091 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.3 t -149.63 176.07 10.98 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.771 -0.215 . . . . 0.0 110.522 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.0 m -57.91 -43.11 83.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.145 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.7 m 57.74 47.33 15.75 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.709 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -120.8 76.7 28.91 Favored Pre-proline 0 CA--C 1.558 1.269 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.22 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.42 155.98 67.49 Favored 'Trans proline' 0 N--CA 1.5 1.876 0 C-N-CA 122.0 1.8 . . . . 0.0 111.432 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.1 m -104.91 128.93 53.34 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.251 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -105.04 142.79 34.2 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.176 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.482 HG21 ' CD2' ' A' ' 27' ' ' HIS . 60.5 t -129.49 128.5 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.459 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 142.69 34.23 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.603 177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -147.13 159.7 43.3 Favored 'General case' 0 C--N 1.345 0.379 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.606 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -100.18 125.32 46.3 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.699 -179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.411 HG13 ' CE1' ' A' ' 41' ' ' TYR . 89.0 t -94.22 119.06 41.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -119.29 104.91 45.16 Favored Pre-proline 0 CA--C 1.552 1.039 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.952 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.01 170.08 21.21 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.421 2.081 . . . . 0.0 112.6 -177.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.11 22.96 0.13 Allowed Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.217 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.76 73.92 Favored Glycine 0 CA--C 1.532 1.102 0 N-CA-C 111.86 -0.496 . . . . 0.0 111.86 179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.12 127.93 71.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 60.0 t -74.74 120.09 23.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -114.29 138.03 51.03 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.629 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -121.33 128.76 52.62 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.755 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -126.17 145.91 50.17 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.894 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 91.8 p -154.32 164.56 38.41 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.388 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CD2' HG21 ' A' ' 12' ' ' VAL . 53.5 t-80 -151.67 151.72 31.85 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.051 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.3 p30 -137.3 166.76 23.01 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.299 -178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.682 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.2 m -122.14 156.08 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.361 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.89 -50.73 64.5 Favored Glycine 0 CA--C 1.547 2.079 0 CA-C-O 119.349 -0.695 . . . . 0.0 112.024 -176.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -60.91 -42.89 34.1 Favored 'Trans proline' 0 N--CA 1.507 2.295 0 CA-C-N 119.513 1.656 . . . . 0.0 110.908 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.682 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 62.79 2.12 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.972 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -61.3 -35.4 77.25 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.839 0.319 . . . . 0.0 111.093 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -91.22 -3.28 57.1 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.285 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -109.83 132.93 53.7 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.489 0.185 . . . . 0.0 110.98 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -155.75 160.79 40.6 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.802 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 70.9 m -114.38 144.53 43.13 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.66 177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.6 mtp -128.29 146.2 50.82 Favored 'General case' 0 CA--C 1.515 -0.39 0 CA-C-O 121.022 0.439 . . . . 0.0 111.324 -178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.553 ' CE1' HD13 ' A' ' 136' ' ' LEU . 69.2 t80 -137.52 112.51 9.04 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.095 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -113.25 130.7 56.16 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.7 p90 -147.88 161.62 40.92 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.028 0.442 . . . . 0.0 112.062 -178.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -131.91 130.82 42.08 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.681 177.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -138.36 156.33 47.71 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.277 0.361 . . . . 0.0 111.916 -177.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -125.53 128.8 48.55 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.924 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.75 -179.64 36.1 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -123.64 10.84 8.48 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 121.339 -0.457 . . . . 0.0 113.208 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.3 m -125.18 129.39 50.04 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.281 0.54 . . . . 0.0 110.689 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -86.75 178.21 7.08 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.124 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -159.41 152.59 22.2 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.85 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -99.9 122.21 42.49 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.936 178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -115.05 148.75 38.49 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.638 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -101.12 144.91 29.45 Favored 'General case' 0 CA--C 1.509 -0.615 0 O-C-N 123.294 0.371 . . . . 0.0 110.202 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 91.1 mtp -125.07 145.17 50.05 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 70.5 m -135.01 134.3 40.31 Favored 'General case' 0 CA--C 1.51 -0.559 0 O-C-N 123.501 0.501 . . . . 0.0 110.565 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.74 138.11 38.97 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.748 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.52 157.52 27.27 Favored Glycine 0 C--O 1.24 0.486 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.414 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.7 p -132.81 159.31 40.16 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.707 0.289 . . . . 0.0 110.944 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 37.8 t -64.9 152.73 42.33 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.123 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -56.28 -30.66 62.77 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 123.153 0.283 . . . . 0.0 111.122 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -97.77 2.41 49.46 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.52 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 60.54 29.92 19.37 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.003 0.43 . . . . 0.0 111.297 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.34 -27.18 56.39 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.394 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -135.38 148.05 49.24 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-O 121.049 0.452 . . . . 0.0 111.837 178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 89.0 m-85 -123.79 138.96 54.42 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.195 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.0 t -139.65 139.2 36.61 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.9 m -132.28 135.81 46.5 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.481 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.614 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.7 m -133.18 133.52 42.9 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.1 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 62.7 mt -125.89 125.67 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.079 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.0 p90 -155.57 165.25 37.13 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-O 121.171 0.51 . . . . 0.0 112.209 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -83.94 130.71 53.98 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.706 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.59 -37.3 9.76 Favored 'Trans proline' 0 N--CA 1.5 1.894 0 C-N-CA 121.717 1.611 . . . . 0.0 111.982 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -67.59 -39.6 84.8 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.237 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.16 -59.54 0.63 Allowed Glycine 0 CA--C 1.527 0.806 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.114 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -141.53 149.07 40.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.5 t -118.03 138.52 52.16 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.923 176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -91.41 87.44 6.43 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 121.205 0.526 . . . . 0.0 111.194 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.4 mt -142.15 150.89 41.68 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.173 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -90.33 95.41 10.17 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -80.12 139.53 36.81 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.071 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 56.3 m -78.71 -43.35 26.04 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 120.859 0.361 . . . . 0.0 110.331 178.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 179.18 166.03 0.98 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.643 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.86 139.02 53.83 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.971 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -141.86 145.27 34.46 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.425 178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.95 142.79 30.93 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.698 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.79 163.22 40.11 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.674 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.01 159.31 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.724 0.297 . . . . 0.0 111.441 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -129.91 144.15 51.17 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.226 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.47 78.38 Favored Glycine 0 CA--C 1.542 1.775 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.324 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -151.17 169.14 22.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.869 0.334 . . . . 0.0 110.641 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.35 149.87 24.99 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.008 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.9 pt -85.84 127.66 39.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.889 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -82.81 -40.24 20.66 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.676 176.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -166.78 126.41 1.5 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.119 178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -120.92 130.17 53.77 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.777 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.2 173.25 17.26 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.173 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -142.29 155.74 45.22 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.236 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' C ' ' HG ' ' A' ' 134' ' ' SER . 94.4 m-85 -114.17 108.23 16.68 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.399 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.0 m -65.56 -40.58 92.99 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.795 0.331 . . . . 0.0 110.746 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -143.81 138.62 28.83 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.538 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.83 141.97 31.88 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.027 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.701 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.82 134.24 56.7 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.585 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -67.72 126.71 30.25 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 63.21 -80.63 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.417 -177.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -144.63 3.34 1.12 Allowed 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.689 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 62.0 mt-10 -139.64 161.71 36.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 120.668 0.27 . . . . 0.0 111.707 -177.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 p 84.43 43.43 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.67 0.788 . . . . 0.0 112.717 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.701 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 64.9 t0 -88.24 115.0 25.41 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.15 177.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.76 108.03 43.45 Favored Pre-proline 0 CA--C 1.565 1.548 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.514 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -86.56 154.78 9.06 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.507 2.138 . . . . 0.0 111.991 177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 96' ' ' ALA . 52.9 mt -70.88 146.09 49.82 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.848 0.356 . . . . 0.0 111.046 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -62.24 130.56 45.93 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.792 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 86.2 m -61.26 -38.27 86.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.812 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.79 -0.48 9.08 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.471 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.57 -37.64 86.98 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 122.531 0.333 . . . . 0.0 110.153 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -161.37 164.85 29.72 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.21 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 18.7 tt0 -112.81 135.49 53.5 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.146 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.38 143.0 42.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.946 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.6 m -140.09 157.91 44.88 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.314 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 26.0 pttm -56.91 -21.88 33.15 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.083 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -147.37 20.73 1.2 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.42 153.17 24.82 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.643 0.259 . . . . 0.0 111.316 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.7 m -135.36 155.15 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.039 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.79 161.2 40.7 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.877 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -113.71 149.89 34.1 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 90.1 mmt-85 -113.86 154.03 45.96 Favored Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.02 151.74 73.22 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.728 1.619 . . . . 0.0 110.584 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.21 13.45 80.77 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.03 153.19 3.62 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-O 120.727 0.299 . . . . 0.0 110.606 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -90.64 139.05 31.08 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.179 -177.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -123.22 -58.33 1.64 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.956 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.48 -37.05 84.47 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.462 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -75.8 135.09 40.25 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.143 -175.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -109.99 156.48 20.43 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.759 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 110' ' ' LEU . 36.7 t -167.87 176.02 6.49 Favored 'General case' 0 C--N 1.347 0.481 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.486 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 10.2 ptpp? -115.2 148.49 39.02 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.413 177.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.553 HD13 ' CE1' ' A' ' 39' ' ' PHE . 4.1 mp -114.74 146.75 40.6 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.072 0.463 . . . . 0.0 111.967 -178.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.1 p -138.07 124.9 27.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.192 177.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -124.45 128.8 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.097 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 68.2 t -116.22 123.49 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 176.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.65 145.39 51.64 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.47 -178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -102.69 133.26 48.01 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.508 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.722 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -59.49 136.78 58.08 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.619 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.0 p -137.56 -39.04 0.58 Allowed 'General case' 0 C--N 1.348 0.513 0 N-CA-C 112.311 0.486 . . . . 0.0 112.311 -179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 63.4 ttm-85 -61.12 -45.4 94.85 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 123.015 0.197 . . . . 0.0 111.492 -178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 145' ' ' THR . 4.2 t 178.72 88.95 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.203 0.525 . . . . 0.0 110.15 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -63.0 -40.48 97.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.963 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.2 mt . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.922 -179.519 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.3 t -61.15 -43.86 98.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 120.669 0.271 . . . . 0.0 110.639 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -151.47 153.87 35.46 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.089 179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.49 177.66 40.86 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.3 m -121.26 120.51 35.35 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -137.53 155.67 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.08 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.2 m -132.35 148.34 52.42 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.391 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 -133.61 65.13 70.64 Favored Pre-proline 0 CA--C 1.561 1.392 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.852 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.38 145.3 98.36 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.258 1.972 . . . . 0.0 111.502 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.2 m -116.26 127.03 54.38 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.456 HG22 ' OG ' ' A' ' 54' ' ' SER . 17.8 p -109.66 131.8 54.73 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.354 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG11 ' CD2' ' A' ' 27' ' ' HIS . 27.3 m -135.68 161.52 38.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.567 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.606 ' HB2' HE22 ' A' ' 52' ' ' GLN . . . -121.34 144.5 48.61 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.438 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -140.88 157.01 45.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.934 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -102.44 126.55 49.51 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.366 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 16' ' ' VAL . 34.7 m -94.35 108.07 20.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.229 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 175.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -104.49 109.65 63.1 Favored Pre-proline 0 CA--C 1.552 1.022 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.701 -175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -77.87 172.41 15.68 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 C-N-CA 122.492 2.128 . . . . 0.0 112.668 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.71 20.39 0.27 Allowed Glycine 0 CA--C 1.538 1.495 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.462 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.7 26.58 74.28 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 111.411 -0.675 . . . . 0.0 111.411 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.7 t -117.96 129.8 73.78 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.7 t -74.76 119.39 22.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.87 138.15 50.7 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.685 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.1 m -120.77 128.54 53.0 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.823 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -126.69 148.08 49.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.885 178.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.2 p -150.0 165.65 32.04 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.909 0.385 . . . . 0.0 111.677 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.49 ' CD2' HG11 ' A' ' 12' ' ' VAL . 58.6 t-80 -150.02 147.41 27.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.692 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -151.15 167.07 28.88 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.086 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.0 m -124.8 157.53 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.444 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.91 -49.82 74.39 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-O 119.331 -0.705 . . . . 0.0 112.359 -176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.65 -44.31 37.76 Favored 'Trans proline' 0 N--CA 1.505 2.189 0 CA-C-N 119.603 1.702 . . . . 0.0 110.698 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.26 51.75 2.45 Favored Glycine 0 CA--C 1.526 0.746 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.962 177.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -60.27 -30.11 69.24 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.76 -5.08 58.32 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.627 176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.416 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 98.0 m-85 -110.8 131.85 54.7 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-O 120.566 0.222 . . . . 0.0 111.082 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.88 156.66 33.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.414 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -115.89 146.54 41.95 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.859 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 78.2 mtm -128.51 150.96 49.94 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.848 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -138.82 113.36 8.96 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.356 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.6 m -114.54 130.84 56.8 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.794 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -152.58 161.82 42.06 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -176.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.95 137.78 45.07 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.625 176.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.6 t -153.47 162.28 41.43 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -121.94 129.02 52.18 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.25 178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.89 177.79 41.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.14 -1.94 16.2 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.408 -0.425 . . . . 0.0 113.027 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.7 m -130.54 131.41 45.04 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 117.284 0.542 . . . . 0.0 110.58 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -82.32 177.34 8.82 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.796 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -147.15 151.78 37.36 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-O 120.989 0.423 . . . . 0.0 111.639 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -100.29 121.43 41.47 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.735 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -118.55 148.55 42.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.456 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.606 HE22 ' HB2' ' A' ' 13' ' ' ALA . 98.8 mm-40 -100.08 142.58 31.37 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.306 0.379 . . . . 0.0 110.35 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.6 mtm -126.22 128.02 46.57 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.334 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.514 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 71.8 m -118.52 129.1 55.17 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 123.491 0.494 . . . . 0.0 110.816 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.78 138.62 48.65 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.767 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.81 155.67 26.28 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.532 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.8 p -131.49 157.98 42.09 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.909 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.9 t -68.36 152.95 44.68 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.077 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.37 -25.51 59.59 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 123.234 0.334 . . . . 0.0 111.183 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -95.93 -0.7 50.46 Favored 'General case' 0 CA--C 1.554 1.111 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.653 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.7 m-70 61.91 25.68 15.45 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 122.613 0.365 . . . . 0.0 111.528 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -87.46 -28.56 22.01 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.986 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -118.08 141.09 48.85 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 120.729 0.3 . . . . 0.0 111.197 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CD2' HG22 ' A' ' 57' ' ' THR . 98.6 m-85 -128.19 137.2 51.95 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.295 178.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.6 t -140.15 138.19 35.02 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.4 m -131.01 135.16 47.35 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.696 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.523 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.8 m -131.63 131.54 43.3 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.56 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.6 mt -123.82 125.55 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.163 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.523 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.9 p90 -156.72 165.42 36.28 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -82.8 123.7 77.83 Favored Pre-proline 0 CA--C 1.562 1.421 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.62 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -70.03 -34.65 13.29 Favored 'Trans proline' 0 N--CA 1.502 2.026 0 C-N-CA 121.763 1.642 . . . . 0.0 112.022 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -68.38 -38.85 81.74 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.206 178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.59 -67.11 0.46 Allowed Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -142.4 152.34 42.73 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 93.6 p -117.14 145.11 44.02 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.087 -0.961 . . . . 0.0 109.854 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -101.44 87.3 3.16 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.271 0.558 . . . . 0.0 111.135 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 75.2 mt -141.92 150.02 40.93 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.392 176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -93.47 95.32 9.19 Favored 'General case' 0 C--N 1.343 0.313 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -81.83 136.5 35.37 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.053 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.8 m -73.12 -43.21 61.98 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 176.7 168.53 0.51 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.449 177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 136' ' ' LEU . 50.3 p90 -140.45 146.95 38.92 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 123.147 0.28 . . . . 0.0 111.166 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -142.24 153.49 44.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.548 -177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' HG11 ' A' ' 117' ' ' VAL . . . -142.82 145.59 33.35 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 123.212 0.32 . . . . 0.0 110.463 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' OE2' HG21 ' A' ' 122' ' ' VAL . 16.2 pt-20 -154.13 163.76 39.58 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -178.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.411 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -130.22 157.88 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 CA-C-O 120.723 0.297 . . . . 0.0 111.461 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -129.54 148.35 51.43 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.396 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.92 -9.0 78.75 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.135 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.735 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -152.15 167.0 29.96 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -104.09 140.27 38.0 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.25 179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.411 ' CG1' HG22 ' A' ' 86' ' ' VAL . 78.8 mt -77.91 122.2 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.54 -177.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -82.83 -39.06 22.19 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.195 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -162.73 132.46 4.4 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.702 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.94 134.91 47.77 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.073 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -157.54 173.15 17.31 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.701 -179.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -144.7 158.68 43.68 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' C ' ' HG ' ' A' ' 134' ' ' SER . 92.9 m-85 -114.94 107.98 16.11 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.629 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -64.39 -42.02 96.35 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.92 0.39 . . . . 0.0 110.592 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -145.13 135.35 23.99 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.244 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.4 148.35 28.28 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.881 178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -51.96 131.69 31.6 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.84 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -87.05 127.84 35.1 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.865 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 66.39 -77.06 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 35.9 mtp-105 -135.8 -16.27 1.75 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -148.06 174.57 11.79 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 111.703 0.261 . . . . 0.0 111.703 -176.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p 95.63 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 124.535 1.134 . . . . 0.0 112.856 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -84.37 114.95 22.25 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.999 176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.73 108.56 62.13 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.146 -177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -84.6 154.81 11.98 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.478 2.119 . . . . 0.0 112.506 177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 134' ' ' SER . 49.0 mt -74.17 152.26 39.85 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 120.81 0.338 . . . . 0.0 111.174 176.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -64.64 132.9 51.02 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.569 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 89.4 m -60.59 -38.43 84.6 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.977 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.66 4.57 3.84 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.41 83.04 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.609 0.242 . . . . 0.0 110.426 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -150.9 163.59 38.31 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.543 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.6 tp10 -118.33 130.2 55.88 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.171 -178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.45 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.9 m -129.14 146.23 34.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.397 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 121' ' ' ALA . 17.0 m -142.15 156.85 45.37 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.265 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.2 pttt -58.99 -21.59 59.13 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.614 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.79 19.76 1.82 Allowed 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -151.73 148.99 28.56 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.94 0.4 . . . . 0.0 111.317 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.445 HG21 ' OE2' ' A' ' 85' ' ' GLU . 57.5 t -131.25 130.67 63.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.673 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -149.98 157.08 42.79 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.933 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.0 p-80 -113.8 135.37 54.03 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.679 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -85.37 146.24 44.27 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 116.222 -0.444 . . . . 0.0 112.023 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -59.94 146.67 95.32 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.14 1.893 . . . . 0.0 111.231 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 78.11 14.65 82.05 Favored Glycine 0 CA--C 1.54 1.636 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.122 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 146.48 20.05 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-N 116.802 0.301 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -71.43 146.05 48.91 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.495 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.4 -54.74 1.35 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.878 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -75.51 -17.51 60.08 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.199 -0.455 . . . . 0.0 112.15 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -78.08 136.77 37.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.755 0.312 . . . . 0.0 111.261 -177.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.43 137.74 51.73 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.836 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.461 ' CB ' HD11 ' A' ' 110' ' ' LEU . 34.2 t -161.39 176.93 10.61 Favored 'General case' 0 C--N 1.348 0.505 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.512 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 17.3 ptpt -115.2 145.34 42.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.53 177.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 82' ' ' PHE . 4.9 mp -112.13 147.85 35.23 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.2 p -138.84 125.05 24.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.247 176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -123.45 127.93 74.45 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.646 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 58.6 t -116.93 123.84 72.26 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.22 146.45 52.02 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.48 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.735 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.2 ttpp -97.31 150.2 21.23 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.154 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.01 139.96 58.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.55 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.71 14.51 1.94 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.6 ttm-85 -137.42 125.84 23.43 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-O 120.545 0.212 . . . . 0.0 110.813 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 30.0 m -137.87 106.24 5.8 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -167.94 154.16 7.53 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.645 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.879 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.489 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 t 69.41 -67.38 0.22 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 122.589 0.356 . . . . 0.0 111.654 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -59.59 -45.05 93.03 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.224 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.11 149.29 21.26 Favored Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 80.8 p -134.66 158.92 42.83 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.515 0.197 . . . . 0.0 110.71 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.85 149.21 31.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.501 177.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 95.1 p -162.37 164.03 27.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.941 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -129.87 68.83 81.26 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.894 177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.5 147.1 57.36 Favored 'Trans proline' 0 N--CA 1.5 1.887 0 C-N-CA 122.099 1.866 . . . . 0.0 112.067 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 76.1 m -132.07 133.6 44.55 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.622 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.3 m -115.01 125.54 53.71 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.621 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.54 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -133.41 133.34 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.425 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -97.85 150.03 21.73 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.194 177.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -143.76 160.32 40.95 Favored 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.09 0.244 . . . . 0.0 111.146 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -98.32 125.79 43.58 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.531 -177.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.5 t -95.43 108.95 21.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.367 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 77.1 mtp85 -112.57 110.7 52.44 Favored Pre-proline 0 CA--C 1.554 1.11 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.918 -177.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.46 171.69 16.45 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.36 2.04 . . . . 0.0 112.583 -178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 143.58 18.65 0.22 Allowed Glycine 0 CA--C 1.543 1.82 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.491 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 27.38 73.31 Favored Glycine 0 CA--C 1.532 1.12 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -114.32 129.52 70.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.9 t -74.86 119.59 22.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -113.5 138.27 50.37 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.499 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.3 m -116.24 128.07 55.28 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.056 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -126.28 146.42 50.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.269 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 82.9 p -152.41 166.15 32.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 120.779 0.323 . . . . 0.0 111.452 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.54 ' CD2' HG21 ' A' ' 12' ' ' VAL . 62.9 t-80 -149.16 144.53 26.66 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.835 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -149.69 166.82 28.21 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.829 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.3 m -126.28 161.5 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.519 -179.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.75 -68.47 1.67 Allowed Glycine 0 CA--C 1.549 2.156 0 CA-C-O 119.443 -0.643 . . . . 0.0 111.913 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.74 -41.55 68.97 Favored 'Trans proline' 0 N--CA 1.509 2.391 0 C-N-CA 122.113 1.875 . . . . 0.0 111.578 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.48 28.9 8.33 Favored Glycine 0 CA--C 1.534 1.24 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.822 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 41.8 p-10 -56.37 -33.26 65.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.756 0.278 . . . . 0.0 111.338 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -62.15 -36.07 80.7 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.768 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.558 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 92.4 m-85 -93.23 134.14 35.72 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.999 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -156.46 154.59 30.64 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -107.73 143.0 36.86 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.803 177.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 74.9 mtm -127.52 139.65 52.65 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-O 121.045 0.45 . . . . 0.0 110.941 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.46 ' CD1' HD11 ' A' ' 68' ' ' ILE . 94.6 m-85 -133.02 111.36 10.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.076 -0.966 . . . . 0.0 110.548 178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.0 m -112.12 132.59 54.77 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.405 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.6 p90 -150.93 160.69 43.75 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.038 0.447 . . . . 0.0 112.188 -178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -124.61 133.49 53.24 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.502 177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -134.28 153.89 51.61 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.012 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -126.71 129.39 48.32 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.146 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 160.54 -172.84 37.0 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -127.75 11.12 6.67 Favored Glycine 0 CA--C 1.541 1.668 0 CA-C-O 119.802 -0.443 . . . . 0.0 113.029 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 82.8 m -124.62 128.32 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.553 0.677 . . . . 0.0 111.501 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -92.12 154.97 18.37 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.171 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.19 173.46 13.9 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 123.118 0.261 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -113.48 129.35 56.57 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.444 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -114.01 146.98 39.4 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.964 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.5 mm100 -100.54 140.22 35.11 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.609 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 68.6 mtm -125.17 139.57 53.64 Favored 'General case' 0 CA--C 1.512 -0.51 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.9 m -136.84 136.04 38.43 Favored 'General case' 0 CA--C 1.515 -0.367 0 O-C-N 123.544 0.527 . . . . 0.0 110.414 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD21 ' CE1' ' A' ' 27' ' ' HIS . 0.8 OUTLIER -139.16 152.16 47.2 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.696 179.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.02 168.36 33.97 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 79.0 p -132.0 160.01 37.09 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.849 0.357 . . . . 0.0 111.238 -178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 29.4 t -67.53 160.53 27.47 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.688 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -57.52 -28.19 63.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.273 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -93.48 -0.95 56.2 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.607 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.9 m-70 61.55 27.5 16.98 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-O 120.754 0.311 . . . . 0.0 111.553 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -93.13 -30.59 15.18 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.675 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -105.51 133.83 49.61 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.817 0.341 . . . . 0.0 111.177 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.4 m-85 -124.04 129.1 50.34 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.323 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.0 t -136.98 142.95 42.57 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 82.4 m -127.92 135.55 50.12 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.896 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.591 HG22 ' CE3' ' A' ' 69' ' ' TRP . 46.2 m -129.57 130.18 45.37 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.438 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 68.3 mt -131.3 126.82 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.458 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.591 ' CE3' HG22 ' A' ' 67' ' ' THR . 29.3 p90 -151.11 162.47 40.8 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 123.284 0.365 . . . . 0.0 110.696 178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 6.4 ptp85 -78.28 153.06 79.32 Favored Pre-proline 0 CA--C 1.566 1.567 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.649 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.29 -42.5 0.22 Allowed 'Trans proline' 0 N--CA 1.509 2.432 0 C-N-CA 122.491 2.127 . . . . 0.0 114.127 -178.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -66.01 -37.65 86.45 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.834 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.52 -20.27 40.03 Favored Glycine 0 CA--C 1.539 1.591 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.028 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.37 120.12 14.28 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-O 120.6 0.238 . . . . 0.0 110.728 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 58.5 m -117.54 141.19 48.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.434 177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.46 87.79 2.64 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.263 0.554 . . . . 0.0 111.513 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.0 mt -141.87 149.34 40.13 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.942 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -94.28 95.1 8.7 Favored 'General case' 0 CA--C 1.522 -0.126 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 176.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -79.37 135.34 36.68 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.145 -177.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 85.0 m -74.22 -43.45 57.08 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.698 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.73 170.26 0.66 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.701 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -128.56 145.54 51.1 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.815 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -141.84 145.76 35.05 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.52 143.69 30.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.959 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.15 166.41 33.54 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.643 178.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.19 159.22 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 120.593 0.235 . . . . 0.0 111.582 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -128.81 139.33 52.23 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.946 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.27 1.83 88.59 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 115.635 -0.712 . . . . 0.0 112.072 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -151.37 160.44 43.76 Favored 'General case' 0 C--N 1.348 0.534 0 CA-C-N 116.881 0.341 . . . . 0.0 111.064 -178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -104.73 146.23 29.25 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.82 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -87.65 120.21 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.387 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -83.45 -42.37 17.01 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.915 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -162.12 123.54 2.7 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.04 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -125.73 136.37 53.1 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.051 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -150.66 163.16 39.21 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.784 0.326 . . . . 0.0 111.083 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -134.24 149.37 50.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.794 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -116.76 113.87 23.18 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.189 0.306 . . . . 0.0 111.738 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.2 m -63.87 -40.89 97.62 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.547 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -143.42 131.12 21.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.297 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.31 140.63 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.198 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.687 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -60.85 132.52 54.14 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.261 0.553 . . . . 0.0 111.688 -178.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -113.36 171.03 7.81 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.709 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.58 -39.17 70.34 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -106.75 6.32 29.52 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -131.73 146.84 52.38 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 120.73 0.3 . . . . 0.0 111.403 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 86.7 p -89.39 166.23 13.86 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.542 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.687 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 41.3 t0 -90.2 115.35 27.36 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.593 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.1 t -103.74 107.79 57.59 Favored Pre-proline 0 CA--C 1.565 1.527 0 CA-C-O 119.515 -0.278 . . . . 0.0 110.675 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -88.37 150.15 6.55 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.49 2.126 . . . . 0.0 112.497 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 72.0 mt -80.72 150.39 29.34 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.375 177.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttpp -72.27 128.27 35.12 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.279 178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 87.0 m -62.26 -37.93 87.36 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.251 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.28 -7.58 9.92 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.499 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.22 -25.97 68.3 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -148.37 161.99 40.46 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.64 0.376 . . . . 0.0 111.028 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.5 tp10 -116.01 131.22 57.0 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.323 -178.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.7 t -127.2 128.83 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.811 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 22.2 m -129.5 156.02 44.81 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.151 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -58.85 -22.65 59.43 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.428 -178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.6 t -117.19 -20.72 9.12 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.33 162.28 41.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.689 0.28 . . . . 0.0 111.635 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 14.6 p -137.04 139.47 44.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.497 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -152.68 147.54 26.23 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.623 178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 49.6 p-80 -80.54 161.35 24.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.571 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 42.0 mtp180 -113.91 157.95 40.53 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.345 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -63.11 148.65 93.08 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.687 1.591 . . . . 0.0 110.886 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 85.26 6.24 84.47 Favored Glycine 0 CA--C 1.548 2.151 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.799 -176.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.7 144.05 6.58 Favored 'General case' 0 C--N 1.353 0.723 0 CA-C-N 116.952 0.376 . . . . 0.0 111.27 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -75.68 146.94 39.8 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.791 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -131.69 -60.26 0.93 Allowed 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.996 0.427 . . . . 0.0 111.139 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.07 -36.32 81.3 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.827 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -76.85 161.41 28.46 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.457 ' C ' HD12 ' A' ' 133' ' ' LEU . 3.4 pp -125.99 160.57 29.68 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.885 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.0 t -169.06 173.72 6.7 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -115.57 149.3 38.43 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.866 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.4 116.08 31.3 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.989 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.2 p -128.6 119.08 49.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.482 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 22.3 pt -142.45 150.31 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-N 115.859 -0.609 . . . . 0.0 112.445 -172.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.64 128.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.663 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.85 146.55 50.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.367 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 9.4 tttt -101.15 150.67 22.7 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.442 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.558 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -63.82 139.49 58.77 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.538 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -62.21 -39.99 94.59 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.0 tpp180 -123.83 136.59 54.48 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -99.47 15.47 26.35 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -58.29 131.26 50.11 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.968 -178.23 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.6 p -151.77 161.58 42.42 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.655 0.264 . . . . 0.0 110.962 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -87.75 146.06 25.83 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.894 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.02 159.31 53.89 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.2 t -148.64 153.43 38.29 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.696 0.284 . . . . 0.0 111.433 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.78 159.82 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.741 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -117.16 125.86 51.89 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -108.98 119.22 49.49 Favored Pre-proline 0 CA--C 1.556 1.184 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.577 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.43 156.25 61.98 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.991 1.794 . . . . 0.0 111.989 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.4 m -109.63 129.92 55.55 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.003 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 87.0 m -106.2 121.16 43.62 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.574 -179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG21 ' CE1' ' A' ' 27' ' ' HIS . 62.3 t -131.55 132.16 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.711 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -101.93 150.25 23.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.091 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -144.49 159.7 42.32 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 123.215 0.322 . . . . 0.0 111.253 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -103.81 127.65 51.28 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.7 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 16' ' ' VAL . 32.7 m -95.43 107.85 20.16 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -101.14 117.02 63.12 Favored Pre-proline 0 CA--C 1.556 1.207 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.483 -176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.85 176.16 10.16 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.558 2.172 . . . . 0.0 112.674 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.47 11.87 0.84 Allowed Glycine 0 CA--C 1.543 1.794 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.348 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.99 26.54 74.2 Favored Glycine 0 CA--C 1.534 1.269 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.1 t -116.95 129.61 73.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.6 t -74.24 119.24 21.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.425 -179.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -114.98 138.41 50.87 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.707 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.5 m -116.94 126.36 52.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.967 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -126.75 146.34 50.26 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.08 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.4 p -149.64 166.46 29.24 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.97 0.414 . . . . 0.0 111.562 -177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.416 ' CE1' HG21 ' A' ' 12' ' ' VAL . 15.2 t-80 -144.9 145.59 31.64 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.663 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 p30 -149.64 166.98 27.67 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.363 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG23 ' H ' ' A' ' 32' ' ' GLY . 33.4 m -125.37 160.88 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.62 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -54.02 -68.45 1.64 Allowed Glycine 0 CA--C 1.548 2.156 0 CA-C-O 119.549 -0.584 . . . . 0.0 111.808 -177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -56.65 -42.35 66.08 Favored 'Trans proline' 0 N--CA 1.509 2.411 0 C-N-CA 122.027 1.818 . . . . 0.0 111.522 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.565 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.16 32.95 5.36 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.709 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -58.5 -34.29 70.77 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.664 0.232 . . . . 0.0 111.324 -177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -63.53 -35.24 79.81 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.984 176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' A' ' 142' ' ' ALA . 99.2 m-85 -91.98 134.82 34.45 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.989 -177.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.1 t -157.11 156.32 32.55 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.977 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.417 ' SG ' HG12 ' A' ' 86' ' ' VAL . 87.9 m -116.29 136.19 53.23 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.331 177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.8 mtt -116.89 147.64 42.01 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.368 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -136.46 112.04 9.34 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.946 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.9 m -112.43 130.56 55.94 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.541 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -149.72 160.98 43.09 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -128.69 127.65 42.54 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.192 -0.913 . . . . 0.0 108.75 175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.1 m -134.11 153.05 52.06 Favored 'General case' 0 C--N 1.346 0.456 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -124.03 128.83 49.93 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.629 177.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 168.34 -178.57 41.87 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.621 -0.992 . . . . 0.0 110.621 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -111.17 2.39 28.31 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-O 119.956 -0.358 . . . . 0.0 113.107 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.414 ' O ' HD21 ' A' ' 77' ' ' LEU . 10.0 t -148.62 150.36 33.12 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 117.358 0.579 . . . . 0.0 111.274 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -89.4 178.45 6.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.375 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -143.32 150.61 39.43 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -99.23 119.12 37.37 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.748 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -113.74 146.65 39.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.379 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -100.62 140.69 34.53 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.521 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.2 mtp -120.72 141.88 50.03 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.5 t -139.56 130.7 26.54 Favored 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 123.517 0.511 . . . . 0.0 110.521 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 55' ' ' LEU . 4.2 pp -130.34 153.36 48.76 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.712 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.16 156.84 26.89 Favored Glycine 0 C--O 1.237 0.341 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.504 HG22 ' CD2' ' A' ' 64' ' ' PHE . 60.9 p -132.57 157.78 43.86 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.895 0.378 . . . . 0.0 111.165 -178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.77 153.76 42.91 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.063 177.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -56.31 -32.09 64.29 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.237 0.335 . . . . 0.0 110.761 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -97.08 2.73 51.63 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.396 177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 61.11 29.2 18.74 Favored 'General case' 0 C--N 1.351 0.641 0 CA-C-O 121.023 0.44 . . . . 0.0 111.265 -178.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -77.93 -27.71 49.45 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.589 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.67 141.76 49.67 Favored 'General case' 0 C--N 1.348 0.523 0 CA-C-O 120.979 0.419 . . . . 0.0 111.799 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 142' ' ' ALA . 71.4 m-85 -124.47 132.2 53.49 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.917 177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 58.0 p -129.03 145.9 51.14 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.576 0.227 . . . . 0.0 111.187 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.29 133.86 45.8 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.645 176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' CE3' ' A' ' 69' ' ' TRP . 59.0 m -129.01 130.5 46.71 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.4 mt -126.65 124.04 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.741 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.626 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -156.58 163.96 38.75 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.943 0.401 . . . . 0.0 111.989 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -84.14 132.89 46.53 Favored Pre-proline 0 CA--C 1.556 1.176 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.443 176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.0 -40.78 15.16 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 121.359 1.372 . . . . 0.0 110.77 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -70.24 -37.55 74.99 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.604 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.98 -18.6 51.85 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.574 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -136.36 122.8 20.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.252 0.526 . . . . 0.0 111.885 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.8 t -118.2 132.53 56.31 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.78 176.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -82.87 85.34 7.13 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-O 121.506 0.67 . . . . 0.0 109.711 178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 47' ' ' THR . 15.1 mt -143.51 150.17 38.55 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.033 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -102.74 88.75 3.29 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.419 ' HE1' HD21 ' A' ' 133' ' ' LEU . 81.7 m-85 -79.12 121.08 24.55 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.292 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.7 m -70.56 -41.94 71.76 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -171.29 158.05 5.24 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.438 177.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -138.76 149.63 45.22 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.192 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -146.02 150.98 37.02 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.944 -175.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 136' ' ' LEU . . . -143.09 140.33 30.85 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.37 178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -152.87 170.0 21.43 Favored 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.271 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG12 ' SG ' ' A' ' 37' ' ' CYS . 35.6 m -129.6 159.16 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.07 0.231 . . . . 0.0 111.437 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -132.05 147.76 52.46 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.993 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.64 2.31 90.62 Favored Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.955 -178.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.22 164.6 38.58 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 122.51 0.324 . . . . 0.0 110.451 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.3 pm0 -104.46 146.55 28.7 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.034 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 20.2 pt -85.94 126.39 40.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.119 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -82.92 -43.86 16.01 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.18 176.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -169.57 124.08 0.8 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.808 178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.487 ' HB1' ' CG2' ' A' ' 138' ' ' ILE . . . -119.74 130.56 55.05 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.851 178.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 24.7 ptt? -147.09 163.87 34.89 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.272 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.479 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -135.34 153.2 51.93 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.113 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -118.16 113.98 22.36 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.418 ' OG ' HD21 ' A' ' 110' ' ' LEU . 74.1 m -67.92 -41.16 83.04 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.089 177.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -131.27 130.52 42.93 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.84 -177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 136.58 34.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.961 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.696 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.77 135.1 57.38 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.234 0.54 . . . . 0.0 111.265 -178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -111.06 170.03 8.38 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.966 -1.016 . . . . 0.0 108.805 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -56.17 -39.11 71.85 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -106.52 3.57 27.24 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -130.43 146.3 51.96 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 120.744 0.307 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.2 p -85.92 165.15 17.0 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.422 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.696 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 36.8 t70 -85.92 115.81 23.77 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.344 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -95.24 109.35 44.42 Favored Pre-proline 0 CA--C 1.566 1.595 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.792 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -84.65 153.63 11.78 Favored 'Trans proline' 0 N--CA 1.498 1.779 0 C-N-CA 122.334 2.023 . . . . 0.0 112.582 178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.9 mt -77.74 151.33 34.16 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.794 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.6 ptpt -87.86 155.58 19.8 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.868 -178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.3 m -63.92 -37.93 89.21 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.898 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -54.84 -23.39 18.2 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.124 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.14 -40.4 97.46 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.986 0.178 . . . . 0.0 110.722 -178.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -161.26 167.12 26.56 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.07 -178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.488 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 33.6 tt0 -118.03 132.92 56.33 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.27 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.77 138.3 54.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.215 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 81.0 p -130.02 166.1 20.81 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.791 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -56.61 -22.67 35.67 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.166 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.1 t -150.21 25.26 0.81 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.542 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -161.07 160.18 30.13 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.79 0.329 . . . . 0.0 111.671 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.8 m -135.08 154.19 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.931 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.488 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -154.38 153.33 31.42 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.031 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.1 p-80 -103.38 151.26 22.97 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.58 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -114.08 148.4 39.94 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.745 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -58.55 144.51 97.1 Favored 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 121.961 1.774 . . . . 0.0 111.344 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.17 14.15 79.57 Favored Glycine 0 CA--C 1.541 1.692 0 CA-C-N 116.342 -0.39 . . . . 0.0 112.186 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.17 151.08 16.18 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.791 0.329 . . . . 0.0 110.688 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -69.95 143.69 52.59 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.221 -178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -124.59 -23.07 4.47 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.992 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -124.89 11.26 8.34 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -107.37 132.5 53.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.844 0.354 . . . . 0.0 111.057 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.419 HD21 ' HE1' ' A' ' 79' ' ' PHE . 8.5 mp -108.29 144.21 36.11 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.356 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.439 ' CB ' HD11 ' A' ' 110' ' ' LEU . 48.4 t -156.42 171.62 19.93 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.655 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.97 149.51 37.23 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.177 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.648 HD22 ' HB2' ' A' ' 84' ' ' ALA . 5.0 mp -111.47 120.92 43.76 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.903 -178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.5 p -125.26 119.38 55.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.487 ' CG2' ' HB1' ' A' ' 94' ' ' ALA . 18.2 pt -137.42 150.57 25.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.157 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.09 128.87 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.111 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -133.19 140.34 47.51 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.942 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -97.35 123.78 41.28 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.739 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.515 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . . . -71.91 137.31 47.31 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.698 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.6 t -153.07 145.01 23.67 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 111.524 179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.65 -23.99 5.0 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.339 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.2 p -124.38 37.12 4.47 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 121.085 0.469 . . . . 0.0 111.034 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.4 -42.0 90.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.493 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 C--O 1.219 -0.521 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.98 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.513 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 90.6 p -70.8 -14.32 62.38 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -141.04 158.22 44.24 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-O 120.61 0.243 . . . . 0.0 111.088 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.13 -178.06 48.04 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.6 p -116.91 21.27 13.41 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.6 t 68.93 65.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 CA-C-O 121.415 0.626 . . . . 0.0 110.087 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.7 t -62.02 -40.45 95.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.322 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 69.58 81.23 0.2 Allowed Pre-proline 0 CA--C 1.555 1.146 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.6 -178.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.02 160.17 50.6 Favored 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.536 2.157 . . . . 0.0 112.693 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.0 m -105.67 129.51 53.88 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.799 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.652 HG23 ' O ' ' A' ' 53' ' ' MET . 86.0 m -114.45 130.08 56.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.032 -177.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' A' ' 53' ' ' MET . 26.8 m -132.88 157.88 43.12 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.846 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -125.54 150.17 47.67 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.621 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -139.65 158.96 43.23 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.1 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -101.64 126.79 48.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.513 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.8 t -95.15 109.08 21.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 75.0 mtp85 -110.19 116.98 52.53 Favored Pre-proline 0 CA--C 1.555 1.154 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.067 -177.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -76.82 175.41 11.41 Favored 'Trans proline' 0 N--CA 1.498 1.739 0 C-N-CA 122.358 2.038 . . . . 0.0 112.471 -178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.06 9.57 0.93 Allowed Glycine 0 CA--C 1.542 1.781 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.335 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.29 26.8 73.69 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.679 -0.568 . . . . 0.0 111.679 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -112.83 128.54 69.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 79.1 t -73.12 120.03 21.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.477 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -117.81 137.96 52.4 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.519 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.7 m -117.2 128.56 55.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.415 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -128.25 133.31 48.78 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.555 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -138.5 163.91 30.76 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.163 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -147.48 140.6 25.13 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.655 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -150.57 167.31 27.62 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.645 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.9 m -124.03 160.66 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.97 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -51.73 -70.14 0.96 Allowed Glycine 0 CA--C 1.545 1.912 0 CA-C-O 119.579 -0.567 . . . . 0.0 111.931 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.01 -41.5 74.4 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 C-N-CA 121.853 1.702 . . . . 0.0 111.315 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.7 36.14 3.8 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.641 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -59.24 -35.84 74.38 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 116.776 0.288 . . . . 0.0 110.521 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.5 mmmm -62.63 -37.38 86.08 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.951 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 89' ' ' ALA . 97.8 m-85 -88.14 118.49 27.75 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.845 -178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 67.7 m -136.49 134.44 37.61 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.254 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -99.5 131.07 45.75 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.6 mtt -117.8 146.36 43.89 Favored 'General case' 0 CA--C 1.509 -0.606 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.735 -177.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -137.44 110.3 7.65 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.089 178.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 85.6 m -108.9 130.03 55.43 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -149.86 159.96 43.96 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.44 132.32 42.65 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.398 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.82 156.45 48.87 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -128.97 129.25 45.17 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.64 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.13 177.7 40.57 Favored Glycine 0 C--N 1.336 0.538 0 N-CA-C 110.199 -1.161 . . . . 0.0 110.199 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -106.77 7.03 38.34 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-O 119.873 -0.404 . . . . 0.0 112.939 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.458 ' O ' HD21 ' A' ' 77' ' ' LEU . 9.8 t -150.8 154.08 36.62 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 117.284 0.542 . . . . 0.0 111.84 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -83.4 178.17 8.16 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.903 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -147.13 150.91 35.91 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.111 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -103.69 127.03 51.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.474 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 50.4 m95 -123.18 144.54 49.29 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.119 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.9 mm-40 -103.79 148.85 25.61 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.63 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 11' ' ' THR . 94.9 mtp -131.02 144.38 51.42 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.079 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.8 t -141.34 130.32 23.21 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 123.532 0.52 . . . . 0.0 110.512 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 pp -136.58 146.09 45.71 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.718 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -141.71 152.81 23.74 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -132.45 159.23 39.95 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.021 0.439 . . . . 0.0 111.293 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 39.5 t -66.74 157.69 32.13 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.342 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -56.75 -30.06 63.2 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.096 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -94.54 1.49 55.68 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.546 177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 61.64 27.13 16.65 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 122.658 0.383 . . . . 0.0 111.621 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -83.28 -25.71 31.33 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.775 177.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -116.12 136.8 52.69 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.975 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -125.99 126.25 44.01 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.719 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 70.3 p -126.02 138.34 53.72 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.062 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 85.9 m -132.42 131.44 41.77 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.008 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 69' ' ' TRP . 63.6 m -127.93 132.09 49.29 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.657 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 70.5 mt -124.01 125.19 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.636 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.0 p90 -154.06 164.69 38.07 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.708 176.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.5 ptp85 -84.62 148.28 51.44 Favored Pre-proline 0 CA--C 1.573 1.857 0 O-C-N 123.237 0.336 . . . . 0.0 110.621 179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.47 -40.36 0.44 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.659 2.24 . . . . 0.0 113.921 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.8 -37.68 88.42 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.988 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.461 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 103.47 -19.42 45.27 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.135 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -141.7 121.18 13.24 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-O 120.912 0.387 . . . . 0.0 111.758 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.409 ' O ' HD22 ' A' ' 133' ' ' LEU . 49.0 m -117.98 140.96 48.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.167 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -116.32 86.57 2.51 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.295 0.569 . . . . 0.0 111.394 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 47' ' ' THR . 67.2 mt -142.69 149.34 38.71 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.03 176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -91.82 89.17 6.94 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.443 ' HE1' HD21 ' A' ' 133' ' ' LEU . 77.1 m-85 -73.17 131.48 42.08 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.722 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.3 m -73.4 -42.82 61.63 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 178.69 167.25 0.88 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.046 178.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 51.3 p90 -144.72 149.88 36.33 Favored 'General case' 0 CA--C 1.502 -0.891 0 O-C-N 123.35 0.406 . . . . 0.0 111.629 179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -145.87 152.81 40.08 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.808 -176.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.541 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -143.02 144.3 32.23 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.6 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -155.5 169.27 24.66 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.602 -179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.01 160.93 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 CA-C-O 120.717 0.294 . . . . 0.0 111.689 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.6 mmm-85 -128.27 142.81 51.04 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.944 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.38 1.93 90.28 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.794 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HB2' ' HE2' ' A' ' 35' ' ' TYR . . . -155.56 164.02 39.2 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 117.073 0.437 . . . . 0.0 111.187 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -104.77 143.98 32.37 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.179 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 94' ' ' ALA . 75.4 mt -88.06 120.34 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.46 -178.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -83.05 -37.95 23.2 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.576 177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 55.0 t80 -151.83 130.07 11.99 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.765 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.498 ' HB2' HG21 ' A' ' 91' ' ' ILE . . . -145.46 138.32 26.09 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.317 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -162.71 173.06 14.35 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.399 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.477 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 150.11 49.5 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.403 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.42 ' C ' ' HG ' ' A' ' 134' ' ' SER . 98.0 m-85 -114.9 107.48 15.46 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.286 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.8 m -66.99 -41.64 86.41 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.015 0.436 . . . . 0.0 110.751 178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -139.82 133.37 30.25 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.939 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.36 146.09 29.56 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.848 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.681 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -55.58 135.73 50.75 Favored 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.415 0.447 . . . . 0.0 110.433 -179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -82.81 124.54 30.39 Favored 'General case' 0 C--O 1.22 -0.478 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.027 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' HG3' ' HG2' ' A' ' 104' ' ' ARG . 0.6 OUTLIER 71.48 -55.9 0.65 Allowed 'General case' 0 CA--C 1.555 1.166 0 O-C-N 123.963 0.789 . . . . 0.0 112.049 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.418 ' HG2' ' HG3' ' A' ' 103' ' ' GLU . 4.5 ptp85 -164.42 -7.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.629 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 21.7 mt-10 -142.4 176.8 8.73 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.869 -176.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t 71.88 49.87 0.25 Allowed 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.603 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.681 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 67.9 t0 -90.44 115.92 27.98 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.626 176.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -96.74 108.47 43.13 Favored Pre-proline 0 CA--C 1.565 1.521 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.332 -176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.66 153.26 8.86 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.471 2.114 . . . . 0.0 111.884 176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 96' ' ' ALA . 63.4 mt -71.61 148.82 46.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.85 0.357 . . . . 0.0 111.308 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -70.2 129.74 40.18 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.986 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.75 -38.69 86.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.09 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -65.96 -11.56 48.44 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.69 -178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -62.79 -31.32 72.27 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 122.939 0.15 . . . . 0.0 111.179 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -154.27 162.01 41.44 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.34 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -117.0 131.9 56.84 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.11 -178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.3 m -128.81 146.04 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.914 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.408 HG22 ' N ' ' A' ' 119' ' ' LYS . 14.4 m -141.7 157.35 45.17 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.432 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.408 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -59.17 -17.89 31.28 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.523 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 t -131.05 -12.11 3.67 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -153.02 160.5 43.0 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.773 0.321 . . . . 0.0 111.784 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 30.3 m -133.57 154.23 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.529 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.32 158.76 40.63 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.619 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -105.06 155.27 19.14 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.372 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -113.69 153.56 45.88 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.49 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.02 142.47 94.08 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 121.906 1.737 . . . . 0.0 111.216 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.11 13.47 77.12 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.27 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.43 143.32 15.53 Favored 'General case' 0 C--N 1.348 0.516 0 CA-C-N 116.965 0.382 . . . . 0.0 110.527 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.22 143.82 48.69 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.388 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -147.56 3.04 0.74 Allowed 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.494 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -133.48 23.74 4.05 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.814 0.34 . . . . 0.0 110.521 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -137.04 135.69 37.76 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.193 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.491 ' N ' HD12 ' A' ' 133' ' ' LEU . 7.9 mp -107.85 140.64 40.66 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.998 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.42 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 34.7 t -155.75 176.53 12.5 Favored 'General case' 0 C--N 1.344 0.348 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -115.49 159.0 21.75 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 115.503 -0.772 . . . . 0.0 110.824 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.541 HD13 ' HB2' ' A' ' 84' ' ' ALA . 30.7 mt -117.42 146.4 43.49 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.957 -177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.22 122.48 18.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.089 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.48 129.17 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.342 -175.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -120.23 121.66 66.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -129.52 146.53 51.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.165 0.507 . . . . 0.0 112.288 -177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.1 137.06 36.74 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.783 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.534 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -59.88 138.55 57.78 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.381 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.5 p -154.54 162.13 41.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.965 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -95.57 124.59 39.67 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.429 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 78.8 m -124.96 120.92 32.95 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -154.78 141.14 18.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.737 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 N--CA 1.468 0.449 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.983 179.771 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.416 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 94.1 p -152.42 159.55 43.38 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.578 0.228 . . . . 0.0 110.804 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -118.5 -47.23 2.55 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.795 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.07 170.7 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.7 p -135.57 163.74 29.43 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 122.282 0.233 . . . . 0.0 110.47 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -125.45 149.8 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.128 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 64.2 m -136.32 155.35 50.19 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.019 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -127.7 66.95 71.93 Favored Pre-proline 0 CA--C 1.559 1.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.8 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.4 151.99 71.15 Favored 'Trans proline' 0 N--CA 1.5 1.893 0 C-N-CA 122.248 1.965 . . . . 0.0 112.059 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 90.8 m -124.53 134.91 52.85 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.261 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.1 p -108.57 137.56 46.33 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.515 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.1 131.14 63.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.475 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.45 146.92 25.81 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.24 178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -147.35 160.45 42.51 Favored 'General case' 0 C--N 1.347 0.467 0 CA-C-O 120.68 0.276 . . . . 0.0 111.571 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -101.93 129.24 48.14 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.16 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 16' ' ' VAL . 35.7 m -95.21 108.07 20.4 Favored 'Isoleucine or valine' 0 C--N 1.344 0.328 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 175.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.2 mtp-105 -102.84 111.33 64.83 Favored Pre-proline 0 CA--C 1.552 1.048 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.374 -176.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -77.08 173.59 14.18 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 122.432 2.088 . . . . 0.0 112.54 -178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.49 14.42 0.61 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.396 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.58 26.66 73.74 Favored Glycine 0 C--N 1.347 1.149 0 N-CA-C 111.505 -0.638 . . . . 0.0 111.505 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.93 128.7 68.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.56 119.34 20.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -113.94 138.04 50.88 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.461 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.9 m -117.25 127.78 54.43 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.955 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -126.49 142.75 51.43 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.84 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.3 p -153.93 164.1 38.96 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 123.219 0.324 . . . . 0.0 111.504 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 16.8 t-160 -147.9 136.77 21.94 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.743 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.9 p-10 -98.03 167.88 10.62 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.672 -178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG12 ' HD2' ' A' ' 31' ' ' PRO . 71.9 t -120.28 131.11 73.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.66 -71.5 0.46 Allowed Glycine 0 CA--C 1.548 2.133 0 CA-C-O 119.369 -0.684 . . . . 0.0 111.886 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD2' HG12 ' A' ' 29' ' ' VAL . 50.9 Cg_exo -57.35 -45.31 35.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.844 1.696 . . . . 0.0 111.425 177.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 56.38 2.35 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -59.91 -35.56 75.14 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.568 0.184 . . . . 0.0 111.451 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.4 tptp -64.69 -36.3 83.82 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.807 177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' HE1' ' HB3' ' A' ' 89' ' ' ALA . 55.4 t80 -75.97 133.88 40.33 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.938 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 t -152.44 151.84 31.27 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.654 178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 20.3 m -102.57 139.73 37.78 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.6 mtp -124.96 137.26 54.26 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.017 0.437 . . . . 0.0 111.459 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.505 ' CD2' HD12 ' A' ' 68' ' ' ILE . 87.0 m-85 -134.97 108.58 7.95 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.9 m -109.72 131.14 55.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.205 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -151.83 160.42 43.56 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -126.81 135.04 50.49 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.711 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.8 m -135.17 156.66 48.62 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -129.78 129.18 43.76 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.122 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.32 38.84 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -118.79 -2.51 14.39 Favored Glycine 0 CA--C 1.543 1.788 0 CA-C-O 119.823 -0.432 . . . . 0.0 113.067 -179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.2 m -131.92 131.75 42.96 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 117.367 0.583 . . . . 0.0 110.668 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.4 p30 -81.48 178.39 8.39 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.948 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.8 tp10 -148.05 151.92 36.52 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-O 120.87 0.367 . . . . 0.0 111.242 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -98.11 122.57 41.41 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.687 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.8 m95 -118.01 151.02 38.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.553 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -100.9 142.78 31.88 Favored 'General case' 0 C--O 1.239 0.527 0 O-C-N 123.208 0.318 . . . . 0.0 110.293 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 85.7 mtp -118.16 149.0 41.79 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.9 t -140.24 124.99 18.19 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 123.575 0.547 . . . . 0.0 110.755 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -129.96 140.18 50.96 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.997 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.35 159.16 27.94 Favored Glycine 0 C--N 1.337 0.613 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.624 HG22 ' CD2' ' A' ' 64' ' ' PHE . 66.8 p -133.03 158.66 42.17 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.89 0.376 . . . . 0.0 111.295 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.3 t -68.69 155.75 39.5 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.047 177.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -55.59 -27.81 51.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.283 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -101.58 3.45 39.99 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.841 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.9 m170 63.5 23.14 13.53 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.715 0.406 . . . . 0.0 111.511 -178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.75 -30.83 32.23 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.879 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -119.88 141.77 49.29 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.189 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.75 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 97.3 m-85 -127.21 140.63 52.1 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.753 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.0 p -132.5 147.22 52.36 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.914 0.387 . . . . 0.0 111.223 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -136.11 130.81 33.91 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.52 HG22 ' CE3' ' A' ' 69' ' ' TRP . 48.5 m -139.13 132.93 30.79 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.428 -177.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.505 HD12 ' CD2' ' A' ' 39' ' ' PHE . 72.5 mt -131.93 128.05 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.577 178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.52 ' CE3' HG22 ' A' ' 67' ' ' THR . 27.4 p90 -152.85 165.98 33.73 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 26.0 tpt85 -78.39 121.25 83.53 Favored Pre-proline 0 CA--C 1.557 1.236 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.184 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.3 -36.99 10.93 Favored 'Trans proline' 0 N--CA 1.501 1.953 0 C-N-CA 121.67 1.58 . . . . 0.0 111.883 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -67.94 -38.81 83.28 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.413 178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.35 -56.93 0.67 Allowed Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -141.2 148.11 39.43 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.915 0.388 . . . . 0.0 111.975 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 42.0 t -118.14 137.54 52.89 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.101 177.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -85.71 86.25 7.37 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-O 121.313 0.577 . . . . 0.0 110.423 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.4 mt -142.93 149.75 38.84 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.456 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -100.65 94.75 6.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.42 134.92 36.06 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.063 -177.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.29 -43.27 61.27 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.8 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -179.84 169.25 1.3 Allowed 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.555 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -127.91 145.94 50.79 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.506 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -143.05 142.6 31.6 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.99 138.97 28.79 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.782 0.325 . . . . 0.0 111.262 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -156.05 164.11 38.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.123 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.437 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.4 m -128.18 160.42 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.049 0.218 . . . . 0.0 110.866 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.66 148.92 50.84 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.401 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.61 1.64 90.06 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.41 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.578 ' HB3' ' HE1' ' A' ' 35' ' ' TYR . . . -162.12 174.83 12.42 Favored 'General case' 0 C--N 1.35 0.63 0 CA-C-N 117.199 0.5 . . . . 0.0 111.836 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -105.11 148.66 26.6 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.452 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.437 ' CG1' HG22 ' A' ' 86' ' ' VAL . 79.2 mt -87.47 128.88 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.729 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -82.18 -40.5 21.67 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.052 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -167.04 133.35 2.26 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.542 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.91 134.83 51.45 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.208 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.8 ptm -161.36 170.62 19.75 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.275 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 135' ' ' LYS . . . -135.05 146.04 48.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.149 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -109.89 107.68 17.7 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 123.271 0.357 . . . . 0.0 111.177 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.7 m -64.21 -39.91 94.96 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.334 177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -139.51 131.36 27.61 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.993 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.74 131.72 34.9 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.163 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.713 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -67.01 130.18 42.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.231 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.9 169.01 9.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.883 173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -56.06 -38.04 70.1 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -99.68 5.58 45.74 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 116.134 -0.484 . . . . 0.0 112.052 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -131.13 175.51 9.04 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 120.644 0.259 . . . . 0.0 111.051 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 91.6 p -124.46 156.15 37.7 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.187 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.713 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 35.5 t70 -85.55 118.09 24.85 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.552 -178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.52 106.61 58.13 Favored Pre-proline 0 CA--C 1.562 1.44 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -92.25 152.61 3.11 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 C-N-CA 122.71 2.273 . . . . 0.0 112.626 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.569 HD11 ' HB3' ' A' ' 134' ' ' SER . 80.4 mt -72.67 152.25 41.81 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.166 175.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -71.11 130.23 40.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.044 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -61.58 -37.95 85.75 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.919 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -61.89 -19.64 62.88 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.516 -0.766 . . . . 0.0 112.668 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -64.55 -20.61 66.34 Favored 'General case' 0 CA--C 1.559 1.307 0 C-N-CA 120.891 -0.323 . . . . 0.0 111.716 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -150.89 161.68 42.22 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 120.693 0.282 . . . . 0.0 110.902 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -117.7 131.68 56.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.389 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.5 120.63 59.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.446 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.411 HG22 ' N ' ' A' ' 119' ' ' LYS . 26.7 m -108.84 157.4 18.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.035 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.411 ' N ' HG22 ' A' ' 118' ' ' THR . 18.9 ptpt -57.56 -22.07 42.4 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.214 -178.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.27 3.79 2.88 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -156.7 166.56 33.04 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.546 0.212 . . . . 0.0 111.164 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.2 p -139.37 139.35 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.321 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.45 149.79 31.34 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -83.58 159.74 21.57 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.293 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -114.67 155.08 46.61 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.47 147.33 70.81 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.718 1.612 . . . . 0.0 111.045 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.51 14.85 80.81 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -53.3 150.74 5.95 Favored 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.808 0.337 . . . . 0.0 111.139 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -78.3 146.44 34.77 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.899 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.27 -54.33 0.57 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.695 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.38 -39.6 93.74 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.393 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -77.63 140.18 39.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.591 -177.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.85 155.59 22.36 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.971 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.569 ' HB3' HD11 ' A' ' 110' ' ' LEU . 35.3 t -168.43 179.49 4.37 Favored 'General case' 0 C--N 1.347 0.461 0 CA-C-O 121.012 0.434 . . . . 0.0 111.936 -176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.426 ' O ' ' HB1' ' A' ' 96' ' ' ALA . 20.2 ptmt -114.82 149.84 36.42 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.472 178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 136' ' ' LEU . 5.0 mp -112.9 144.65 42.09 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.934 0.397 . . . . 0.0 111.688 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.6 p -140.13 124.97 19.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.029 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.8 mp -123.48 127.74 74.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.803 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.8 t -113.92 121.49 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.567 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.68 144.7 51.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.051 0.453 . . . . 0.0 111.886 -177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.509 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.8 ttmt -97.52 135.15 39.78 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.063 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.75 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -57.1 132.96 54.5 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.157 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 66.3 m -108.13 -63.6 1.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.809 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -157.43 155.34 30.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.005 0.431 . . . . 0.0 111.624 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.2 p -131.98 33.96 3.88 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.167 178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -57.71 -51.85 67.84 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.659 -174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.449 ' C ' HD12 ' A' ' 147' ' ' LEU . 3.2 pp . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 118.087 -0.959 . . . . 0.0 110.631 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 53.76 -178.59 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.539 0.209 . . . . 0.0 110.71 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -115.34 126.3 54.28 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.084 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.29 142.11 15.71 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.524 HG21 ' OE1' ' A' ' 59' ' ' GLU . 80.9 p -130.45 158.94 38.54 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.603 0.24 . . . . 0.0 110.759 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -132.04 156.03 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.772 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.7 m -130.4 147.26 52.08 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.817 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -129.97 70.37 82.07 Favored Pre-proline 0 CA--C 1.56 1.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.572 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.54 150.57 63.7 Favored 'Trans proline' 0 N--CA 1.503 2.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.76 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.3 m -117.6 129.92 56.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.331 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 84.9 m -104.53 125.51 50.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -131.64 132.81 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.131 -177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.21 149.82 26.47 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.539 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -144.7 160.25 41.52 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.0 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -98.71 127.12 44.53 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.615 -177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.7 t -95.27 108.72 21.34 Favored 'Isoleucine or valine' 0 C--N 1.344 0.334 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -109.38 112.11 59.36 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.181 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -80.06 176.09 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.562 2.174 . . . . 0.0 112.529 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.08 10.41 1.0 Allowed Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.394 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 81.49 4.25 90.45 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 112.137 -0.385 . . . . 0.0 112.137 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.8 t -88.94 129.26 40.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.8 t -73.52 119.99 21.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -115.52 138.03 51.45 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.975 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -122.25 131.46 53.94 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.24 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -127.36 131.32 50.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.3 p -136.87 163.45 30.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.138 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -147.41 142.51 27.11 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.042 -178.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -141.14 155.93 46.03 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.424 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.779 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -128.37 158.15 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.829 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.23 -50.72 64.56 Favored Glycine 0 CA--C 1.545 1.931 0 CA-C-O 119.496 -0.613 . . . . 0.0 111.677 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.1 -42.49 43.13 Favored 'Trans proline' 0 N--CA 1.505 2.148 0 CA-C-N 119.456 1.628 . . . . 0.0 110.678 177.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.779 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.15 53.56 2.51 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.966 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -61.14 -34.78 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 116.82 0.31 . . . . 0.0 111.071 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -91.96 3.42 55.25 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.626 ' OH ' ' HB1' ' A' ' 142' ' ' ALA . 73.7 m-85 -124.3 121.77 35.92 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 121.204 -0.198 . . . . 0.0 110.749 -177.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.9 m -138.07 138.87 39.18 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.584 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -102.1 133.36 47.08 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 175.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 54.2 mtt -122.86 141.9 51.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 120.918 0.39 . . . . 0.0 111.412 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.676 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 58.9 m-85 -133.91 112.82 11.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.274 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 91.9 m -117.02 129.63 56.14 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.183 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -154.83 161.16 41.57 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.97 134.39 51.52 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.625 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.7 m -135.1 154.83 51.53 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-O 120.996 0.427 . . . . 0.0 112.118 -177.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -124.41 129.1 50.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.205 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 166.02 -177.38 41.11 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.38 -1.29 13.94 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 121.316 -0.468 . . . . 0.0 113.243 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 59.8 m -129.59 129.97 45.09 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.509 0.654 . . . . 0.0 111.289 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.4 p30 -88.13 178.58 6.59 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.777 177.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -159.42 173.99 15.38 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.411 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -112.08 129.68 56.14 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.205 -178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -113.18 151.4 30.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.181 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -110.39 144.09 39.67 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.494 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.431 ' HG2' HG23 ' A' ' 68' ' ' ILE . 98.6 mtp -127.0 143.08 51.39 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.258 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.8 t -116.81 123.55 47.37 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.277 177.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.88 136.0 53.29 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.797 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -157.44 156.41 27.25 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.676 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.448 HG22 ' CD2' ' A' ' 64' ' ' PHE . 64.0 p -135.59 160.81 37.35 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.548 -0.326 . . . . 0.0 110.795 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.6 t -67.56 156.71 36.09 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.636 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' OE1' HG21 ' A' ' 5' ' ' THR . 12.0 pt-20 -52.54 -39.36 61.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.354 -178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -101.6 11.75 38.4 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.602 177.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 59.49 33.11 22.12 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 122.623 0.369 . . . . 0.0 111.911 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -74.44 -31.08 62.15 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.069 176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -130.65 145.18 51.85 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.332 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.2 m-85 -120.53 140.43 51.47 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.199 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -139.33 143.03 37.63 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 70.9 m -131.18 136.18 48.07 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.965 177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.7 m -130.1 139.88 50.88 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 120.798 0.332 . . . . 0.0 111.354 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.676 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.4 mp -136.34 125.97 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.589 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 23.0 p90 -152.66 165.26 35.8 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 177.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 34.6 tpt85 -79.98 119.04 75.37 Favored Pre-proline 0 CA--C 1.557 1.223 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.366 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.99 -24.3 28.8 Favored 'Trans proline' 0 N--CA 1.504 2.121 0 C-N-CA 122.051 1.834 . . . . 0.0 112.818 -177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -94.33 -10.77 31.65 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 126.65 -83.47 0.34 Allowed Glycine 0 C--N 1.346 1.131 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -140.21 155.66 46.82 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.925 0.393 . . . . 0.0 111.891 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 48.1 t -116.74 137.0 52.51 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.783 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -98.18 87.11 3.83 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 121.552 0.692 . . . . 0.0 110.542 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.7 mt -140.86 150.35 43.13 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.047 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -85.31 86.83 7.35 Favored 'General case' 0 C--N 1.346 0.422 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.647 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.476 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -72.2 129.15 37.77 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.01 -179.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.6 m -73.85 -43.41 58.74 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.6 pt20 175.81 171.88 0.35 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.907 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.67 150.11 44.51 Favored 'General case' 0 CA--C 1.51 -0.596 0 O-C-N 123.199 0.312 . . . . 0.0 111.363 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 81.4 mttt -145.67 150.92 37.19 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.425 -176.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.41 142.88 31.4 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.596 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -154.67 168.37 27.05 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.536 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.39 160.58 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 120.797 0.332 . . . . 0.0 111.189 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.4 mmm-85 -126.21 136.31 52.67 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.601 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.32 2.39 90.47 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.057 -0.519 . . . . 0.0 112.861 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -152.88 159.58 43.02 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 117.076 0.438 . . . . 0.0 110.778 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -104.86 144.17 32.14 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.479 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -88.1 118.7 34.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.578 -177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -82.88 -35.61 26.07 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.818 176.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.24 132.58 8.11 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.526 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -146.01 144.5 30.13 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.981 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.0 ptp -159.29 166.49 31.14 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.26 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.444 ' HB2' ' HG ' ' A' ' 136' ' ' LEU . . . -136.73 140.43 42.61 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.805 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -110.44 106.84 16.3 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.435 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 62.2 m -66.69 -39.62 88.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.579 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -126.97 130.54 50.28 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.604 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.06 135.86 37.28 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.536 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 107' ' ' ASP . . . -60.67 133.0 55.65 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.225 0.536 . . . . 0.0 111.641 -178.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -113.79 170.59 8.15 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.063 177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -56.72 -39.37 73.81 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -107.83 6.97 27.94 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -134.65 153.54 51.94 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-O 120.725 0.298 . . . . 0.0 111.203 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 98.7 p -104.34 154.65 19.57 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.516 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 3.6 p-10 -82.37 157.25 23.82 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.533 -177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -126.47 105.87 24.06 Favored Pre-proline 0 CA--C 1.558 1.261 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.573 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -86.43 148.32 8.81 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.275 1.983 . . . . 0.0 112.37 178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.94 137.16 37.18 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.604 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.55 170.19 10.14 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.995 -177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -64.04 -11.48 29.75 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.297 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -61.57 -34.18 75.15 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 122.606 0.362 . . . . 0.0 111.941 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -62.23 -37.71 86.44 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.125 -176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -157.75 162.8 38.54 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -114.15 133.57 55.49 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.948 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.43 146.37 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.605 178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.0 m -141.49 157.57 44.97 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.324 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.414 ' N ' HG22 ' A' ' 118' ' ' THR . 22.4 ptmt -57.77 -21.48 41.82 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.881 -0.6 . . . . 0.0 112.184 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -142.59 14.16 1.96 Allowed 'General case' 0 CA--C 1.545 0.786 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.23 156.52 29.0 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.741 0.305 . . . . 0.0 111.482 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 m -135.5 153.53 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.07 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.44 157.69 37.41 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.012 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.43 155.94 18.66 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.04 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.6 mmt85 -113.53 153.67 45.71 Favored Pre-proline 0 CA--C 1.544 0.718 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.691 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.65 148.4 71.99 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 121.924 1.749 . . . . 0.0 111.027 178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.53 14.07 80.61 Favored Glycine 0 CA--C 1.543 1.823 0 N-CA-C 111.795 -0.522 . . . . 0.0 111.795 -178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.34 149.67 12.65 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.8 0.333 . . . . 0.0 110.704 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -76.05 145.08 40.41 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.031 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -142.66 -35.68 0.41 Allowed 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.834 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -88.83 -1.33 58.04 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -119.81 136.94 54.27 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.975 0.416 . . . . 0.0 111.17 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' A' ' 79' ' ' PHE . 4.4 mm? -100.24 147.55 25.61 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.67 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 37.4 t -152.28 171.82 17.39 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-O 121.268 0.556 . . . . 0.0 112.472 -177.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -114.69 144.84 42.8 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.893 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' A' ' 96' ' ' ALA . 6.4 mp -110.21 139.9 44.89 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.323 0.389 . . . . 0.0 111.332 -177.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.3 p -134.04 122.81 42.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.52 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -124.59 127.36 72.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.286 -175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -115.81 117.74 56.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -125.57 145.83 49.95 Favored 'General case' 0 CA--C 1.511 -0.539 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.567 -177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -97.33 136.08 38.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.214 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.626 ' HB1' ' OH ' ' A' ' 35' ' ' TYR . . . -60.76 134.71 57.35 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.444 178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.9 t -156.56 145.07 19.88 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.847 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -137.54 129.39 28.77 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.307 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 57.7 p -136.0 -62.53 0.68 Allowed 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.01 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 66.83 -71.16 0.1 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.488 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.476 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.176 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.6 m -127.51 155.93 42.98 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 110.858 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? 73.17 -70.16 0.17 Allowed 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.121 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.92 -146.89 50.43 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 74.4 p -133.12 161.18 35.1 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.654 0.264 . . . . 0.0 110.943 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -130.15 159.93 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.725 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 96.1 p -151.05 164.78 35.66 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.458 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -127.32 156.62 74.58 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.106 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -65.56 145.43 82.1 Favored 'Trans proline' 0 N--CA 1.505 2.197 0 C-N-CA 121.941 1.76 . . . . 0.0 112.123 -178.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.9 m -132.37 140.5 48.52 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.044 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -127.56 142.78 51.28 Favored 'General case' 0 C--N 1.351 0.669 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -132.21 133.98 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.295 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.59 150.34 20.33 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.401 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -146.7 161.64 40.18 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.795 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -97.15 127.79 43.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.424 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 67.9 t -94.6 107.3 19.22 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -110.12 115.49 54.69 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.763 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.04 174.93 12.0 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.317 2.011 . . . . 0.0 112.991 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.07 8.42 0.65 Allowed Glycine 0 CA--C 1.545 1.911 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.387 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.81 26.87 73.27 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 111.442 -0.663 . . . . 0.0 111.442 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.68 129.38 67.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.4 t -73.47 117.96 18.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -109.64 138.04 46.58 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.241 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.4 m -119.11 126.73 52.33 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.881 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -128.18 148.01 50.59 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.355 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -149.93 164.24 35.97 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.958 -179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.455 ' ND1' HD21 ' A' ' 55' ' ' LEU . 19.5 t-160 -146.11 138.39 25.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.267 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -108.01 162.05 14.39 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.861 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 31' ' ' PRO . 6.9 p -131.89 149.56 32.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.217 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.17 -50.66 65.38 Favored Glycine 0 CA--C 1.552 2.386 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.162 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 29' ' ' VAL . 52.3 Cg_exo -59.54 -42.42 47.84 Favored 'Trans proline' 0 N--CA 1.51 2.462 0 CA-C-N 119.779 1.79 . . . . 0.0 111.676 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -93.19 90.16 1.39 Allowed Glycine 0 C--N 1.332 0.36 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.229 179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.0 p-10 -63.85 -34.08 77.12 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.58 0.229 . . . . 0.0 111.242 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -105.56 -9.71 17.26 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.155 -0.475 . . . . 0.0 112.14 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.697 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 52.2 t80 -82.06 127.64 33.3 Favored 'General case' 0 C--N 1.35 0.593 0 CA-C-O 120.398 0.142 . . . . 0.0 111.025 -178.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.1 t -154.03 150.61 28.42 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.955 178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 99.1 m -100.26 146.14 27.26 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.788 177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 99.1 mtp -125.26 145.94 49.77 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 120.886 0.374 . . . . 0.0 111.427 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 68' ' ' ILE . 13.7 m-85 -136.62 107.94 6.85 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.283 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 84.8 m -110.39 125.22 52.99 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -157.24 164.17 37.99 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.495 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -135.45 139.36 44.03 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.971 178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -137.51 155.97 48.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -130.12 130.24 44.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.117 177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 172.61 178.62 42.84 Favored Glycine 0 C--N 1.335 0.487 0 N-CA-C 110.104 -1.199 . . . . 0.0 110.104 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -104.33 1.54 43.38 Favored Glycine 0 CA--C 1.54 1.611 0 CA-C-O 119.851 -0.416 . . . . 0.0 113.031 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -148.27 151.02 34.72 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-N 117.316 0.558 . . . . 0.0 111.553 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -81.03 178.83 8.18 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.554 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.04 150.1 36.27 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.992 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -98.51 124.83 43.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.592 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.7 m95 -125.46 142.11 51.68 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.087 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -103.27 137.6 41.18 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.893 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 67.5 mtm -113.69 122.81 48.27 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.2 t -122.91 127.99 49.69 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 123.221 0.326 . . . . 0.0 111.386 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.3 pp -130.29 153.23 48.86 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.912 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -148.84 171.33 29.16 Favored Glycine 0 CA--C 1.519 0.304 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.653 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.3 p -131.81 159.02 39.74 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.917 0.389 . . . . 0.0 111.647 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 44.1 t -67.96 154.73 40.99 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.95 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -54.09 -35.04 61.66 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.079 0.237 . . . . 0.0 111.04 -178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -103.66 12.29 34.98 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.923 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 60.84 29.85 19.28 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -83.46 -32.12 26.19 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.865 176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -122.59 141.07 52.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 0.0 111.512 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CD2' HG22 ' A' ' 57' ' ' THR . 92.3 m-85 -126.63 138.66 53.46 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.901 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.403 HG22 HG22 ' A' ' 139' ' ' VAL . 80.3 p -132.42 145.83 51.5 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.062 0.458 . . . . 0.0 112.06 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 95.7 m -128.2 130.75 48.49 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.352 175.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.446 HG22 ' CE3' ' A' ' 69' ' ' TRP . 53.6 m -130.88 133.77 46.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.09 0.243 . . . . 0.0 111.047 -177.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 39' ' ' PHE . 67.9 mt -127.07 126.75 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.446 ' CE3' HG22 ' A' ' 67' ' ' THR . 33.2 p90 -151.89 162.57 40.84 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.253 176.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 8.7 ptp85 -88.62 149.19 43.62 Favored Pre-proline 0 CA--C 1.576 1.942 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.319 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -75.04 -35.36 3.16 Favored 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 122.636 2.224 . . . . 0.0 113.632 -178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -63.69 -38.63 91.83 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.917 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.485 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 111.38 -36.57 4.13 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 110.739 -0.944 . . . . 0.0 110.739 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -142.2 130.92 22.75 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.717 0.294 . . . . 0.0 111.509 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 36.6 t -119.33 136.2 54.37 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.47 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -96.27 86.91 4.34 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.357 0.598 . . . . 0.0 110.977 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.6 mt -142.03 149.86 40.53 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.73 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -94.15 97.78 10.52 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 176.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.17 134.52 36.69 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.212 -176.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.495 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.5 m -73.49 -43.98 58.89 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.891 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 174.02 166.19 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -127.4 145.01 50.97 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.46 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -144.12 146.44 32.78 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.129 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.88 142.18 30.68 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.106 0.253 . . . . 0.0 111.331 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.84 170.35 22.28 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.509 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 32.2 m -129.55 159.85 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -127.99 144.4 51.1 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.99 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.79 9.95 86.56 Favored Glycine 0 CA--C 1.543 1.797 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.746 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.84 173.84 14.0 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-O 120.71 0.29 . . . . 0.0 111.157 -178.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -114.06 151.29 32.72 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.924 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 19.9 pt -90.19 136.23 24.39 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.603 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.2 mp0 -98.33 -39.76 8.65 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.386 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.9 t80 -164.1 125.01 2.2 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.505 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.08 132.46 54.89 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.733 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -155.35 170.71 21.27 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.713 -178.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.99 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -140.08 155.76 46.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.992 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.439 ' HB2' ' HZ1' ' A' ' 135' ' ' LYS . 95.2 m-85 -118.22 109.64 16.6 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 120.663 0.268 . . . . 0.0 111.599 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.426 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.2 m -64.2 -40.77 96.78 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.044 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -126.17 127.29 45.47 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.369 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.41 133.73 34.91 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.453 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -61.5 132.91 54.93 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.768 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -113.77 108.51 17.2 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.246 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.8 tp10 44.38 -86.8 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.417 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.0 mtm-85 -93.37 3.58 55.37 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.508 ' O ' ' HB1' ' A' ' 101' ' ' ALA . 58.2 mt-10 -115.93 133.29 56.18 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.768 0.318 . . . . 0.0 111.309 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 82.8 p -74.65 160.44 30.81 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.58 -0.737 . . . . 0.0 111.092 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -86.57 161.16 18.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.596 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.96 107.18 54.63 Favored Pre-proline 0 CA--C 1.561 1.377 0 CA-C-O 119.467 -0.301 . . . . 0.0 110.3 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -83.72 142.28 10.15 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.162 1.908 . . . . 0.0 112.669 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.426 HD21 ' OG ' ' A' ' 98' ' ' SER . 77.4 mt -75.52 148.78 38.68 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.624 176.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -75.25 154.99 37.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.915 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.8 m -64.1 -38.75 92.2 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.575 176.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -55.57 -16.76 4.34 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.217 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.36 -39.66 95.14 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 110.338 -0.245 . . . . 0.0 110.338 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -153.65 163.2 40.39 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.918 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -114.61 139.44 49.62 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.68 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -127.53 146.95 32.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.698 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 119' ' ' LYS . 12.3 m -137.31 158.19 44.97 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.237 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 118' ' ' THR . 22.2 ptmt -53.76 -22.37 9.22 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.93 -179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.4 t -149.86 18.49 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -159.82 158.18 30.59 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.757 0.313 . . . . 0.0 111.711 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.61 151.8 32.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.201 178.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.27 147.65 23.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -80.86 153.46 27.63 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.461 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -114.92 153.96 47.01 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.794 178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.89 143.81 95.16 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.981 1.787 . . . . 0.0 110.888 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 10.34 79.97 Favored Glycine 0 CA--C 1.545 1.913 0 CA-C-N 116.275 -0.42 . . . . 0.0 112.165 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.45 145.69 21.97 Favored 'General case' 0 C--N 1.348 0.506 0 CA-C-N 116.978 0.389 . . . . 0.0 110.652 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -84.18 142.34 30.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.747 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -128.03 -41.56 1.61 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.493 178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.59 -4.35 59.14 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.504 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -103.98 133.74 48.42 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.868 0.366 . . . . 0.0 111.115 -178.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.541 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -104.67 155.09 19.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.395 178.239 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.2 t -168.47 175.92 6.04 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HZ1' ' HB2' ' A' ' 97' ' ' TYR . 22.5 pttp -115.3 146.89 41.06 Favored 'General case' 0 C--N 1.345 0.392 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.695 176.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.99 HD23 ' HB2' ' A' ' 96' ' ' ALA . 52.2 mt -106.05 145.68 31.1 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.028 -0.533 . . . . 0.0 112.215 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -142.49 125.67 14.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 115.448 -0.797 . . . . 0.0 109.302 175.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.23 130.47 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.284 -176.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.403 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -112.83 120.04 61.92 Favored 'Isoleucine or valine' 0 C--O 1.244 0.764 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.697 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -129.79 143.65 50.92 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.799 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -101.09 121.25 41.48 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.518 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.476 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -63.04 136.49 57.84 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 123.331 0.395 . . . . 0.0 111.278 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 92.1 p -65.28 -38.13 89.33 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.052 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -150.71 135.66 17.53 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 109.976 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 7.1 m -134.39 51.77 2.1 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-O 121.482 0.658 . . . . 0.0 110.687 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -62.82 -41.3 99.25 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.429 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.478 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.4 pp . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 118.08 -0.962 . . . . 0.0 111.082 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 95.0 p -64.2 -23.75 67.42 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 111.717 0.265 . . . . 0.0 111.717 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? 55.06 -179.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.527 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.92 89.64 1.91 Allowed Glycine 0 C--N 1.341 0.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 88.3 m -63.35 -45.7 89.98 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.505 HG23 ' OE2' ' A' ' 8' ' ' GLU . 35.8 m -134.81 152.53 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.766 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.9 m -106.11 -8.02 17.67 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.505 ' OE2' HG23 ' A' ' 6' ' ' VAL . 47.3 mp0 46.19 56.1 15.98 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 120.481 0.181 . . . . 0.0 110.637 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.35 152.53 60.99 Favored 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.404 2.069 . . . . 0.0 112.505 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -112.2 129.88 56.11 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.875 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -106.84 126.71 52.66 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.985 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.0 t -129.76 133.38 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.784 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -107.09 148.03 29.28 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.635 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -145.18 160.19 41.82 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 120.868 -0.333 . . . . 0.0 111.814 -178.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -102.52 127.83 49.42 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.019 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 16' ' ' VAL . 12.5 p -95.25 108.75 21.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 175.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -106.42 109.69 63.31 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.343 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.8 173.87 13.67 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.539 2.159 . . . . 0.0 112.802 -178.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.51 13.21 0.57 Allowed Glycine 0 CA--C 1.544 1.845 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.355 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.43 26.86 72.45 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 111.744 -0.543 . . . . 0.0 111.744 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -110.92 127.88 67.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.3 t -75.47 119.53 23.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.093 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -115.49 138.05 51.43 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.836 -179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.3 m -114.45 127.05 55.62 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.317 178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -128.17 135.76 50.19 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.619 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 80.7 p -144.83 165.4 28.22 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.449 0.468 . . . . 0.0 111.331 -177.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -144.38 144.27 31.34 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.423 -179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -136.66 159.86 40.56 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.547 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.625 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.5 m -125.07 153.14 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.336 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.43 67.79 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-O 119.429 -0.651 . . . . 0.0 111.917 -177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.04 -43.66 34.84 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 121.772 1.648 . . . . 0.0 111.215 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.625 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -92.82 74.45 1.31 Allowed Glycine 0 CA--C 1.526 0.779 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.328 178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.24 -36.22 81.32 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.615 0.208 . . . . 0.0 111.293 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.88 -4.32 30.59 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -96.57 116.95 29.95 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.1 p -137.42 159.44 41.94 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.5 m -122.58 131.26 53.74 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.476 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 59.0 mtt -122.21 146.02 47.65 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 121.142 0.496 . . . . 0.0 112.246 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -139.34 110.98 7.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.296 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -109.14 130.69 55.48 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -149.72 161.57 41.94 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -176.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.31 132.66 41.6 Favored 'General case' 0 C--O 1.244 0.79 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.843 175.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -135.99 156.93 48.0 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -176.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -125.84 130.15 50.79 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.441 177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.49 179.34 37.83 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.19 -1.52 18.66 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-O 119.994 -0.336 . . . . 0.0 112.632 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.2 m -131.67 132.11 43.69 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 117.148 0.474 . . . . 0.0 110.454 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.1 p-10 -81.05 178.58 8.33 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.443 0.464 . . . . 0.0 110.916 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -149.04 150.88 33.53 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.277 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -100.28 120.23 39.6 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.101 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.0 m95 -114.72 145.8 41.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.677 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -101.39 146.14 28.0 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.537 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 76.4 mtm -130.04 149.65 51.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.274 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.486 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 78.1 p -130.18 140.08 50.78 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.365 177.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 63.7 mt -132.39 139.2 47.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.703 -178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -156.04 147.71 16.76 Favored Glycine 0 N--CA 1.467 0.759 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.89 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.2 p -135.67 159.51 41.39 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.443 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.1 t -69.89 151.37 45.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.04 177.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -58.43 -25.72 62.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 120.679 0.276 . . . . 0.0 110.936 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -96.91 0.54 49.2 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.453 176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.0 m170 65.41 25.33 11.98 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.875 0.47 . . . . 0.0 110.929 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 pt20 -80.07 -28.69 39.12 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.045 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -126.43 134.21 51.05 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 120.882 0.373 . . . . 0.0 111.796 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -121.09 126.08 48.88 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.31 177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 75.5 p -129.38 139.62 51.63 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.002 0.43 . . . . 0.0 111.576 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.0 m -132.8 131.32 40.95 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.351 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.506 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.6 m -131.49 132.92 44.61 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.788 0.327 . . . . 0.0 111.414 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 68.9 mt -126.34 125.55 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.932 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.506 ' CE3' HG22 ' A' ' 67' ' ' THR . 20.7 p90 -155.76 165.56 36.16 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 178.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -89.06 129.91 46.4 Favored Pre-proline 0 CA--C 1.558 1.277 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.972 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -65.43 -36.23 35.69 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 121.547 1.498 . . . . 0.0 110.954 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -68.08 -37.59 81.41 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.679 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 102.71 -18.28 50.74 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.697 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -141.33 128.27 20.62 Favored 'General case' 0 C--N 1.349 0.571 0 CA-C-N 117.39 0.595 . . . . 0.0 112.239 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 40.5 t -119.26 138.58 52.9 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.075 177.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -93.2 87.13 5.56 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-O 121.28 0.562 . . . . 0.0 110.707 179.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 30.8 mt -142.64 149.3 38.75 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.556 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -97.28 88.29 4.4 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -72.73 132.16 43.28 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.0 m -73.44 -43.16 60.94 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 176.01 164.37 0.38 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.809 176.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -137.33 149.56 47.12 Favored 'General case' 0 CA--C 1.507 -0.707 0 O-C-N 123.242 0.339 . . . . 0.0 111.613 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -145.6 149.44 34.53 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.331 -176.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.79 144.9 32.77 Favored 'General case' 0 C--O 1.236 0.393 0 O-C-N 123.308 0.38 . . . . 0.0 110.727 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -155.51 158.76 39.02 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.154 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG22 HD11 ' A' ' 91' ' ' ILE . 34.3 m -131.26 164.44 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -136.71 159.43 41.85 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.346 -177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.26 0.87 89.64 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.798 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.44 171.05 20.45 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 116.846 0.323 . . . . 0.0 110.454 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -103.45 144.57 31.22 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.766 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 86' ' ' VAL . 76.1 mt -87.34 120.98 37.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -81.36 -37.63 27.93 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.455 177.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -165.95 136.2 3.48 Favored 'General case' 0 C--N 1.346 0.438 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.743 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.64 138.45 30.7 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.011 178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.4 ptm -164.15 172.27 13.94 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.554 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.927 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -132.56 148.98 52.38 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.556 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -114.49 114.62 26.04 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.753 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 71.1 m -65.86 -40.63 91.87 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.038 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -143.29 136.42 27.97 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.592 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -93.8 110.92 22.55 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.045 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 47.64 98.15 0.01 OUTLIER 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.009 178.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -62.13 129.56 41.37 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 64.11 -80.09 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.032 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 82.0 mtm180 -137.1 -12.56 1.65 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -150.22 162.35 40.64 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.238 0.542 . . . . 0.0 112.363 -176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.7 p 66.81 98.82 0.05 OUTLIER 'General case' 0 C--O 1.234 0.277 0 CA-C-N 114.935 -1.03 . . . . 0.0 112.958 175.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -80.37 161.44 25.0 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.431 178.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.8 t -111.52 106.29 56.89 Favored Pre-proline 0 CA--C 1.562 1.434 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -85.11 144.73 9.57 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 C-N-CA 122.421 2.081 . . . . 0.0 112.546 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 74.1 mt -73.28 146.41 45.39 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.375 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.479 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 39.8 ttmt -63.94 134.18 54.61 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.294 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 88.2 m -59.1 -38.26 79.13 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 177.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.479 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 35.4 tt0 -54.51 -12.68 0.76 Allowed 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.81 -1.086 . . . . 0.0 111.944 178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -62.93 -39.71 95.42 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 122.615 0.366 . . . . 0.0 110.663 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -156.79 164.51 38.01 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.662 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -114.9 130.46 56.91 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.479 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 63.1 t -124.21 122.75 64.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.287 176.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.7 m -119.32 157.68 27.63 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.939 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.4 pttm -55.52 -21.39 16.56 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.044 -0.525 . . . . 0.0 112.096 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -146.57 17.75 1.31 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.53 146.01 21.97 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.889 0.376 . . . . 0.0 111.648 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.31 130.81 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.7 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -147.87 147.61 29.96 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.296 0.372 . . . . 0.0 111.397 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -78.41 152.4 32.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.033 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.3 mmm-85 -115.48 158.76 40.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.131 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -66.75 149.69 83.56 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.653 1.569 . . . . 0.0 110.774 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.37 12.36 82.13 Favored Glycine 0 CA--C 1.544 1.893 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.07 148.5 13.74 Favored 'General case' 0 C--N 1.349 0.582 0 CA-C-O 120.821 0.343 . . . . 0.0 110.723 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -87.67 143.63 27.08 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.434 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -121.82 -64.07 1.25 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.046 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -72.73 -20.51 61.19 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -77.62 140.02 39.58 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.826 0.346 . . . . 0.0 111.154 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.9 149.08 35.68 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.132 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 47.4 t -165.71 174.21 9.97 Favored 'General case' 0 C--N 1.344 0.345 0 CA-C-O 121.016 0.436 . . . . 0.0 111.879 -177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -115.23 152.17 33.16 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.361 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 96' ' ' ALA . 49.0 mt -112.97 143.3 44.5 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.525 0.516 . . . . 0.0 111.737 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.8 p -136.91 123.97 30.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.202 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.526 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.6 mp -123.85 126.65 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.865 -176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.75 119.64 61.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -132.15 140.13 48.65 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.735 -177.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -100.41 134.91 42.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.35 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.42 113.0 8.0 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.061 178.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 46.4 t -155.89 138.65 15.2 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.235 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.6 ttm105 -162.79 137.81 6.72 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.705 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 145' ' ' THR . 9.4 t -160.27 65.96 0.34 Allowed 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.385 0.612 . . . . 0.0 110.495 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.2 tm-20 -61.99 -40.36 95.36 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.69 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 C--O 1.221 -0.424 0 CA-C-O 118.01 -0.995 . . . . 0.0 110.956 -179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m -104.05 107.8 18.86 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.589 0.233 . . . . 0.0 110.645 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 tptt 39.89 30.2 0.06 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 115.96 -0.564 . . . . 0.0 112.208 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -147.16 158.23 27.66 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 m 63.61 104.57 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.4 m -125.14 158.79 32.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.359 -177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 36.3 t -115.45 132.61 56.57 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.858 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -75.12 116.23 52.34 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.587 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.62 148.17 92.26 Favored 'Trans proline' 0 N--CA 1.504 2.089 0 C-N-CA 122.176 1.918 . . . . 0.0 111.843 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.0 m -107.52 127.55 53.72 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.502 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.64 HG23 ' O ' ' A' ' 53' ' ' MET . 88.5 m -119.48 127.72 53.31 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.491 -178.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.523 HG21 ' CD2' ' A' ' 27' ' ' HIS . 65.6 t -132.52 131.12 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.189 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.66 151.02 19.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.966 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -142.9 159.69 41.77 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.719 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -103.42 128.74 50.48 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.334 -178.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.0 t -95.02 115.5 34.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 31.8 mtp-105 -117.63 107.86 43.98 Favored Pre-proline 0 CA--C 1.555 1.15 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.115 -178.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.19 172.16 16.76 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.499 2.133 . . . . 0.0 112.586 -178.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.64 22.53 0.15 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.335 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.78 26.68 74.12 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 61.2 t -116.75 128.83 74.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.0 t -74.12 120.11 22.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.5 m-70 -112.86 138.29 49.93 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.871 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 56.8 m -118.81 127.53 53.62 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.775 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -126.32 144.61 50.75 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.971 178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 87.1 p -152.15 165.02 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 123.287 0.367 . . . . 0.0 111.198 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.529 ' ND1' HD11 ' A' ' 55' ' ' LEU . 63.2 t-80 -149.01 146.75 27.93 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -149.14 166.43 28.81 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.739 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.3 m -124.79 156.86 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.558 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.53 -49.97 72.76 Favored Glycine 0 CA--C 1.546 2.007 0 CA-C-O 119.322 -0.71 . . . . 0.0 112.009 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.03 -43.1 45.32 Favored 'Trans proline' 0 N--CA 1.506 2.214 0 CA-C-N 119.449 1.624 . . . . 0.0 110.644 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.09 59.47 2.36 Favored Glycine 0 CA--C 1.529 0.94 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.962 177.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 39.0 p-10 -63.27 -33.13 74.84 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -90.61 -2.54 57.87 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.422 ' CD2' ' HB2' ' A' ' 89' ' ' ALA . 95.7 m-85 -111.12 119.32 38.59 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 120.834 0.349 . . . . 0.0 111.216 -178.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.6 m -136.64 135.78 38.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.391 -178.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.4 m -99.42 136.64 39.07 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 175.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 60.9 mtt -122.83 147.38 46.61 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.217 0.532 . . . . 0.0 112.139 -178.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.575 ' HD1' HD13 ' A' ' 68' ' ' ILE . 1.1 t80 -138.48 110.78 7.41 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.435 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.9 p -111.81 144.32 41.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.041 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.442 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.6 p90 -161.37 161.82 30.54 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.24 137.93 38.0 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.417 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.1 t -153.32 160.68 42.75 Favored 'General case' 0 CA--C 1.515 -0.404 0 CA-C-O 121.13 0.49 . . . . 0.0 111.823 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -118.01 128.93 55.26 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.236 177.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.06 174.08 37.95 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.96 5.78 12.39 Favored Glycine 0 CA--C 1.543 1.809 0 C-N-CA 121.532 -0.366 . . . . 0.0 112.874 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 88.9 m -123.58 130.46 52.7 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 117.167 0.483 . . . . 0.0 110.31 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.3 p-10 -80.43 178.89 8.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.022 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -148.64 151.23 34.61 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.115 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -101.52 126.18 48.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.712 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 53.4 m95 -127.53 147.49 50.33 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.211 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -114.72 145.82 41.63 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 11' ' ' THR . 90.5 mtp -119.49 144.14 47.16 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.567 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.7 t -139.24 123.35 17.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 123.486 0.491 . . . . 0.0 110.376 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD11 ' ND1' ' A' ' 27' ' ' HIS . 1.1 pt? -142.27 151.58 42.19 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.224 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -146.7 156.66 27.11 Favored Glycine 0 C--O 1.238 0.389 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.59 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.03 155.6 45.15 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 110.263 -0.273 . . . . 0.0 110.263 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.1 t -68.46 151.43 46.83 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.099 177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -57.03 -28.41 62.48 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 120.688 0.28 . . . . 0.0 111.017 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -99.74 2.51 44.27 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.533 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.9 m170 65.22 21.79 12.11 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.757 0.423 . . . . 0.0 110.897 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -74.17 -28.8 61.47 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -132.45 141.26 48.75 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-O 120.964 0.411 . . . . 0.0 112.009 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.723 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 91.2 m-85 -126.12 140.03 52.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.678 178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.3 t -139.85 136.43 33.97 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.33 178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -133.51 132.96 41.6 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.784 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.476 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.7 m -129.73 131.06 46.19 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.475 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.575 HD13 ' HD1' ' A' ' 39' ' ' PHE . 68.0 mt -127.81 124.95 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.319 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.476 ' CE3' HG22 ' A' ' 67' ' ' THR . 16.6 p90 -155.14 164.88 38.23 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 123.033 0.208 . . . . 0.0 111.022 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.422 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.3 ptp85 -84.14 156.08 63.53 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.573 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -83.31 -40.2 0.11 Allowed 'Trans proline' 0 N--CA 1.505 2.18 0 C-N-CA 122.61 2.207 . . . . 0.0 114.009 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.49 -38.72 92.01 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.879 -176.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 101.56 -15.82 56.97 Favored Glycine 0 CA--C 1.542 1.733 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.635 -177.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -137.69 120.0 15.8 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 116.861 0.33 . . . . 0.0 111.135 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 54.3 m -118.26 142.11 47.82 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.712 176.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -116.84 87.31 2.67 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.125 0.488 . . . . 0.0 111.013 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mp -141.44 149.69 41.32 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.79 177.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -93.01 87.31 5.71 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' HD12 ' A' ' 133' ' ' LEU . 6.3 m-85 -75.94 123.36 25.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.509 -179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.0 m -73.07 -42.37 63.12 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 123.861 0.726 . . . . 0.0 109.439 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -174.94 163.2 3.24 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.496 178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -145.8 148.68 33.19 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.228 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.4 148.42 33.32 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.815 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.672 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -130.52 136.51 49.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.033 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -149.33 165.88 30.65 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.222 -177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.94 160.5 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.51 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -128.87 138.82 52.25 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.196 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 3.08 89.58 Favored Glycine 0 CA--C 1.541 1.685 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.761 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' HB2' ' CD2' ' A' ' 35' ' ' TYR . . . -152.43 164.27 37.86 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.979 0.39 . . . . 0.0 110.967 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 21.8 pt-20 -104.0 147.35 27.48 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 109.903 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 75.6 mt -87.56 124.56 40.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.818 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 85.3 mt-10 -81.89 -41.21 21.25 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.956 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -162.15 134.96 5.92 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.361 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.97 138.86 39.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.436 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.7 ptm -157.89 172.74 17.92 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.14 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.949 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.31 151.84 49.09 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.276 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -116.94 107.56 14.73 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.838 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.4 m -64.74 -41.11 96.16 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.779 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -147.72 135.93 21.42 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.562 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.3 141.78 31.57 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.627 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -61.94 129.12 39.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.119 0.485 . . . . 0.0 111.754 -178.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.47 170.31 8.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.433 175.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -56.15 -39.17 71.88 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 92.9 mtm180 -104.5 6.63 34.92 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -133.01 157.84 44.2 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-O 120.943 0.401 . . . . 0.0 111.575 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.4 t -108.09 140.14 41.71 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.792 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.637 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 18.8 t70 -64.07 128.81 37.44 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.609 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.9 t -110.69 106.44 57.75 Favored Pre-proline 0 CA--C 1.56 1.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.192 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -92.08 139.64 2.11 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 122.601 2.2 . . . . 0.0 112.003 177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 86.1 mt -82.05 139.32 34.55 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.144 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.9 ptmt -86.4 151.88 23.18 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.935 -177.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -66.83 -18.44 65.38 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.709 179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -62.7 -26.44 68.67 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.37 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -63.34 -37.69 88.24 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.299 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -153.59 161.2 42.41 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.647 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 37.5 tt0 -113.12 130.06 56.31 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.254 0.549 . . . . 0.0 111.966 -178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 84' ' ' ALA . 35.4 m -128.84 138.27 55.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.626 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.3 m -131.81 157.43 43.9 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.714 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -56.99 -22.86 41.7 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.866 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -145.44 21.2 1.52 Allowed 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.28 152.57 30.44 Favored 'General case' 0 C--N 1.347 0.457 0 CA-C-O 120.885 0.374 . . . . 0.0 111.299 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 59.9 t -129.55 130.8 67.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.532 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -146.76 163.48 35.85 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 123.353 0.408 . . . . 0.0 110.936 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -122.07 151.7 40.6 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.779 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -113.66 158.25 39.36 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.741 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -66.86 148.47 82.4 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.613 1.542 . . . . 0.0 110.742 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 84.46 9.81 80.95 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.104 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.16 147.74 29.08 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 116.944 0.372 . . . . 0.0 110.383 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -76.17 147.15 38.67 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.321 0.581 . . . . 0.0 112.442 -178.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -148.57 21.22 1.04 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.475 177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -161.42 24.46 0.13 Allowed 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.7 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -135.37 140.19 44.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.732 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.572 HD22 ' N ' ' A' ' 133' ' ' LEU . 0.6 OUTLIER -109.69 151.36 26.99 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.445 -179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 40.6 t -167.23 176.48 6.72 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.03 151.26 35.84 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.966 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.949 HD23 ' HB2' ' A' ' 96' ' ' ALA . 58.9 mt -114.9 145.59 42.03 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.281 -176.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -137.29 124.48 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.315 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -126.5 128.36 71.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.329 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 120.04 63.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 175.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -130.1 145.18 51.67 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.557 -177.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -97.28 138.79 34.22 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.365 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.723 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.41 138.11 58.04 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.881 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 93.8 p -62.7 -35.53 80.01 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.763 178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -155.24 161.33 41.18 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 87.5 m -123.04 117.75 26.17 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 108.76 -0.829 . . . . 0.0 108.76 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -167.18 155.06 9.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.536 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 85.6 mt . . . . . 0 N--CA 1.472 0.658 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.861 179.902 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.4 t -57.35 -16.83 9.92 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -59.27 -40.05 84.82 Favored 'General case' 0 C--N 1.344 0.354 0 O-C-N 123.018 0.199 . . . . 0.0 110.788 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.24 -31.19 5.68 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.5 p 61.93 155.06 0.04 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 123.073 0.549 . . . . 0.0 109.75 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.88 156.15 38.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 86.5 p -120.64 -42.27 2.54 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.167 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -131.46 79.64 69.06 Favored Pre-proline 0 CA--C 1.557 1.214 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.548 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.49 154.55 68.65 Favored 'Trans proline' 0 N--CA 1.502 1.991 0 C-N-CA 122.053 1.836 . . . . 0.0 111.43 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -111.58 129.21 56.14 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.115 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.9 m -115.42 124.91 52.37 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.398 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.463 HG21 ' CD2' ' A' ' 27' ' ' HIS . 68.2 t -130.89 133.55 62.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.836 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -102.54 150.36 23.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -143.04 160.2 40.83 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.003 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -103.43 127.4 50.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.593 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 92.7 t -95.03 109.45 22.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 176.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -109.67 111.96 58.81 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -74.3 170.84 19.29 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.472 2.115 . . . . 0.0 112.88 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.33 11.87 0.64 Allowed Glycine 0 CA--C 1.545 1.964 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.341 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.14 26.77 73.1 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.3 t -110.2 128.38 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 76.7 t -71.7 121.59 22.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.382 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -118.05 138.12 52.44 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.709 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -122.04 131.73 54.14 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.656 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -134.06 134.11 41.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.419 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 95.4 p -137.59 165.19 26.93 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.902 0.382 . . . . 0.0 111.687 -177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.463 ' CD2' HG21 ' A' ' 12' ' ' VAL . 59.7 t-80 -148.79 147.87 29.3 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.72 -178.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -148.69 166.97 26.78 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.058 -178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG13 ' H ' ' A' ' 32' ' ' GLY . 13.2 p -123.83 147.69 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.449 -177.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -41.54 -71.39 0.34 Allowed Glycine 0 CA--C 1.55 2.264 0 CA-C-O 119.4 -0.667 . . . . 0.0 112.755 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_exo -56.16 -39.73 89.37 Favored 'Trans proline' 0 N--CA 1.506 2.222 0 C-N-CA 121.988 1.792 . . . . 0.0 111.253 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 29' ' ' VAL . . . -92.55 36.91 3.52 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.633 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -59.5 -36.32 75.83 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.731 0.301 . . . . 0.0 110.726 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm -63.83 -36.7 84.76 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.951 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.734 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 88.3 m-85 -90.3 116.88 28.61 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.065 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -131.08 132.43 44.87 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.408 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 86.0 m -88.86 140.65 29.22 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 175.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.2 mtp -126.49 147.72 49.79 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 120.957 0.408 . . . . 0.0 111.136 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -138.52 114.2 9.83 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.43 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.405 HG22 ' NZ ' ' A' ' 83' ' ' LYS . 88.7 m -110.59 130.14 55.64 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.341 -0.845 . . . . 0.0 108.728 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -147.12 160.11 42.81 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 112.316 -177.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -139.13 133.83 32.02 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.837 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -136.76 157.13 47.48 Favored 'General case' 0 C--N 1.344 0.336 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.713 -177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -128.37 129.5 46.32 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.139 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 150.87 -178.88 28.02 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 -178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -113.19 4.74 25.3 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.228 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.6 m -124.67 130.41 52.38 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 117.485 0.643 . . . . 0.0 110.707 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -82.15 179.64 7.73 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.831 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -144.71 152.01 39.76 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.419 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -101.57 129.48 47.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.182 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.0 m95 -126.17 144.95 50.56 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.47 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -105.78 138.73 41.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.197 177.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 93.5 mtp -120.7 139.67 52.72 Favored 'General case' 0 CA--C 1.505 -0.762 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.413 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 74.1 m -134.64 137.08 43.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 177.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.54 151.45 46.12 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.017 -179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -150.13 156.88 26.96 Favored Glycine 0 C--O 1.24 0.476 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.413 HG22 ' CD2' ' A' ' 64' ' ' PHE . 82.3 p -131.62 158.29 41.44 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.878 0.371 . . . . 0.0 111.219 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.0 t -69.71 154.64 41.7 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.182 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -57.41 -27.12 62.08 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.633 -0.258 . . . . 0.0 111.193 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -95.32 -0.37 52.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.71 177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.8 m-70 60.98 27.9 17.73 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.848 0.356 . . . . 0.0 111.482 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -85.66 -32.14 22.14 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.879 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -116.62 135.13 54.05 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.414 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD2' HG22 ' A' ' 57' ' ' THR . 72.9 m-85 -121.69 130.85 53.74 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.869 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.425 HG22 HG22 ' A' ' 139' ' ' VAL . 77.4 p -129.24 142.01 50.97 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 123.238 0.336 . . . . 0.0 111.377 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.8 m -134.8 134.35 40.77 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.066 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.507 HG22 ' CE3' ' A' ' 69' ' ' TRP . 60.4 m -128.0 131.52 49.21 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.488 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.6 mt -124.28 124.83 69.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.514 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CE3' HG22 ' A' ' 67' ' ' THR . 19.5 p90 -156.12 160.2 39.72 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.693 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.462 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 11.7 ptp85 -85.09 155.72 60.6 Favored Pre-proline 0 CA--C 1.565 1.538 0 O-C-N 123.297 0.373 . . . . 0.0 110.428 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.14 -40.75 0.77 Allowed 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.633 2.222 . . . . 0.0 113.72 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -63.73 -39.31 93.97 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.779 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.462 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 100.69 -20.38 48.36 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.517 -178.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -141.39 120.98 13.32 Favored 'General case' 0 C--N 1.348 0.513 0 CA-C-N 116.832 0.316 . . . . 0.0 111.349 178.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 34.2 t -118.86 136.54 53.97 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.658 178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -108.71 85.8 2.17 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.399 0.619 . . . . 0.0 111.499 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 50.8 mt -142.06 150.54 41.36 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.581 176.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -86.87 95.12 9.76 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -81.63 135.88 35.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.132 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 90.4 m -73.75 -43.24 59.62 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 175.0 161.37 0.22 Allowed 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.71 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -120.52 138.85 53.62 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.448 178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.405 ' NZ ' HG22 ' A' ' 40' ' ' THR . 8.9 mtmp? -141.14 147.04 37.82 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.181 0.301 . . . . 0.0 111.546 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.04 144.89 31.84 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -155.62 171.36 20.1 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.71 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.573 HG22 HD11 ' A' ' 91' ' ' ILE . 34.8 m -127.72 161.38 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 120.708 0.29 . . . . 0.0 111.706 -178.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -124.55 133.7 53.22 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.562 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.41 13.99 79.64 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.233 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -149.57 160.12 43.75 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.019 0.41 . . . . 0.0 111.622 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -104.45 157.72 16.97 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.496 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.573 HD11 HG22 ' A' ' 86' ' ' VAL . 39.8 mm -88.34 119.91 36.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.584 -175.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -83.74 -44.85 14.01 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.569 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -171.76 125.97 0.59 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.352 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.33 135.39 54.17 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.081 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 23.3 ptt? -158.03 168.32 27.44 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.413 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.862 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -135.66 152.84 51.6 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.437 -178.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -118.88 108.35 14.71 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.28 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.401 ' OG ' HD21 ' A' ' 110' ' ' LEU . 65.3 m -63.25 -40.65 98.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.276 177.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.64 127.76 29.84 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.524 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.76 137.89 33.52 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.116 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -57.31 127.28 31.19 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.123 0.487 . . . . 0.0 111.031 -179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -113.34 170.28 8.34 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.908 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -56.15 -38.6 71.09 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -106.55 3.18 26.77 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -130.43 150.13 51.79 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 120.899 0.381 . . . . 0.0 111.654 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 85.5 p -91.65 165.96 13.05 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 34.9 t70 -89.52 115.37 26.88 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.573 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.9 t -105.11 107.55 59.15 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 119.533 -0.27 . . . . 0.0 110.458 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -87.0 151.15 8.33 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 112.936 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.401 HD21 ' OG ' ' A' ' 98' ' ' SER . 82.0 mt -87.07 151.6 23.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.803 176.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.29 34.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.445 -179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.5 m -64.78 -37.9 89.15 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.333 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -54.31 -19.05 4.71 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.973 -177.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.9 tp10 -63.82 -33.12 74.96 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.41 0.148 . . . . 0.0 111.085 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -149.8 161.56 42.01 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -178.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -120.36 128.25 53.06 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.721 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.3 146.55 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.238 178.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 70.9 p -138.85 165.8 26.1 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.074 178.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -59.96 -18.32 44.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.721 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.8 t -140.9 5.44 1.95 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -176.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.17 160.65 37.46 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 28.0 m -136.77 145.76 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.43 178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.35 148.38 24.59 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.84 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.5 p-80 -98.37 143.86 28.38 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.236 0.541 . . . . 0.0 111.621 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -85.04 159.75 56.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.916 178.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -66.95 146.91 79.23 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.559 1.506 . . . . 0.0 110.548 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 81.26 14.09 79.49 Favored Glycine 0 CA--C 1.544 1.891 0 N-CA-C 111.876 -0.49 . . . . 0.0 111.876 -178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -50.81 141.35 13.34 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 116.886 0.343 . . . . 0.0 110.795 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -76.45 147.3 38.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.459 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -126.67 -48.39 1.53 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.375 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -80.26 -4.1 51.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -177.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -78.58 161.24 27.13 Favored 'General case' 0 C--N 1.346 0.422 0 CA-C-O 121.099 0.476 . . . . 0.0 112.2 -178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.1 129.22 37.66 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.508 174.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 33.5 t -162.29 172.83 15.05 Favored 'General case' 0 C--N 1.344 0.34 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -115.98 156.93 25.38 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.846 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 96' ' ' ALA . 39.5 mt -120.69 144.42 48.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.789 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.6 p -134.33 126.5 49.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.427 178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.516 ' N ' HD12 ' A' ' 138' ' ' ILE . 4.7 mp -126.04 126.7 70.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.173 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 65' ' ' THR . 74.6 t -116.95 119.42 61.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 175.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -127.46 143.32 51.21 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.01 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -97.46 129.9 44.61 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.855 -179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.734 ' HB1' ' CZ ' ' A' ' 35' ' ' TYR . . . -61.76 120.35 10.5 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 123.539 0.524 . . . . 0.0 111.374 -178.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 84.1 p -76.97 160.17 29.36 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.306 177.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 72.46 -45.63 0.63 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 6.2 m 77.67 48.86 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.594 0.711 . . . . 0.0 110.38 -177.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -61.95 -40.96 97.35 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.218 -0.553 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.772 179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.705 0 N-CA-C 110.371 -1.091 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.6 t -71.53 -61.31 1.82 Allowed 'General case' 0 C--N 1.347 0.474 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -137.23 -50.47 0.63 Allowed 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.231 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 91.99 158.16 34.27 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 89.1 m -127.18 129.82 48.58 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.3 t -125.98 126.64 70.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.545 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.4 m -137.85 -78.85 0.37 Allowed 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.008 0.374 . . . . 0.0 112.008 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 177.47 138.05 0.23 Allowed Pre-proline 0 CA--C 1.563 1.442 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.91 149.52 69.57 Favored 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 122.075 1.85 . . . . 0.0 111.512 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.3 m -110.5 131.46 55.03 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.561 -178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.651 HG23 ' O ' ' A' ' 53' ' ' MET . 89.1 m -118.73 129.67 55.39 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.229 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG23 ' CE1' ' A' ' 27' ' ' HIS . 93.2 t -131.4 134.34 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.205 178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' HB2' ' NE2' ' A' ' 52' ' ' GLN . . . -91.76 150.7 20.97 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -144.43 159.68 42.33 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.656 177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.64 126.8 52.07 Favored 'General case' 0 C--N 1.344 0.329 0 CA-C-O 120.895 0.379 . . . . 0.0 111.94 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.588 HG13 ' CE1' ' A' ' 41' ' ' TYR . 87.6 t -95.33 111.25 25.49 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -112.87 120.18 41.28 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.298 -177.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -73.57 170.99 18.67 Favored 'Trans proline' 0 N--CA 1.5 1.879 0 C-N-CA 122.383 2.055 . . . . 0.0 112.684 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.17 7.08 0.84 Allowed Glycine 0 CA--C 1.545 1.963 0 CA-C-N 115.548 -0.751 . . . . 0.0 112.334 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 27.27 73.21 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.73 129.88 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.51 121.29 26.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.504 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -120.45 138.7 53.65 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.642 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.0 m -114.5 125.89 54.33 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.522 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -129.4 148.05 51.27 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.022 177.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 90.0 p -146.41 161.74 39.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.903 0.382 . . . . 0.0 111.459 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.517 ' CE1' HG23 ' A' ' 12' ' ' VAL . 23.6 t-160 -136.64 131.64 33.94 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.964 -178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.6 p-10 -123.55 165.6 16.86 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.49 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 p -128.3 147.23 32.88 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.61 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -48.82 -72.33 0.47 Allowed Glycine 0 CA--C 1.55 2.22 0 CA-C-O 119.323 -0.709 . . . . 0.0 112.72 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -55.81 -43.24 59.13 Favored 'Trans proline' 0 N--CA 1.508 2.364 0 C-N-CA 121.888 1.726 . . . . 0.0 111.55 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.01 43.56 2.56 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -59.28 -35.53 73.91 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.635 0.255 . . . . 0.0 110.64 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -62.32 -39.77 94.14 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.756 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -86.53 142.0 28.65 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.63 -178.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -151.92 155.74 38.68 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 15.0 m -110.5 140.53 44.69 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 96.9 mtp -124.36 142.74 51.04 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-O 120.968 0.413 . . . . 0.0 111.418 -178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -140.38 110.2 6.43 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.14 179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 93.7 m -106.85 130.45 54.53 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.588 ' CE1' HG13 ' A' ' 16' ' ' VAL . 53.5 p90 -145.21 160.0 42.14 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -177.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.93 132.67 34.76 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.867 -1.06 . . . . 0.0 109.437 176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.0 m -134.48 158.37 44.1 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-O 120.978 0.418 . . . . 0.0 112.057 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -130.51 129.41 42.85 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.191 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 152.6 -177.63 30.22 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -109.4 5.02 31.39 Favored Glycine 0 CA--C 1.544 1.851 0 CA-C-O 119.901 -0.389 . . . . 0.0 113.001 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 58.8 m -128.37 132.4 48.55 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 117.354 0.577 . . . . 0.0 111.112 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 46.9 p-10 -80.41 -179.51 7.18 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.232 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -145.12 149.84 35.73 Favored 'General case' 0 C--N 1.338 0.095 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.523 -179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -101.4 131.95 47.23 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.881 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.5 m95 -128.46 145.01 51.23 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.016 -0.538 . . . . 0.0 112.245 -177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 13' ' ' ALA . 66.1 mm-40 -104.01 136.29 43.92 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.516 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.651 ' O ' HG23 ' A' ' 11' ' ' THR . 93.7 mtp -117.98 139.0 51.8 Favored 'General case' 0 CA--C 1.499 -0.998 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.6 t -140.78 124.05 16.66 Favored 'General case' 0 CA--C 1.513 -0.468 0 O-C-N 123.482 0.489 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD11 ' HB ' ' A' ' 29' ' ' VAL . 3.5 pp -128.07 148.05 50.55 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.243 178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.53 164.6 27.69 Favored Glycine 0 C--O 1.236 0.261 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.629 HG22 ' CD2' ' A' ' 64' ' ' PHE . 68.6 p -129.76 158.16 40.18 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.836 0.351 . . . . 0.0 111.207 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.5 t -67.19 153.41 43.73 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.332 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -54.95 -31.85 60.85 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 123.232 0.332 . . . . 0.0 111.045 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -101.76 6.02 41.53 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.677 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 59.91 29.93 19.47 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 120.928 0.394 . . . . 0.0 111.467 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -79.15 -31.86 44.14 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.359 177.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -131.6 152.48 50.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.46 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CD2' HG22 ' A' ' 57' ' ' THR . 93.3 m-85 -130.76 145.03 51.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.483 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 68.6 p -135.01 148.04 49.84 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 120.864 0.364 . . . . 0.0 111.665 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 26.4 m -129.83 136.74 49.92 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.1 177.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.655 HG22 ' CE3' ' A' ' 69' ' ' TRP . 45.4 m -135.18 130.98 36.18 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 121.191 -0.203 . . . . 0.0 111.196 -179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 66.0 mt -130.25 124.76 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.64 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.655 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.3 p90 -154.57 162.33 41.19 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.194 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.489 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 8.8 ptp85 -84.38 152.82 61.6 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 120.894 -0.322 . . . . 0.0 110.343 178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -75.22 -40.71 0.77 Allowed 'Trans proline' 0 N--CA 1.511 2.558 0 C-N-CA 122.637 2.225 . . . . 0.0 113.92 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.22 -39.0 93.37 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.73 -177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.489 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 110.67 -31.88 7.0 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.072 -178.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -141.68 126.13 17.72 Favored 'General case' 0 C--N 1.348 0.503 0 CA-C-O 120.823 0.344 . . . . 0.0 111.381 177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 30.6 t -118.55 135.51 54.37 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.544 178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -101.58 87.04 3.07 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.286 0.565 . . . . 0.0 110.986 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 49.2 mt -142.63 150.34 40.13 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.555 177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.99 98.36 11.52 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -83.13 137.06 34.22 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.33 -176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.8 m -73.49 -43.87 59.15 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.753 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 22.5 pt20 177.01 165.11 0.52 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.651 178.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -124.98 146.03 49.59 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.933 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HB3' HG21 ' A' ' 122' ' ' VAL . 95.4 mttt -142.77 141.64 31.75 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.653 178.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 136' ' ' LEU . . . -144.16 140.04 29.14 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 123.208 0.317 . . . . 0.0 111.203 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -156.07 166.59 33.02 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.541 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.403 HG22 ' CG1' ' A' ' 91' ' ' ILE . 35.9 m -128.1 157.74 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-O 120.712 0.291 . . . . 0.0 111.386 -178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.7 mmm-85 -128.96 149.56 50.75 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.011 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.18 0.5 88.69 Favored Glycine 0 CA--C 1.546 2.013 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.153 -178.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -161.0 168.6 24.21 Favored 'General case' 0 C--N 1.347 0.465 0 CA-C-N 116.861 0.33 . . . . 0.0 110.495 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 25.6 pt-20 -104.2 150.0 24.77 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.101 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.403 ' CG1' HG22 ' A' ' 86' ' ' VAL . 76.8 mt -87.43 124.48 40.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -176.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -82.42 -41.63 19.63 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.077 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -160.71 135.43 7.49 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.415 -179.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -137.42 139.9 40.96 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.386 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.3 ptm -159.04 173.45 16.43 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.203 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.971 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -137.0 155.24 49.96 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.11 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.427 ' HB2' ' HZ2' ' A' ' 135' ' ' LYS . 97.7 m-85 -117.95 112.29 20.1 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 123.135 0.272 . . . . 0.0 111.681 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.2 m -63.61 -41.9 98.26 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.056 0.455 . . . . 0.0 109.971 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -151.2 131.41 13.58 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.316 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.09 141.12 32.23 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.091 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -65.44 107.24 1.61 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.035 -178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -113.75 108.43 17.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.498 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 46.73 -87.05 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 96.3 mtm-85 -90.49 1.6 56.53 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -114.81 139.21 49.92 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.706 0.289 . . . . 0.0 111.235 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 84.8 p -84.14 164.92 18.87 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.283 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -88.38 114.91 25.48 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.401 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.6 t -102.14 106.9 50.56 Favored Pre-proline 0 CA--C 1.565 1.537 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.455 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -88.85 150.02 5.93 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.713 2.276 . . . . 0.0 112.802 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.61 ' HB2' ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm? -72.42 146.73 46.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.975 -1.012 . . . . 0.0 110.743 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -70.4 128.41 36.1 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 7.9 t -57.58 -33.31 68.04 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.56 -179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.28 -7.17 34.56 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.343 179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.03 -36.59 82.01 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -150.76 161.75 42.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.548 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -115.35 135.0 54.59 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.379 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.4 m -124.62 147.34 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 120.965 0.412 . . . . 0.0 111.394 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 119' ' ' LYS . 16.4 m -138.75 158.08 44.89 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.137 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.421 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -57.62 -21.32 38.7 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.169 -179.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.9 t -139.36 5.04 2.24 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -177.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -155.94 162.32 40.4 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.687 0.279 . . . . 0.0 111.737 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.479 HG21 ' HB3' ' A' ' 83' ' ' LYS . 14.9 p -143.25 140.69 26.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.5 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -144.59 149.17 35.33 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.772 0.32 . . . . 0.0 111.391 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 54.0 p-80 -80.37 157.54 26.29 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.413 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? -115.16 157.94 42.33 Favored Pre-proline 0 CA--C 1.545 0.756 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.543 179.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.45 147.12 90.49 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.695 1.596 . . . . 0.0 110.684 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 80.4 14.07 80.75 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.76 146.06 18.0 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-O 120.888 0.375 . . . . 0.0 111.048 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -85.04 146.48 27.15 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.832 -178.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -122.07 -56.64 1.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.687 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -70.23 -22.3 62.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.524 -178.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -77.49 136.15 38.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.956 0.408 . . . . 0.0 111.432 -177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -119.97 142.16 49.02 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.913 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 81.9 p -163.28 178.18 8.38 Favored 'General case' 0 CA--C 1.51 -0.558 0 CA-C-O 121.063 0.458 . . . . 0.0 112.056 -176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HZ2' ' HB2' ' A' ' 97' ' ' TYR . 23.4 pttp -115.33 153.49 30.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.532 176.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.971 HD23 ' HB2' ' A' ' 96' ' ' ALA . 63.4 mt -110.89 149.62 30.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.183 0.516 . . . . 0.0 112.154 -177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.8 p -138.02 126.22 31.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.112 177.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -126.77 129.66 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.417 -176.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.6 t -118.56 121.13 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -133.11 143.76 49.51 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.977 0.418 . . . . 0.0 111.667 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -106.73 137.1 45.4 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.682 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -69.46 112.06 5.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 178.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 47.7 t -164.38 151.36 11.45 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.553 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 57.59 35.82 26.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.379 177.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.1 p -134.86 157.3 47.18 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.875 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -168.37 -69.38 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.354 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 71.6 mt . . . . . 0 C--O 1.219 -0.536 0 CA-C-O 117.917 -1.04 . . . . 0.0 111.828 177.819 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.432 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m 62.25 128.46 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.697 0.284 . . . . 0.0 111.13 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.4 mmmt -120.72 139.61 52.82 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.73 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.67 176.58 37.22 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.3 t -153.89 150.13 28.05 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.508 0.194 . . . . 0.0 111.242 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.5 m -131.91 151.71 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.895 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 70.7 m -102.36 -6.16 23.35 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 61.3 148.87 0.09 OUTLIER Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 122.235 0.214 . . . . 0.0 110.857 -178.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -70.78 150.81 62.62 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.003 1.802 . . . . 0.0 112.108 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 89.5 m -122.33 133.28 54.67 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.947 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.2 m -110.27 126.03 53.75 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.862 -178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.536 HG21 ' CD2' ' A' ' 27' ' ' HIS . 58.1 t -130.33 132.31 64.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.413 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -103.4 150.32 23.94 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.502 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -143.01 159.5 42.12 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 123.075 0.234 . . . . 0.0 111.334 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -100.34 127.41 46.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.484 -178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.99 111.41 25.57 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 175.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 81.6 mtp180 -111.11 110.16 56.62 Favored Pre-proline 0 CA--C 1.553 1.065 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.248 -177.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.3 170.57 19.74 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.282 1.988 . . . . 0.0 112.362 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 145.88 20.19 0.14 Allowed Glycine 0 CA--C 1.54 1.609 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.617 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.26 26.66 73.9 Favored Glycine 0 CA--C 1.533 1.215 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.71 128.94 74.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.5 t -77.47 119.92 27.01 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -115.14 138.34 51.01 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.875 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 67.4 m -120.92 131.82 54.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.467 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -134.37 138.0 44.55 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.816 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 93.1 p -136.92 166.01 24.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 111.694 -178.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.536 ' CD2' HG21 ' A' ' 12' ' ' VAL . 60.3 t-80 -145.72 146.21 31.16 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.729 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -147.38 166.99 25.5 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.651 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.641 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.3 m -123.1 155.19 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.698 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.68 -51.0 61.66 Favored Glycine 0 CA--C 1.543 1.818 0 CA-C-O 119.293 -0.726 . . . . 0.0 111.697 -177.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.55 -49.84 8.06 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 121.683 1.589 . . . . 0.0 110.484 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.73 51.05 2.3 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.116 177.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -59.6 -36.95 77.3 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.855 0.327 . . . . 0.0 110.689 -178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -64.25 -39.68 94.44 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.597 178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' OH ' ' HB3' ' A' ' 140' ' ' ALA . 45.8 t80 -82.07 130.81 35.19 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.282 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -150.3 147.44 27.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.224 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 91.2 m -105.79 143.82 33.4 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.906 178.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 97.2 mtp -123.75 146.76 48.07 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 123.39 0.431 . . . . 0.0 111.323 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' CD1' HD13 ' A' ' 68' ' ' ILE . 35.6 t80 -137.63 110.09 7.45 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.14 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.6 m -111.45 131.45 55.2 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.974 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -150.82 161.02 43.47 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -141.49 139.71 33.37 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.05 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.3 t -153.91 163.46 40.02 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 121.225 0.536 . . . . 0.0 112.32 -178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -122.84 129.94 52.27 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.415 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 162.84 176.55 35.01 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.08 5.55 13.52 Favored Glycine 0 CA--C 1.54 1.631 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.843 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 84.2 m -123.38 128.85 50.47 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 117.231 0.515 . . . . 0.0 110.622 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -88.96 177.13 6.75 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.749 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -154.79 173.39 16.51 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -114.63 128.7 56.46 Favored 'General case' 0 C--O 1.235 0.329 0 O-C-N 123.533 0.521 . . . . 0.0 111.305 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -116.59 147.24 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.438 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -105.97 138.73 41.65 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.573 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.5 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -125.02 138.01 54.22 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.088 178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.484 ' HG ' ' HH2' ' A' ' 69' ' ' TRP . 72.1 m -132.23 139.28 48.24 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.455 178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.83 146.11 45.25 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.449 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -144.89 155.52 26.48 Favored Glycine 0 C--O 1.238 0.364 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.533 HG22 ' CD2' ' A' ' 64' ' ' PHE . 73.1 p -132.04 157.37 44.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.152 -177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -69.06 152.61 45.0 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.007 177.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -57.01 -30.31 64.08 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.164 0.29 . . . . 0.0 110.914 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -95.35 -0.35 52.79 Favored 'General case' 0 CA--C 1.551 1.012 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.342 176.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 61.27 27.49 17.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 122.706 0.402 . . . . 0.0 111.415 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -77.61 -29.75 52.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.58 177.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -127.54 142.2 51.44 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.332 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' ' HB2' ' A' ' 142' ' ' ALA . 90.1 m-85 -126.86 136.51 52.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.565 178.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 72.8 p -132.62 145.52 51.16 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.828 0.347 . . . . 0.0 111.64 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 84.0 m -132.48 134.22 44.78 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.214 176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.522 HG22 ' CE3' ' A' ' 69' ' ' TRP . 41.4 m -131.29 132.93 44.9 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 123.214 0.321 . . . . 0.0 111.132 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.5 HG23 ' HG2' ' A' ' 53' ' ' MET . 2.8 mt -129.44 126.51 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.588 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.522 ' CE3' HG22 ' A' ' 67' ' ' THR . 38.8 p90 -150.03 162.73 39.82 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 21.0 tpt85 -78.0 122.85 86.03 Favored Pre-proline 0 CA--C 1.554 1.126 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.569 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.02 -36.44 22.21 Favored 'Trans proline' 0 N--CA 1.501 1.934 0 C-N-CA 121.644 1.563 . . . . 0.0 111.827 -177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -68.07 -38.86 82.9 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.981 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.05 -19.65 50.97 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.348 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -130.67 120.22 23.58 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 117.014 0.407 . . . . 0.0 110.79 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.0 t -118.95 127.98 53.98 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.933 179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -116.14 85.74 2.35 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.726 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -141.73 150.75 42.22 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.893 -1.048 . . . . 0.0 108.828 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 70.1 t80 -86.15 88.16 7.55 Favored 'General case' 0 C--N 1.346 0.425 0 C-N-CA 120.352 -0.539 . . . . 0.0 109.817 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -76.56 131.39 38.91 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.483 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.2 m -73.13 -43.34 61.78 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 177.81 169.33 0.7 Allowed 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.044 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' HZ ' HD13 ' A' ' 110' ' ' LEU . 50.8 p90 -140.22 149.27 42.69 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.269 0.355 . . . . 0.0 111.153 178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HZ2' ' HA ' ' A' ' 124' ' ' HIS . 65.6 mmtt -142.06 154.24 44.8 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.996 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.11 141.39 34.2 Favored 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.172 0.295 . . . . 0.0 110.908 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 pt-20 -155.56 162.91 40.57 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.8 m -129.76 159.66 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 CA-C-O 120.765 0.317 . . . . 0.0 111.523 -179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -129.73 148.17 51.59 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.539 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.41 1.95 90.53 Favored Glycine 0 CA--C 1.544 1.882 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.34 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -160.94 170.03 21.42 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 116.994 0.397 . . . . 0.0 111.373 -178.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.19 149.09 26.23 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.554 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 80.3 mt -88.15 126.43 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.745 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -82.43 -41.75 19.46 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.252 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -164.02 136.07 4.85 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.638 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.46 137.38 47.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.144 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -156.6 170.09 23.17 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.241 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.536 ' HB3' HD12 ' A' ' 110' ' ' LEU . . . -146.51 153.1 40.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.937 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -115.22 107.65 15.56 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 120.81 0.338 . . . . 0.0 111.83 -179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.404 ' OG ' HD21 ' A' ' 110' ' ' LEU . 72.9 m -70.6 -41.63 72.06 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.912 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.68 134.66 28.96 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.498 -177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.71 143.37 30.07 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.774 176.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.73 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -58.54 139.72 55.29 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.046 0.45 . . . . 0.0 111.455 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -88.69 130.93 35.21 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.513 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 61.27 -79.72 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 O-C-N 123.59 0.556 . . . . 0.0 110.719 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 80.9 mtp180 -136.15 -6.59 2.07 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -151.5 167.83 26.81 Favored 'General case' 0 C--N 1.362 1.14 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.4 t 101.15 34.99 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 125.653 1.581 . . . . 0.0 112.146 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 60.6 t0 -85.08 114.71 22.42 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.666 177.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.47 107.06 59.29 Favored Pre-proline 0 CA--C 1.562 1.412 0 O-C-N 123.168 0.293 . . . . 0.0 111.196 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -85.78 150.75 9.92 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 122.314 2.009 . . . . 0.0 111.677 175.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.536 HD12 ' HB3' ' A' ' 96' ' ' ALA . 67.3 mt -75.5 147.15 40.02 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.29 177.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 113' ' ' GLU . 22.9 ttmm -83.72 131.6 34.92 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.244 -179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -54.79 -31.14 58.56 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.304 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.46 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 55.0 mt-10 -62.57 -9.75 9.84 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.056 178.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -62.51 -35.15 78.48 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -150.41 160.85 43.45 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.048 -179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -112.95 132.83 55.18 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.309 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.7 t -125.75 131.41 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.643 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 25.4 m -128.58 156.15 43.8 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.74 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -58.77 -20.25 47.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.158 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 t -143.07 19.08 1.94 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -161.49 157.76 25.48 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.627 0.251 . . . . 0.0 111.338 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.4 p -146.91 138.52 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.053 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.22 146.9 27.84 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.861 0.362 . . . . 0.0 111.274 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.418 ' HA ' ' HZ2' ' A' ' 83' ' ' LYS . 56.2 p-80 -76.62 159.13 30.54 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.671 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -114.32 156.97 43.66 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.371 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.57 147.56 70.68 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 121.759 1.639 . . . . 0.0 110.88 178.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.8 14.59 80.74 Favored Glycine 0 CA--C 1.546 1.994 0 N-CA-C 111.981 -0.448 . . . . 0.0 111.981 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.97 145.45 35.88 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-O 120.991 0.424 . . . . 0.0 111.409 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -78.56 146.62 34.14 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.215 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -121.88 -73.01 0.66 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.559 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.9 75.96 9.76 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.231 0.539 . . . . 0.0 110.57 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -152.18 141.48 21.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.596 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 133' ' ' LEU . 3.4 pp -107.26 134.25 50.62 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.16 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 21.0 t -163.72 177.63 8.53 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 121.009 0.433 . . . . 0.0 111.892 -178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -128.22 148.74 50.64 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.529 178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 mp -109.67 143.95 38.72 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.258 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 14.7 p -137.8 124.26 27.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.228 176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.512 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -125.75 129.3 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.219 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 62.5 t -116.25 121.06 66.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.577 ' HB3' ' OH ' ' A' ' 35' ' ' TYR . . . -128.67 145.5 51.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.968 0.413 . . . . 0.0 111.715 -176.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -96.47 121.57 38.42 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.251 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.656 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . . . -59.21 129.62 42.96 Favored 'General case' 0 C--O 1.236 0.347 0 O-C-N 123.332 0.395 . . . . 0.0 110.363 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.0 t -60.9 -47.55 85.87 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.173 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.3 ttp-105 -170.49 130.28 0.88 Allowed 'General case' 0 C--O 1.238 0.48 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.767 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.1 t -158.2 148.7 20.4 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.914 0.388 . . . . 0.0 111.325 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -165.85 32.03 0.05 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.699 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.763 -179.601 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 63.5 m -130.66 152.87 49.55 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.682 0.277 . . . . 0.0 111.063 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.48 -39.83 92.32 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.457 178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.33 174.01 37.82 Favored Glycine 0 C--N 1.336 0.563 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 71.3 p -126.27 153.66 44.46 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.684 0.278 . . . . 0.0 110.705 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.6 m -135.55 155.78 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.203 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.4 m -133.42 149.61 51.79 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.376 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.2 65.59 73.44 Favored Pre-proline 0 CA--C 1.561 1.399 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.88 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -75.1 152.07 39.84 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 122.279 1.986 . . . . 0.0 111.404 178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.603 HG21 ' CE1' ' A' ' 27' ' ' HIS . 14.5 t -133.52 149.91 51.69 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.301 0.376 . . . . 0.0 110.905 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.1 m -117.47 121.64 41.59 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.818 178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.5 t -131.23 131.67 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.647 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -110.46 149.7 29.93 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.75 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -146.97 160.61 42.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.864 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -104.14 126.88 51.61 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.463 -178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.3 t -94.8 111.96 26.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -115.7 118.99 38.32 Favored Pre-proline 0 CA--C 1.553 1.061 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.73 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.47 174.71 12.34 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.292 1.995 . . . . 0.0 112.605 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 144.55 11.86 0.29 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.463 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.61 26.67 73.7 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 111.696 -0.562 . . . . 0.0 111.696 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.0 t -114.32 128.73 71.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 59.9 t -75.55 119.12 22.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -111.93 137.85 49.36 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.373 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.5 m -120.61 128.8 53.37 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.496 178.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -128.52 128.4 44.25 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 84.7 p -126.34 159.89 31.93 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.933 0.397 . . . . 0.0 111.475 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.603 ' CE1' HG21 ' A' ' 10' ' ' THR . 57.8 t-80 -131.09 128.26 39.85 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.246 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -141.96 148.54 38.77 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.228 -178.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.738 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.0 m -128.85 158.05 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.509 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.75 -50.98 61.82 Favored Glycine 0 CA--C 1.547 2.07 0 CA-C-O 119.422 -0.655 . . . . 0.0 111.649 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.18 -43.05 37.94 Favored 'Trans proline' 0 N--CA 1.506 2.229 0 C-N-CA 121.766 1.644 . . . . 0.0 110.432 177.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.738 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.1 35.11 4.23 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 114.878 -1.055 . . . . 0.0 111.213 178.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -57.02 -31.54 65.22 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -88.69 -3.44 58.78 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.524 ' HD2' ' HB2' ' A' ' 89' ' ' ALA . 91.8 m-85 -124.99 131.16 53.46 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 122.918 0.136 . . . . 0.0 110.796 -178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 p -140.16 162.18 35.87 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 120.91 0.386 . . . . 0.0 111.731 -179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 87.4 m -119.6 125.02 47.76 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.239 -0.891 . . . . 0.0 108.815 172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 57.3 mtt -116.07 141.98 47.41 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-O 120.851 0.358 . . . . 0.0 111.762 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.641 ' CE2' HD11 ' A' ' 68' ' ' ILE . 43.7 m-85 -132.48 111.32 11.17 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.707 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 86.5 m -114.44 128.84 56.55 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.791 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -155.73 161.97 40.62 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 -178.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.425 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -127.47 139.5 52.77 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.596 177.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 48.9 m -134.18 156.1 48.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.104 0.478 . . . . 0.0 112.14 -177.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -133.23 130.05 38.53 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.094 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 163.01 -176.43 39.27 Favored Glycine 0 C--N 1.335 0.51 0 N-CA-C 110.044 -1.222 . . . . 0.0 110.044 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -112.79 -0.57 25.83 Favored Glycine 0 CA--C 1.54 1.652 0 CA-C-O 119.841 -0.422 . . . . 0.0 113.114 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.402 ' O ' HD21 ' A' ' 77' ' ' LEU . 69.1 p -128.46 154.23 46.3 Favored 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.42 0.61 . . . . 0.0 111.627 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -90.73 179.26 5.84 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.611 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -150.03 151.21 32.91 Favored 'General case' 0 C--N 1.34 0.153 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.256 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -104.26 132.01 50.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.279 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -128.85 146.27 50.98 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.554 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -112.61 145.11 40.95 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.229 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.547 ' HG2' HG23 ' A' ' 68' ' ' ILE . 78.6 mtm -130.7 143.93 51.08 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 178.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -139.99 126.69 20.5 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.22 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' HG ' HG22 ' A' ' 10' ' ' THR . 0.8 OUTLIER -137.01 146.61 45.5 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 123.238 0.336 . . . . 0.0 111.131 179.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -143.75 150.95 22.93 Favored Glycine 0 C--O 1.239 0.44 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 80.8 p -132.28 156.23 46.91 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.722 -0.239 . . . . 0.0 110.358 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.2 t -67.22 152.08 46.38 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.141 178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -57.25 -28.24 62.76 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 123.118 0.261 . . . . 0.0 110.909 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -94.15 -1.9 53.5 Favored 'General case' 0 CA--C 1.548 0.904 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.497 177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 61.96 29.51 17.8 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-O 120.857 0.36 . . . . 0.0 111.316 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 -74.5 -29.55 61.46 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.419 177.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -134.0 143.83 48.36 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.555 178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.757 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 83.9 m-85 -124.66 134.36 52.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.463 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 HG22 HG22 ' A' ' 139' ' ' VAL . 68.2 p -133.58 132.73 41.19 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.737 0.303 . . . . 0.0 111.386 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.1 m -131.03 133.07 45.39 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.274 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.619 HG22 ' CE3' ' A' ' 69' ' ' TRP . 54.3 m -129.5 137.56 50.88 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 120.991 0.424 . . . . 0.0 111.612 -177.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.641 HD11 ' CE2' ' A' ' 39' ' ' PHE . 1.4 mp -131.7 122.84 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.262 -176.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.619 ' CE3' HG22 ' A' ' 67' ' ' THR . 22.5 p90 -157.05 164.91 37.42 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.831 177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.443 ' HG3' ' H ' ' A' ' 73' ' ' GLY . 10.0 ptp85 -84.04 155.55 64.06 Favored Pre-proline 0 CA--C 1.57 1.721 0 O-C-N 123.159 0.287 . . . . 0.0 110.597 178.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -81.76 -39.36 0.18 Allowed 'Trans proline' 0 N--CA 1.507 2.301 0 C-N-CA 122.593 2.195 . . . . 0.0 113.88 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.2 -39.22 93.54 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.893 0.378 . . . . 0.0 111.883 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.443 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 104.44 -15.83 49.42 Favored Glycine 0 CA--C 1.537 1.441 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.371 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 29.0 mtpt -140.28 120.54 13.89 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 116.989 0.394 . . . . 0.0 111.346 178.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 52.1 m -117.73 135.19 54.2 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.087 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -112.8 86.52 2.39 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.315 0.579 . . . . 0.0 110.971 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 47' ' ' THR . 72.8 mt -142.92 150.09 39.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.375 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -94.39 97.32 10.11 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -81.39 135.69 35.67 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.505 -176.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 87.4 m -73.57 -42.61 61.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.454 177.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 175.83 170.38 0.38 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.221 178.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -140.92 147.47 38.88 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.393 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -146.34 150.87 36.55 Favored 'General case' 0 C--O 1.237 0.428 0 O-C-N 123.584 0.552 . . . . 0.0 111.072 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.92 140.75 31.28 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.303 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.21 170.1 22.04 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.579 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.46 160.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 O-C-N 123.078 0.236 . . . . 0.0 111.181 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -127.21 142.36 51.5 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.304 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.93 9.3 86.73 Favored Glycine 0 CA--C 1.538 1.524 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.397 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.524 ' HB2' ' HD2' ' A' ' 35' ' ' TYR . . . -154.22 168.49 26.38 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.896 0.348 . . . . 0.0 110.856 -179.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -104.02 149.03 25.54 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.033 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.7 mt -88.02 124.04 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.369 -178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -82.58 -41.61 19.35 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.905 178.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -170.93 143.95 2.1 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.528 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -143.4 140.27 30.37 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.331 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 20.1 ptp -156.42 172.15 19.01 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.178 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.756 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -134.38 148.19 50.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.569 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.76 112.15 23.44 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 123.097 0.248 . . . . 0.0 111.321 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 70.7 m -62.87 -42.21 99.68 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.249 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 34.6 tttp -141.92 138.53 32.08 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.622 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 138.44 33.76 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.448 176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -48.45 134.66 15.0 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.962 -178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -95.33 130.4 42.12 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.784 -177.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 69.6 -77.33 0.05 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.382 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -134.2 -11.37 2.53 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -168.51 176.09 5.92 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-O 121.095 0.474 . . . . 0.0 112.201 -175.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.5 p 93.57 53.76 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.797 1.239 . . . . 0.0 113.04 177.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -90.53 145.64 24.72 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.448 174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 61.7 t -118.8 106.57 43.67 Favored Pre-proline 0 CA--C 1.56 1.348 0 CA-C-O 119.422 -0.323 . . . . 0.0 110.613 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.04 143.0 7.83 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.29 1.993 . . . . 0.0 112.184 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.444 HD11 ' CB ' ' A' ' 134' ' ' SER . 63.3 mt -74.85 143.48 43.86 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.131 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -65.78 126.53 28.75 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 109.962 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.5 t -63.64 -30.4 71.51 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.277 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.13 -23.29 67.27 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.136 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.9 -18.1 64.91 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -152.59 162.41 41.27 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.725 0.298 . . . . 0.0 111.64 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 38.4 tt0 -121.0 132.98 55.23 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.513 -179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.81 136.71 59.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.234 -0.893 . . . . 0.0 110.271 175.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 119' ' ' LYS . 23.6 m -134.27 156.73 47.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.081 179.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' N ' HG22 ' A' ' 118' ' ' THR . 22.3 ptmt -59.2 -20.95 58.34 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.436 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.7 t -138.68 12.23 2.71 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.53 154.54 26.86 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.653 0.263 . . . . 0.0 110.913 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.33 148.59 31.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -155.86 164.42 38.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.219 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -120.37 155.12 34.04 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.182 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 41.4 mmt180 -113.58 156.11 43.94 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.802 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.63 140.94 75.95 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 121.763 1.642 . . . . 0.0 110.407 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.13 13.91 75.97 Favored Glycine 0 CA--C 1.543 1.834 0 N-CA-C 111.701 -0.56 . . . . 0.0 111.701 -177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -48.88 146.14 3.44 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 116.894 0.347 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -71.37 141.27 50.38 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.538 -178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.65 -68.19 0.45 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.361 0.413 . . . . 0.0 111.125 -179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.51 86.5 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.581 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -76.72 144.31 39.4 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.35 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.479 HD12 ' C ' ' A' ' 133' ' ' LEU . 3.9 pp -109.07 158.65 17.55 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.9 -178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.444 ' CB ' HD11 ' A' ' 110' ' ' LEU . 46.1 t -170.44 173.84 5.43 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -115.13 157.09 24.08 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.359 176.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.756 HD23 ' HB2' ' A' ' 96' ' ' ALA . 68.7 mt -117.11 148.48 41.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 13.9 p -141.59 125.06 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.388 176.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.504 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -126.9 129.14 71.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.382 -176.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.431 HG22 HG22 ' A' ' 65' ' ' THR . 58.7 t -118.15 120.26 63.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -131.7 142.37 49.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.837 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.49 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 22.2 ttpp -99.45 143.47 29.66 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.561 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.757 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.75 141.96 56.4 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.983 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 90.8 p -62.86 -37.4 86.7 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -154.91 156.33 35.9 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.189 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 67.9 p -126.2 -15.6 5.7 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.664 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 59.3 39.89 21.92 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.208 0.528 . . . . 0.0 110.402 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 77.2 mt . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.965 -1.016 . . . . 0.0 110.79 -179.899 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.489 -1.445 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 p 58.64 27.81 16.31 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.616 0.246 . . . . 0.0 111.603 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -94.99 97.62 10.1 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.17 -7.62 67.58 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.657 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 HG22 ' OG ' ' A' ' 7' ' ' SER . 72.8 m -124.25 124.84 43.31 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 117.129 0.464 . . . . 0.0 110.288 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.66 -49.77 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.544 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.433 ' OG ' HG22 ' A' ' 5' ' ' THR . 50.0 m 56.47 45.7 22.05 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-O 121.383 0.611 . . . . 0.0 110.366 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -70.14 157.51 89.69 Favored Pre-proline 0 CA--C 1.56 1.328 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.562 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.16 151.25 66.72 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.197 1.931 . . . . 0.0 111.736 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.41 HG22 ' HE1' ' A' ' 27' ' ' HIS . 91.5 m -120.73 129.61 53.7 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.4 -178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -121.46 125.79 47.73 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.927 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -136.14 133.24 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.177 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.62 151.18 19.57 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.746 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -140.48 159.78 41.44 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.254 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -99.29 128.28 45.39 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.594 -178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.472 HG13 ' CE1' ' A' ' 41' ' ' TYR . 60.4 t -95.3 108.37 20.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 79.1 mtp180 -105.76 112.55 64.46 Favored Pre-proline 0 CA--C 1.554 1.098 0 O-C-N 123.297 0.373 . . . . 0.0 111.839 -176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -78.39 175.83 10.63 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.541 2.16 . . . . 0.0 112.378 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 138.86 15.74 0.61 Allowed Glycine 0 CA--C 1.542 1.744 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.332 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.88 73.81 Favored Glycine 0 CA--C 1.533 1.187 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 57.5 t -118.64 129.91 74.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 66.1 t -75.15 119.09 22.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -112.79 138.4 49.68 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.72 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -115.67 126.88 54.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.009 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.41 148.07 49.68 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.897 177.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.9 p -152.5 165.53 34.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.842 0.353 . . . . 0.0 111.476 -177.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.41 ' HE1' HG22 ' A' ' 10' ' ' THR . 21.7 t-160 -146.7 136.77 23.47 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.713 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -114.35 164.74 13.51 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.55 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -121.24 152.15 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.409 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.35 -51.29 59.7 Favored Glycine 0 CA--C 1.544 1.892 0 CA-C-O 119.306 -0.719 . . . . 0.0 111.777 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -60.4 -46.43 17.96 Favored 'Trans proline' 0 N--CA 1.504 2.138 0 C-N-CA 121.931 1.754 . . . . 0.0 110.937 177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.64 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.27 78.44 1.09 Allowed Glycine 0 CA--C 1.525 0.673 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.19 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -61.84 -36.58 81.61 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.694 0.283 . . . . 0.0 110.682 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -88.46 -30.08 19.69 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.718 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.91 127.66 33.27 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.58 -178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.0 t -155.78 155.45 33.07 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.488 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.9 m -114.77 147.43 39.77 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.12 177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.1 mtt -128.01 151.2 49.43 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.983 -176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -138.93 113.47 8.99 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.016 178.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 89.9 m -114.21 130.59 56.62 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.472 ' CE1' HG13 ' A' ' 16' ' ' VAL . 55.2 p90 -148.89 161.52 41.69 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.82 127.74 46.57 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.799 175.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.5 m -134.61 153.81 51.8 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.987 0.422 . . . . 0.0 112.111 -176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.5 tp60 -125.5 128.92 48.75 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.932 177.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.98 -176.72 38.39 Favored Glycine 0 CA--C 1.522 0.517 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -119.16 -1.91 13.96 Favored Glycine 0 CA--C 1.54 1.634 0 C-N-CA 121.373 -0.441 . . . . 0.0 113.099 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 64.2 m -130.53 133.64 46.41 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 117.277 0.539 . . . . 0.0 110.628 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 48.6 p-10 -80.32 178.32 8.37 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.643 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 -145.44 150.38 36.4 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.145 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -99.63 118.99 37.36 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.486 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.7 m95 -118.02 146.96 43.67 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.991 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -100.83 150.65 22.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.872 0.368 . . . . 0.0 111.012 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 88.3 mtp -127.01 150.36 49.47 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.3 t -139.78 133.53 30.55 Favored 'General case' 0 C--O 1.235 0.337 0 O-C-N 123.423 0.452 . . . . 0.0 111.374 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.407 HD11 ' ND1' ' A' ' 27' ' ' HIS . 80.3 mt -117.69 140.03 50.21 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.516 178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -149.08 154.14 25.61 Favored Glycine 0 C--O 1.236 0.244 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.731 HG22 ' HD2' ' A' ' 64' ' ' PHE . 65.0 p -129.91 158.21 40.15 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 78.1 p -71.73 163.03 28.53 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.148 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.13 -27.62 67.2 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.585 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -105.53 7.16 32.82 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.621 178.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 41.8 m-70 57.77 26.47 13.15 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 120.844 0.355 . . . . 0.0 111.23 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -81.45 -28.32 34.23 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.718 178.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -128.91 147.45 50.84 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.327 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.731 ' HD2' HG22 ' A' ' 57' ' ' THR . 68.4 m-85 -128.5 143.05 50.91 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.835 179.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 25.1 m -138.49 134.95 34.63 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.937 -175.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 72.5 m -119.82 133.24 55.67 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.393 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.463 HG22 ' CE3' ' A' ' 69' ' ' TRP . 57.1 m -131.16 131.42 44.05 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.746 0.308 . . . . 0.0 111.213 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 69.1 mt -125.83 123.84 65.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.627 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CE3' HG22 ' A' ' 67' ' ' THR . 18.7 p90 -153.71 166.01 34.18 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -97.96 131.08 27.31 Favored Pre-proline 0 CA--C 1.559 1.292 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.128 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.18 -36.2 29.78 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 121.79 1.66 . . . . 0.0 111.126 -178.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -66.72 -39.23 87.92 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.729 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.77 -14.1 64.45 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.559 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -140.47 126.9 20.03 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 117.264 0.532 . . . . 0.0 111.933 179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 70.5 m -119.24 137.62 53.54 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.79 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -105.81 84.52 2.08 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.716 0.77 . . . . 0.0 111.408 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 32.8 mt -143.98 150.6 38.54 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-N 114.57 -1.196 . . . . 0.0 109.23 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -87.5 87.74 7.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.971 0.415 . . . . 0.0 110.152 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -77.6 130.67 37.19 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.746 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -72.75 -42.58 63.89 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 177.04 170.69 0.52 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.955 177.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -139.61 149.7 44.11 Favored 'General case' 0 CA--C 1.51 -0.561 0 O-C-N 123.199 0.312 . . . . 0.0 111.255 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -145.97 153.82 41.22 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.916 -176.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -143.13 143.86 31.99 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.86 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -155.69 163.25 40.15 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.912 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.5 m -129.16 158.62 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 CA-C-O 120.886 0.375 . . . . 0.0 111.89 -179.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 -130.49 150.29 51.77 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.222 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.52 1.88 90.54 Favored Glycine 0 CA--C 1.544 1.844 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.283 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -159.88 170.69 20.88 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-N 116.949 0.374 . . . . 0.0 111.01 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' ' HB1' ' A' ' 140' ' ' ALA . 15.7 pt-20 -104.73 147.0 28.17 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 77.1 mt -87.59 125.36 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.444 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -83.12 -40.92 19.15 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.137 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -170.67 142.62 2.03 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.46 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.24 140.51 48.69 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.409 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.4 ptp -153.58 166.51 32.52 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.89 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.975 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -136.45 151.23 49.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.34 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -119.55 109.95 16.3 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.194 0.309 . . . . 0.0 111.183 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.417 ' OG ' HD21 ' A' ' 110' ' ' LEU . 73.7 m -63.78 -41.54 97.94 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.77 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -143.27 135.8 27.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.542 -179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -83.0 142.77 31.11 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.006 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.697 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -57.82 134.83 56.62 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.804 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -67.66 122.67 18.56 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 63.75 -79.81 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 O-C-N 123.491 0.494 . . . . 0.0 110.603 -177.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmm180 -137.52 -12.3 1.57 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.664 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 44.1 mt-10 -128.57 161.88 28.58 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.0 p 85.87 42.34 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.028 0.931 . . . . 0.0 112.498 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.697 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 66.1 t0 -90.05 115.44 27.33 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.544 178.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.2 t -103.62 108.03 58.12 Favored Pre-proline 0 CA--C 1.567 1.607 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.703 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -90.0 149.63 4.78 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.528 2.152 . . . . 0.0 113.052 177.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 98' ' ' SER . 80.7 mt -82.81 160.47 22.23 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.837 175.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -91.21 126.77 36.39 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.567 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.8 t -56.5 -22.32 31.99 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.968 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -61.51 -28.3 69.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.55 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -63.37 -16.15 59.6 Favored 'General case' 0 CA--C 1.555 1.152 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -176.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -150.04 163.46 38.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 120.733 0.301 . . . . 0.0 111.464 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -119.71 136.02 54.59 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.689 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -128.26 147.66 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.909 178.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 119' ' ' LYS . 18.6 m -136.67 157.59 46.41 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.509 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 118' ' ' THR . 0.1 OUTLIER -56.79 -23.96 47.08 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.651 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.6 t -149.56 26.24 0.84 Allowed 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.709 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 118' ' ' THR . . . -156.69 159.55 38.49 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.548 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 12.5 p -143.16 138.49 26.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.599 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -149.23 160.26 43.53 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -105.02 154.76 19.69 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.357 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 55.2 mmm-85 -113.88 153.55 46.06 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.278 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -57.01 143.32 93.04 Favored 'Trans proline' 0 N--CA 1.499 1.828 0 C-N-CA 121.847 1.698 . . . . 0.0 110.557 177.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 83.45 13.47 76.13 Favored Glycine 0 CA--C 1.545 1.948 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 -178.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.44 147.1 27.31 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.868 0.334 . . . . 0.0 110.342 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -83.14 143.92 30.19 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.974 -177.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -138.61 -40.69 0.5 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.252 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -89.18 -10.02 48.71 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -102.82 136.75 42.07 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.809 0.338 . . . . 0.0 111.101 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -101.13 140.17 35.8 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.967 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -158.68 173.45 16.56 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.918 -177.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -115.63 150.37 36.81 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.944 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.975 HD23 ' HB2' ' A' ' 96' ' ' ALA . 62.6 mt -113.65 145.39 41.38 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.929 -177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.4 p -136.62 123.09 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.757 176.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.499 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -122.81 128.39 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.958 -176.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.14 123.25 67.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . 0.427 ' HB1' ' O ' ' A' ' 90' ' ' GLU . . . -131.58 144.59 51.19 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.01 0.433 . . . . 0.0 111.669 -177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? -97.19 132.85 42.55 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.776 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.597 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -60.25 113.05 2.17 Favored 'General case' 0 C--O 1.236 0.343 0 O-C-N 123.314 0.384 . . . . 0.0 110.575 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 73.7 m -64.14 -39.85 94.9 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.99 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 40.8 ttm-85 -117.44 160.99 20.29 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.954 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 85.8 m -112.8 119.24 37.35 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -148.72 141.54 24.65 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.4 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.468 0.442 0 CA-C-O 118.091 -0.957 . . . . 0.0 110.872 -179.397 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.8 t -148.74 142.18 25.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.6 0.238 . . . . 0.0 110.917 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -150.09 135.78 18.38 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.586 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -107.38 134.3 12.13 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 110.921 -0.871 . . . . 0.0 110.921 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.551 HG22 ' OE1' ' A' ' 59' ' ' GLU . 8.8 t -88.53 -47.22 8.47 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 111.477 0.177 . . . . 0.0 111.477 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.422 ' N ' HG23 ' A' ' 5' ' ' THR . 57.4 t -129.14 125.39 62.39 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.3 p -165.96 62.26 0.11 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.475 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -62.68 135.21 95.64 Favored Pre-proline 0 CA--C 1.558 1.264 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.436 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.92 158.12 13.67 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.48 2.12 . . . . 0.0 112.461 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.661 HG21 ' CE1' ' A' ' 27' ' ' HIS . 86.0 m -121.67 130.14 53.26 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.407 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.9 m -109.37 127.47 54.37 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.759 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 HG21 ' CD2' ' A' ' 27' ' ' HIS . 59.7 t -128.93 129.91 68.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.467 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.37 146.11 41.88 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.13 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -148.37 160.35 43.11 Favored 'General case' 0 C--N 1.349 0.561 0 CA-C-O 120.666 0.27 . . . . 0.0 111.701 -179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -101.98 128.88 48.2 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.995 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.9 t -94.74 108.64 21.06 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -109.65 111.97 58.86 Favored Pre-proline 0 CA--C 1.551 1.006 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.947 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 170.81 18.31 Favored 'Trans proline' 0 N--CA 1.498 1.794 0 C-N-CA 122.406 2.071 . . . . 0.0 112.747 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 146.49 15.82 0.16 Allowed Glycine 0 CA--C 1.542 1.736 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.504 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.06 26.97 73.6 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 58.6 t -113.37 128.94 69.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 63.6 t -75.93 119.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.24 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -114.79 138.06 51.2 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.646 -179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 70.7 m -121.25 129.77 53.34 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.728 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.64 146.29 50.6 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.105 178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -152.67 164.67 37.27 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 123.315 0.385 . . . . 0.0 111.312 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.661 ' CE1' HG21 ' A' ' 10' ' ' THR . 55.7 t-80 -149.79 146.97 27.46 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.756 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.8 p30 -150.33 166.94 28.49 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.918 -178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG23 ' H ' ' A' ' 32' ' ' GLY . 28.9 m -123.48 157.42 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.356 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.49 -51.86 56.56 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-O 119.308 -0.718 . . . . 0.0 111.967 -176.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -60.68 -45.75 19.84 Favored 'Trans proline' 0 N--CA 1.505 2.153 0 CA-C-N 119.561 1.681 . . . . 0.0 110.535 177.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.664 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.91 40.02 2.83 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.321 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -58.59 -36.19 73.59 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.705 0.253 . . . . 0.0 110.839 -178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -70.53 -24.37 62.81 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.4 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -99.6 133.04 44.51 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.661 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.8 t -155.39 158.51 38.77 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.5 m -112.6 141.97 45.74 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.689 177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 64.0 mtt -127.29 143.91 51.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 120.781 0.324 . . . . 0.0 111.297 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.651 ' CZ ' HD11 ' A' ' 68' ' ' ILE . 68.0 m-85 -137.33 114.35 10.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.057 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 88.1 m -113.71 128.78 56.56 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.991 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -153.56 162.8 40.92 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.08 146.37 35.36 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.04 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.9 t -153.37 163.27 40.23 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 71.9 tp60 -127.02 129.33 47.86 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.091 -0.958 . . . . 0.0 110.483 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.43 178.82 42.12 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -114.36 3.08 23.65 Favored Glycine 0 CA--C 1.544 1.845 0 C-N-CA 121.629 -0.32 . . . . 0.0 112.74 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.612 ' O ' HD21 ' A' ' 77' ' ' LEU . 56.6 m -129.61 134.47 47.72 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 117.129 0.465 . . . . 0.0 110.591 -179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 44.0 p-10 -80.5 178.31 8.41 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.577 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -145.66 151.03 37.39 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.271 -179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -103.89 122.85 46.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.839 -0.618 . . . . 0.0 110.187 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.8 m95 -120.44 138.62 53.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.088 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -106.03 145.31 31.56 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.478 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.52 ' HG2' HG23 ' A' ' 68' ' ' ILE . 97.3 mtp -128.72 141.36 51.35 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.495 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.8 m -135.41 132.53 37.62 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.8 176.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.529 HD21 ' ND1' ' A' ' 27' ' ' HIS . 4.0 pp -138.24 152.81 48.94 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.73 -179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -145.96 157.8 27.48 Favored Glycine 0 C--O 1.24 0.474 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.45 HG22 ' CD2' ' A' ' 64' ' ' PHE . 80.5 p -133.81 158.28 43.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.751 0.31 . . . . 0.0 111.062 -178.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 40.6 t -66.46 153.36 43.07 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.09 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.551 ' OE1' HG22 ' A' ' 5' ' ' THR . 16.4 pt-20 -57.2 -30.07 64.24 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.926 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -96.16 2.53 53.18 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.375 176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 61.27 28.84 18.31 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 121.029 0.442 . . . . 0.0 111.272 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -81.54 -27.83 34.22 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.572 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -122.54 139.48 53.85 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.118 178.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.45 ' CD2' HG22 ' A' ' 57' ' ' THR . 96.3 m-85 -126.91 136.23 52.02 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.82 177.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -139.74 138.57 36.04 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.883 0.373 . . . . 0.0 111.738 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 73.2 m -130.48 136.22 48.75 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.39 178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.472 HG22 ' CE3' ' A' ' 69' ' ' TRP . 61.7 m -127.72 135.59 50.37 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.974 0.416 . . . . 0.0 111.018 -178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.651 HD11 ' CZ ' ' A' ' 39' ' ' PHE . 1.2 mp -129.12 122.52 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.75 -176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.472 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -153.9 163.86 39.34 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 123.081 0.238 . . . . 0.0 110.63 177.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 28.3 ptt-85 -97.35 153.89 38.24 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.947 177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.79 -36.9 1.36 Allowed 'Trans proline' 0 N--CA 1.509 2.414 0 C-N-CA 122.867 2.378 . . . . 0.0 113.696 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -65.23 -39.16 92.36 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.867 -176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 101.7 -29.11 13.2 Favored Glycine 0 CA--C 1.533 1.188 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -142.94 119.99 11.38 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-O 120.525 0.202 . . . . 0.0 111.015 176.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 31.8 t -117.34 116.12 26.59 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.073 177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -74.71 87.78 2.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.245 0.545 . . . . 0.0 111.553 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.612 HD21 ' O ' ' A' ' 47' ' ' THR . 70.8 mt -142.14 149.78 40.23 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.891 177.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -97.21 92.57 6.08 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -77.56 132.93 38.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.903 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.3 m -73.4 -43.22 60.96 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 179.87 171.41 1.08 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.435 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.3 p90 -144.72 148.83 34.64 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.089 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -145.85 150.65 36.53 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.673 0.608 . . . . 0.0 111.122 -177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -142.15 139.32 32.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 178.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -152.76 166.35 32.49 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.446 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.06 157.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 O-C-N 123.162 0.289 . . . . 0.0 111.151 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 55.5 mmm-85 -128.77 145.74 51.1 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.904 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.24 3.17 90.71 Favored Glycine 0 CA--C 1.545 1.92 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.067 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.73 169.14 24.05 Favored 'General case' 0 C--N 1.349 0.576 0 CA-C-N 116.97 0.385 . . . . 0.0 111.154 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -104.34 149.74 25.09 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.495 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.6 mt -87.91 124.69 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 120.754 0.311 . . . . 0.0 110.734 -177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.0 mt-10 -82.6 -41.33 19.65 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.967 177.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 21.6 t80 -168.87 129.62 1.17 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.369 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -126.1 130.45 51.11 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.125 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 28.1 ptm -157.38 166.61 32.59 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.136 -179.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' C ' HD13 ' A' ' 110' ' ' LEU . . . -135.12 154.19 51.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.423 ' C ' ' HG ' ' A' ' 134' ' ' SER . 99.7 m-85 -111.0 113.32 25.78 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 120.602 0.239 . . . . 0.0 111.527 -179.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 73.7 m -65.38 -41.02 94.18 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.564 178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 58.2 tptt -148.8 144.13 26.79 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.583 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.82 151.22 27.47 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.121 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.615 ' HB1' ' C ' ' A' ' 105' ' ' GLU . . . -54.21 134.61 44.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.046 -178.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -68.49 126.11 28.61 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 63.68 -78.92 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 O-C-N 123.519 0.512 . . . . 0.0 110.52 -178.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 39.7 mmt180 -136.64 -14.55 1.66 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.406 0.282 . . . . 0.0 111.724 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.615 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 39.8 mt-10 -141.37 167.17 22.82 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -176.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.2 p 91.63 37.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 124.295 1.038 . . . . 0.0 112.458 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 38.0 t70 -74.13 121.98 22.01 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.657 -0.702 . . . . 0.0 109.915 176.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 60.9 t -99.92 108.53 52.16 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 119.425 -0.321 . . . . 0.0 110.467 -178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.12 156.35 14.95 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.292 1.995 . . . . 0.0 112.165 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.475 HD23 ' CE1' ' A' ' 129' ' ' PHE . 6.2 mp -71.62 153.89 41.79 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.549 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.64 125.88 31.7 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.111 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 9.6 t -67.91 -22.51 65.07 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.13 -23.43 67.32 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -66.12 -20.09 66.04 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -154.3 163.3 40.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 53.5 tp10 -123.04 131.52 53.74 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.607 -178.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.18 145.75 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.088 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.4 p -138.86 166.13 25.25 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.763 178.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -58.76 -22.59 58.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.035 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.3 t -143.44 15.98 1.84 Allowed 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -160.66 161.53 32.4 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.7 0.286 . . . . 0.0 111.73 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.71 152.94 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.525 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 116' ' ' GLU . . . -153.58 163.16 40.46 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.416 177.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -122.16 153.29 38.95 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -113.56 151.83 44.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.751 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.36 141.11 89.44 Favored 'Trans proline' 0 N--CA 1.503 2.072 0 C-N-CA 122.065 1.843 . . . . 0.0 111.711 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 79.41 13.86 82.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.051 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -49.16 153.99 0.88 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-O 120.863 0.363 . . . . 0.0 111.417 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.475 ' CE1' HD23 ' A' ' 110' ' ' LEU . 60.7 m-85 -61.41 142.67 56.81 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.14 -178.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -155.0 -40.69 0.09 Allowed 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.07 -10.49 44.54 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -103.66 136.69 42.89 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.551 0.215 . . . . 0.0 110.922 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 26.8 mt -100.74 142.02 32.8 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.423 ' HG ' ' C ' ' A' ' 97' ' ' TYR . 46.6 t -160.29 170.2 21.59 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.161 0.505 . . . . 0.0 112.356 -177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -114.58 145.8 41.54 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.701 177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.577 ' HB2' HD13 ' A' ' 68' ' ' ILE . 4.4 mp -108.61 148.25 30.64 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.079 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 11.6 p -139.57 122.46 17.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.121 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.8 mp -123.07 126.62 73.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.977 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 57.7 t -117.39 119.29 61.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -126.65 143.78 51.12 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.56 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -96.96 137.65 35.73 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.233 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -59.8 137.45 58.05 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.6 t -106.46 -64.63 1.15 Allowed 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.991 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? 44.74 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.924 -179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.401 ' O ' HG22 ' A' ' 145' ' ' THR . 7.5 m 76.6 -5.83 2.11 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.856 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 55.1 31.58 16.56 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 120.793 0.33 . . . . 0.0 111.107 178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.742 179.444 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 t 61.24 150.21 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.481 0.312 . . . . 0.0 111.31 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -152.89 109.76 3.47 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.44 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.74 24.56 76.25 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.012 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 81.2 p -130.35 163.55 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.714 0.257 . . . . 0.0 110.96 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.2 m -128.58 159.85 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.778 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 66.0 m -123.81 145.19 49.24 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.667 -179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -79.84 152.37 74.59 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.225 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.15 158.93 51.11 Favored 'Trans proline' 0 N--CA 1.501 1.959 0 C-N-CA 122.359 2.04 . . . . 0.0 111.592 179.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' HG ' ' A' ' 55' ' ' LEU . 9.0 t -102.15 146.63 27.68 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.418 179.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.5 m -114.44 123.38 49.29 Favored 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.491 0.495 . . . . 0.0 110.93 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.7 t -131.94 132.03 61.56 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.896 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.27 151.0 21.53 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.596 179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -142.94 160.35 40.51 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.598 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -100.71 125.94 47.2 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.045 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 16' ' ' VAL . 8.8 p -95.06 107.68 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.0 mtp-105 -104.02 112.12 65.39 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.231 -176.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -75.27 173.93 13.67 Favored 'Trans proline' 0 N--CA 1.497 1.689 0 C-N-CA 122.413 2.075 . . . . 0.0 112.734 -178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 142.77 10.81 0.46 Allowed Glycine 0 CA--C 1.543 1.809 0 CA-C-N 115.399 -0.819 . . . . 0.0 112.281 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 71.37 25.28 75.7 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -116.79 124.94 73.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' A' ' 42' ' ' ALA . 26.8 m -70.65 122.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.028 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -116.63 137.1 52.43 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.402 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 68.2 m -114.75 126.78 55.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.535 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -130.17 118.93 22.19 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.337 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.6 p -107.08 168.44 9.21 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.099 -178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.482 ' CE1' HD11 ' A' ' 55' ' ' LEU . 63.4 t-80 -150.81 141.42 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.077 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.5 p-10 -151.03 166.52 30.49 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.241 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.463 HG23 ' H ' ' A' ' 32' ' ' GLY . 30.4 m -127.12 158.95 37.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.073 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -44.05 -70.67 0.53 Allowed Glycine 0 CA--C 1.548 2.117 0 CA-C-O 119.451 -0.639 . . . . 0.0 112.181 -175.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -56.5 -39.09 93.69 Favored 'Trans proline' 0 N--CA 1.506 2.207 0 C-N-CA 121.842 1.694 . . . . 0.0 111.17 178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.14 36.3 3.77 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.933 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.0 -36.14 76.55 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 117.575 0.687 . . . . 0.0 110.767 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -62.91 -38.15 89.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.074 178.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -95.46 136.03 36.35 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.265 -176.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.2 t -154.89 151.52 28.66 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.087 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.4 m -111.53 123.94 51.26 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.72 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 65.7 mtm -102.33 143.8 31.63 Favored 'General case' 0 CA--C 1.493 -1.243 0 CA-C-O 120.881 0.372 . . . . 0.0 110.556 177.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.442 ' CE2' HD11 ' A' ' 68' ' ' ILE . 80.6 m-85 -128.54 108.25 10.37 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.83 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 92.1 m -106.52 129.67 54.43 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.45 ' CE1' HG23 ' A' ' 16' ' ' VAL . 50.0 p90 -152.6 159.89 43.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.993 0.425 . . . . 0.0 112.059 -177.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' A' ' 22' ' ' VAL . . . -134.65 133.65 40.33 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.107 178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -137.84 159.18 42.7 Favored 'General case' 0 C--N 1.345 0.382 0 CA-C-O 121.076 0.465 . . . . 0.0 112.184 -177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -130.03 129.2 43.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.075 178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.05 -175.81 40.12 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -116.32 -2.66 19.69 Favored Glycine 0 CA--C 1.541 1.715 0 CA-C-O 119.826 -0.43 . . . . 0.0 113.058 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 62.3 m -131.31 132.17 44.33 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 117.32 0.56 . . . . 0.0 110.968 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.66 178.47 8.18 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.422 177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -149.46 154.04 38.21 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.821 0.343 . . . . 0.0 111.334 -178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -103.52 116.61 32.69 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.998 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.9 m95 -109.93 150.95 27.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.015 178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -99.25 140.7 33.03 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.22 0.325 . . . . 0.0 110.13 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 74.1 mtm -123.88 143.52 50.31 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.541 ' HG ' ' HZ3' ' A' ' 69' ' ' TRP . 99.2 p -137.5 140.06 40.92 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 123.504 0.502 . . . . 0.0 110.361 177.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 27' ' ' HIS . 0.7 OUTLIER -145.69 150.56 36.52 Favored 'General case' 0 CA--C 1.513 -0.471 0 O-C-N 123.389 0.431 . . . . 0.0 110.949 179.343 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -155.1 160.79 30.0 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.459 HG22 ' CD2' ' A' ' 64' ' ' PHE . 81.0 p -133.02 159.24 40.61 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.666 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 41.1 t -66.86 153.32 43.74 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.089 177.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -56.28 -31.74 63.92 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 123.238 0.336 . . . . 0.0 111.254 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -101.17 9.36 42.02 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.505 176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 58.6 31.83 21.51 Favored 'General case' 0 C--N 1.349 0.567 0 C-N-CA 122.665 0.386 . . . . 0.0 111.892 178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -76.88 -27.5 55.02 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.626 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -134.4 148.7 50.71 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.965 0.412 . . . . 0.0 111.639 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD2' HG22 ' A' ' 57' ' ' THR . 97.8 m-85 -125.46 139.58 53.51 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.256 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.408 HG22 HG22 ' A' ' 139' ' ' VAL . 74.9 p -135.37 143.58 46.15 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 90.2 m -136.73 132.3 34.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.131 176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.705 HG22 ' CE3' ' A' ' 69' ' ' TRP . 56.3 m -132.5 135.17 45.83 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 HD11 ' CE2' ' A' ' 39' ' ' PHE . 66.9 mt -129.62 127.85 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.635 178.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.705 ' CE3' HG22 ' A' ' 67' ' ' THR . 23.8 p90 -157.4 163.29 38.72 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.462 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -84.4 125.05 72.87 Favored Pre-proline 0 CA--C 1.56 1.359 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.89 -37.04 9.39 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 121.718 1.612 . . . . 0.0 112.411 -177.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -70.41 -38.73 74.68 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.302 178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 153.12 -72.76 0.27 Allowed Glycine 0 C--N 1.336 0.564 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.502 ' HB3' HD22 ' A' ' 133' ' ' LEU . 55.0 mtmt -141.55 158.02 44.37 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.441 ' O ' HD23 ' A' ' 133' ' ' LEU . 36.8 t -116.91 115.17 24.97 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.712 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -76.64 87.77 3.32 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.33 0.586 . . . . 0.0 111.899 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 60.5 mt -141.55 149.17 40.47 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.085 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.787 ' CD1' ' HB2' ' A' ' 131' ' ' ALA . 60.0 t80 -86.11 99.84 11.78 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -82.55 131.29 35.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.293 -177.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 84.4 m -74.07 -42.77 59.67 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.334 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -178.54 162.74 1.46 Allowed 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.762 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -125.77 144.65 50.54 Favored 'General case' 0 N--CA 1.478 0.959 0 O-C-N 123.12 0.263 . . . . 0.0 111.545 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -145.63 141.99 28.65 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.481 177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.64 139.97 28.37 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.628 178.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -153.48 171.65 18.36 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.44 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.4 164.25 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.6 mtt85 -131.06 146.32 52.33 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.32 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.18 -1.1 81.95 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 114.711 -1.131 . . . . 0.0 111.572 -178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.98 162.92 40.84 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-O 120.739 0.304 . . . . 0.0 110.924 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -105.16 153.46 21.51 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.512 177.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 91' ' ' ILE . 3.8 mp -89.07 116.76 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -176.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -82.31 -37.31 25.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.476 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -156.09 133.44 10.8 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.743 179.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.54 138.55 30.95 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.712 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -160.29 170.04 21.93 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.353 -178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.788 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -143.69 151.5 40.15 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.072 -179.121 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -116.32 110.92 19.37 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.5 m -66.61 -41.9 87.67 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.785 176.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 24.7 tptm -148.74 136.21 20.39 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.834 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -94.61 122.97 37.75 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.835 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.548 ' HB1' ' HA ' ' A' ' 105' ' ' GLU . . . 42.88 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.713 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -58.92 128.33 36.69 Favored 'General case' 0 C--N 1.34 0.191 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 65.03 -75.47 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.709 -178.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 53.4 mmm-85 -133.72 -15.94 2.34 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 122.331 0.252 . . . . 0.0 111.632 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.548 ' HA ' ' HB1' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -161.99 178.67 8.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.083 0.468 . . . . 0.0 111.921 -175.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.6 t 70.16 82.6 0.16 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.341 178.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -69.21 130.63 43.18 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.611 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.0 t -102.06 108.26 55.92 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.583 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -83.44 155.46 14.19 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 122.411 2.074 . . . . 0.0 112.336 178.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 38.5 mt -70.02 142.49 52.75 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.469 176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -67.47 133.3 49.26 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.403 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 84.9 m -60.97 -37.64 83.14 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.069 179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.22 -17.16 25.44 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.486 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 15.8 tm-20 -63.47 -35.36 80.19 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.525 0.202 . . . . 0.0 110.833 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -150.25 160.08 43.97 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.621 -178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -121.31 128.72 52.59 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.264 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.9 m -129.08 142.14 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.258 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.412 HG22 ' N ' ' A' ' 119' ' ' LYS . 17.7 m -141.82 157.59 44.83 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.516 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' N ' HG22 ' A' ' 118' ' ' THR . 10.6 ptpp? -57.52 -21.68 39.59 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.087 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.8 t -124.56 -19.13 5.48 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -146.58 148.35 32.04 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.05 0.452 . . . . 0.0 112.14 -178.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.9 t -131.77 132.95 61.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.42 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -153.89 148.67 26.48 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.04 177.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 51.7 p-80 -79.23 162.91 25.39 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.368 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -114.12 152.65 46.03 Favored Pre-proline 0 CA--C 1.542 0.654 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.141 178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -57.84 144.04 94.5 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 121.938 1.759 . . . . 0.0 110.927 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.63 14.32 76.11 Favored Glycine 0 CA--C 1.543 1.792 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 -179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -47.42 144.81 2.77 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 120.98 0.419 . . . . 0.0 111.272 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -79.65 147.2 32.1 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.362 -177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -139.74 157.15 46.23 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.802 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.787 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . . . 53.5 20.23 1.99 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.763 -177.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -105.33 126.47 52.14 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.605 ' H ' HD12 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -100.54 133.08 45.51 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -178.145 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 38.6 t -160.86 170.04 21.46 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.881 0.372 . . . . 0.0 111.935 -177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -115.23 151.26 34.79 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.041 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.788 HD23 ' HB2' ' A' ' 96' ' ' ALA . 65.0 mt -112.44 137.43 50.64 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.637 -176.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.3 p -135.84 117.67 20.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.378 176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.6 mp -125.92 129.15 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.331 -176.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.408 HG22 HG22 ' A' ' 65' ' ' THR . 58.9 t -116.73 119.58 62.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.515 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -123.02 138.3 54.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.98 0.419 . . . . 0.0 111.665 -178.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -109.52 135.92 49.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.454 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -61.1 112.24 2.03 Favored 'General case' 0 C--O 1.234 0.274 0 O-C-N 123.132 0.27 . . . . 0.0 110.766 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.2 t -64.23 -45.84 86.43 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.06 179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -159.18 159.56 34.47 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.062 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 72.9 p -116.85 12.04 14.64 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.208 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 tp10 -61.25 -49.01 78.83 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.146 0.498 . . . . 0.0 110.071 -179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 53.6 mt . . . . . 0 CA--C 1.54 0.562 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.091 176.171 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.414 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -111.35 119.28 38.34 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.613 0.244 . . . . 0.0 110.778 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mptt 49.34 -175.55 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.936 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 154.74 25.8 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.727 -0.949 . . . . 0.0 110.727 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 66.8 m -129.43 132.11 46.91 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.614 0.245 . . . . 0.0 110.438 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 35.0 m -104.31 40.94 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.791 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.6 m -117.26 146.32 43.37 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.275 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -145.43 159.48 48.22 Favored Pre-proline 0 CA--C 1.557 1.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.952 -178.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -68.26 158.8 55.97 Favored 'Trans proline' 0 N--CA 1.505 2.174 0 C-N-CA 122.036 1.824 . . . . 0.0 111.222 178.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.441 HG21 ' CE1' ' A' ' 27' ' ' HIS . 10.6 t -127.8 149.51 50.23 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.906 -176.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 86.1 m -114.49 119.62 37.47 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.592 177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.0 t -130.53 129.57 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.821 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.76 150.01 23.23 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.48 161.25 40.18 Favored 'General case' 0 C--N 1.346 0.445 0 O-C-N 123.093 0.246 . . . . 0.0 111.253 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -101.1 125.54 47.72 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.674 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 95.9 t -94.86 107.2 19.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.258 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.2 mtp-105 -105.25 120.7 48.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.726 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -84.3 174.32 8.12 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.237 1.958 . . . . 0.0 112.611 -176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.75 13.31 0.54 Allowed Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.564 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 70.55 27.11 73.05 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.4 t -113.3 129.13 69.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 68.0 t -73.69 120.47 22.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.192 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -116.44 139.48 50.39 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.942 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.8 m -113.08 125.79 54.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.844 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -130.19 126.35 37.19 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.094 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m -139.27 168.12 20.53 Favored 'General case' 0 C--O 1.235 0.322 0 O-C-N 123.298 0.373 . . . . 0.0 111.129 -177.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' HIS . . . . . 0.639 ' ND1' HD21 ' A' ' 55' ' ' LEU . 60.9 t-80 -147.98 144.04 27.7 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.209 -177.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -152.57 166.77 31.02 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.523 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.706 HG23 ' H ' ' A' ' 32' ' ' GLY . 27.4 m -126.54 157.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.562 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -59.51 -51.27 60.1 Favored Glycine 0 CA--C 1.545 1.945 0 CA-C-O 119.274 -0.736 . . . . 0.0 111.849 -176.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -60.76 -45.0 22.58 Favored 'Trans proline' 0 N--CA 1.504 2.143 0 CA-C-N 119.538 1.669 . . . . 0.0 110.391 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 29' ' ' VAL . . . -93.58 37.31 3.43 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 114.777 -1.102 . . . . 0.0 111.44 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -58.05 -35.64 71.63 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.559 0.18 . . . . 0.0 110.939 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -70.77 -20.27 62.63 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.527 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -105.65 132.79 51.37 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.674 -0.239 . . . . 0.0 110.537 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -153.08 152.71 31.63 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.8 m -116.16 119.43 35.78 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.693 177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 63.5 mtt -104.55 142.63 34.3 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 122.969 0.508 . . . . 0.0 111.071 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.432 ' CD2' HD12 ' A' ' 68' ' ' ILE . 93.9 m-85 -131.96 112.64 12.58 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.041 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 87.1 m -114.28 130.53 56.65 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.587 179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -156.74 159.66 38.53 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' A' ' 80' ' ' THR . . . -123.62 135.25 53.84 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.795 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 49.8 m -130.98 152.29 50.46 Favored 'General case' 0 C--N 1.348 0.538 0 CA-C-O 121.068 0.461 . . . . 0.0 111.919 -177.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -130.5 128.83 42.01 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.491 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 171.3 -178.75 43.5 Favored Glycine 0 C--O 1.238 0.4 0 N-CA-C 110.232 -1.147 . . . . 0.0 110.232 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -110.24 5.81 30.27 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.105 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.1 t -149.28 149.46 30.96 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 117.758 0.779 . . . . 0.0 112.855 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -76.6 160.93 28.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.604 178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -133.65 149.36 51.56 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.35 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -102.72 124.46 48.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.715 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -125.62 145.48 50.12 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.159 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -101.15 150.35 23.03 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.036 178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 71.8 mtm -128.79 145.47 51.18 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 41.9 t -140.77 124.99 17.46 Favored 'General case' 0 CA--C 1.512 -0.514 0 O-C-N 123.51 0.506 . . . . 0.0 110.269 178.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.639 HD21 ' ND1' ' A' ' 27' ' ' HIS . 3.3 pp -143.78 146.21 32.94 Favored 'General case' 0 CA--C 1.513 -0.476 0 O-C-N 123.369 0.418 . . . . 0.0 110.82 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.49 165.74 30.54 Favored Glycine 0 C--N 1.333 0.37 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.335 -178.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.617 HG22 ' CD2' ' A' ' 64' ' ' PHE . 65.7 p -129.45 156.81 43.5 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 76.3 p -71.08 162.21 29.81 Favored 'General case' 0 C--O 1.237 0.413 0 O-C-N 123.328 0.393 . . . . 0.0 110.122 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -60.06 -28.92 68.19 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -102.72 5.89 39.18 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.554 178.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 58.25 28.39 16.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.934 0.397 . . . . 0.0 111.188 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -81.05 -29.16 35.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.552 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -129.37 142.55 50.78 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.045 0.45 . . . . 0.0 111.575 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.816 ' HE1' ' HB2' ' A' ' 142' ' ' ALA . 74.6 m-85 -129.04 139.29 52.11 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.499 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -140.35 138.27 34.73 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 71.1 m -130.49 132.41 45.63 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.13 177.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.6 m -135.13 135.11 40.89 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.577 0.214 . . . . 0.0 111.577 -177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.432 HD12 ' CD2' ' A' ' 39' ' ' PHE . 67.5 mt -129.1 129.3 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.118 178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . . . . . . . . . 25.0 p90 -152.8 162.92 40.67 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.863 175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' CZ ' HD12 ' A' ' 133' ' ' LEU . 22.4 ptt-85 -83.84 155.19 64.85 Favored Pre-proline 0 CA--C 1.56 1.345 0 O-C-N 123.053 0.221 . . . . 0.0 111.303 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.93 -40.24 0.75 Allowed 'Trans proline' 0 N--CA 1.508 2.365 0 C-N-CA 122.679 2.253 . . . . 0.0 113.997 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -66.36 -37.81 86.15 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.287 -176.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' ARG . . . 99.28 -15.49 60.19 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -141.36 119.71 12.25 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-O 120.693 0.283 . . . . 0.0 111.091 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 63.3 m -119.19 143.48 47.22 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.928 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -115.19 87.09 2.58 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.314 0.578 . . . . 0.0 111.117 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.1 mt -141.84 150.28 41.41 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.311 176.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -96.86 92.75 6.29 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -77.95 137.71 38.47 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.904 -177.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 62.6 m -76.0 -41.91 49.7 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.408 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pp0? 179.74 169.25 1.17 Allowed 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.587 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.08 144.19 47.06 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -145.39 144.85 30.9 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.668 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.38 139.5 28.48 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.292 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -152.96 158.44 42.08 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.632 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.1 163.36 35.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 O-C-N 123.226 0.329 . . . . 0.0 111.6 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -135.67 154.85 51.16 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.169 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.95 1.72 90.36 Favored Glycine 0 CA--C 1.545 1.929 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.341 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 141' ' ' LYS . . . -150.36 172.84 14.77 Favored 'General case' 0 C--N 1.348 0.512 0 CA-C-N 116.955 0.377 . . . . 0.0 111.037 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -103.4 157.68 16.86 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.314 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 30.9 mm -88.7 119.65 36.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.892 -173.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -87.89 -43.89 11.47 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.812 175.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -175.24 143.19 0.66 Allowed 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.066 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.88 135.39 23.15 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.315 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 25.1 ptp -166.28 167.86 15.65 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.796 -179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 136' ' ' LEU . . . -118.63 142.48 47.6 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.733 178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -109.03 107.63 18.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.35 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 75.1 m -64.04 -40.61 96.7 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.564 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -126.67 133.4 50.96 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.841 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.94 124.19 33.44 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.162 175.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 107' ' ' ASP . . . -48.95 131.25 18.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.391 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -72.71 129.38 38.09 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.095 177.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 63.25 -82.35 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.642 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.5 mmm180 -135.86 -7.83 2.12 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.619 0.599 . . . . 0.0 112.619 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.613 ' C ' ' HB1' ' A' ' 101' ' ' ALA . 14.1 mp0 -138.96 174.53 10.41 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -171.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t 76.28 44.12 0.14 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.05 0.94 . . . . 0.0 112.754 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 101' ' ' ALA . 37.5 t70 -90.72 114.92 27.37 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.9 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 59.5 t -97.84 108.26 44.99 Favored Pre-proline 0 CA--C 1.562 1.431 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.276 -178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.7 144.62 6.53 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.526 2.151 . . . . 0.0 112.467 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.697 HD21 ' OE2' ' A' ' 132' ' ' GLU . 66.7 mt -78.25 148.2 34.03 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.475 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -68.23 149.44 49.5 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.438 -176.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 85.1 m -63.36 -38.16 90.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.361 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -54.41 -15.76 1.86 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.874 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.9 -39.55 94.86 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.664 0.269 . . . . 0.0 110.396 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -152.82 162.32 41.44 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.582 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -114.0 128.48 56.41 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.42 -177.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.4 t -127.84 129.32 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.604 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.484 ' OG1' ' HB3' ' A' ' 121' ' ' ALA . 73.3 p -133.64 164.81 26.35 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.789 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -22.49 44.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.13 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.5 t -145.24 19.17 1.57 Allowed 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.484 ' HB3' ' OG1' ' A' ' 118' ' ' THR . . . -156.74 152.64 27.24 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.871 0.367 . . . . 0.0 111.344 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 13.0 p -147.02 132.73 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.047 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -155.75 154.41 31.41 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.777 0.322 . . . . 0.0 111.702 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -79.36 157.06 27.72 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.933 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -115.17 152.35 46.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.803 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.22 144.22 95.9 Favored 'Trans proline' 0 N--CA 1.505 2.151 0 C-N-CA 122.049 1.833 . . . . 0.0 110.972 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 82.45 14.41 76.29 Favored Glycine 0 CA--C 1.544 1.89 0 C-N-CA 121.334 -0.46 . . . . 0.0 112.241 -179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -51.81 151.74 3.29 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.018 0.437 . . . . 0.0 111.188 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -84.33 145.19 28.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.237 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -135.02 -60.94 0.76 Allowed 'General case' 0 C--N 1.343 0.32 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.399 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.89 -36.13 78.43 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.254 -179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.697 ' OE2' HD21 ' A' ' 110' ' ' LEU . 37.8 tt0 -76.83 139.01 40.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.879 -179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.483 HD23 ' H ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER -109.36 155.3 21.38 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.723 178.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 t -167.64 178.34 5.4 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.3 156.92 23.5 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.483 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 96' ' ' ALA . 70.1 mt -113.27 143.43 44.42 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.413 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.8 p -143.53 124.73 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.42 177.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 138' ' ' ILE . 4.7 mp -128.25 128.29 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.928 -178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.7 t -119.83 124.11 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 178.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -130.91 149.87 52.34 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.205 -178.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.588 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 37.5 ttpt -104.88 140.4 38.19 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.708 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.816 ' HB2' ' HE1' ' A' ' 64' ' ' PHE . . . -59.77 138.39 57.79 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.784 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.8 t -126.08 130.83 51.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.498 179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -154.43 160.0 41.39 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.633 -178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 73.6 p -119.71 -21.88 7.09 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.249 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 58.69 160.2 0.03 OUTLIER 'General case' 0 C--N 1.346 0.416 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.2 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' C ' HD12 ' A' ' 147' ' ' LEU . 4.5 pp . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.013 -0.994 . . . . 0.0 111.031 -179.534 . . . . . . . . 1 1 . 1 stop_ save_